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1. Introduction 
Ways and means of regulating human fertility have expanded enormously during the 
second half of the 20th century. Contraceptives have been developed to prevent pregnancy 
(the most impressive being oral contraceptives), while assisted reproductive techniques 
have become available to improve the probability of pregnancy for subfertile couples. The 
ability to regulate fecundity and changes in society in the past few decennia have led to 
an increase in the age at which a woman gives birth to her first child. In the Netherlands, 
the average age in 1950 was 26.6 years; this decreased to 24.8 years in 1970 and was 
followed by an increase in 1990 to 27.6 years.1-2 This trend can also be seen in other 
western societies.3,4 A higher proportion of couples will seek professional help, because 
more problems with fecundity appear with increasing age4 and the age span for 
reproduction is smaller if a woman decides to have her first baby at an older age. A 
Danish study performed in 1989 revealed that about 12% of women aged 25-44 years had 
sought medical advice at some time because of fertility problems. More than half of these 
women conceived spontaneously afterwards.3 A Dutch study estimated that 10.4% of 
women will seek specialist medical help for infertility at some time during reproductive 
life (at age of 15-44 years) and that requests for advice from general practitioners will be 
1.8 times higher.5 A study performed in 1988 in the United States revealed that per year, 
about 2.3% of women of reproductive age received medical advice or treatment for 
infertility.6 The use of medical assistance depends on factors such as the prevalence of 
fertility problems, the availability of infertility treatment for a population at a specific 
time, the cost and financial resources. Despite the advances in infertility treatments, three 
to four per cent of all women remain involuntarily childless.7-8 
Greater knowledge about human fecundity is required to assist rational decision-
making on prevention strategies and treatment modalities for infertility. The aim of this 
thesis is to increase the level of insight into the variation in human fecundity under natural 
conditions and during treatment with in vitro fertilization. Fecundity is defined as the 
ability to conceive within one menstrual cycle when pregnancy is desired and no 
contraceptive methods are used. Fecundability is the probability of conceiving during one 
such menstrual cycle. 
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Natural fecundity; The menstrual cycle 
The central theme of the first part of this thesis is the fecundity of couples under natural 
conditions. We focus on women. Normal fecundability is estimated to be between 20% 
and 35% per cycle in women of 20-30 years of age.1 An overview of the regulation of the 
menstrual cycle, from the initiation of follicular growth until ovulation, is given below.9 
Primordial follicles are formed in the female fetus at a gestational age of 16-20 weeks. 
Each follicle contains an oocyte arrested in the diplotene stage of the first meiotic 
prophase. Follicular growth is a continuous process, occurring at all ages until the number 
of primordial follicles is exhausted. Follicular growth is initiated independently of 
hormonal influence. The number of developing follicles is proportional to the number of 
primordial follicles left. 
During the menstrual cycle, a rise in follicle stimulating hormone (FSH) stimulates a 
group of follicles to further growth. FSH induces granulosa cells to aromatize androgen 
to oestrogen. The presence of FSH and oestrogen increase the FSH receptor content of the 
follicle. The dominant follicle is selected during days 5-7 after the first day of the 
menstrual cycle, when peripheral levels of oestradiol begin to rise and, because of negative 
feedback to the pituitary, peripheral FSH decreases. The number of FSH receptors on the 
granulosa cells and the vascularization of the theca cells of the dominant follicle are larger 
than those of the other follicles. Increased vascularization promotes the delivery of 
gonadotrophins to the dominant follicle. With declining FSH levels, the midfollicular rise 
in oestradiol was thought to give positive feedback on luteinizing hormone (LH) 
secretion.9 However, a recent study has suggested that the increase in LH secretion is the 
consequence of a decline in the inhibitory effect of oestradiol when oestradiol levels 
decrease.10 LH stimulates thecal cells to produce androgens which are converted into 
oestrogens through FSH-induced aromatization in the granulosa cells. LH initiates 
luteinization and progesterone production in the granulosa cells. The rise in progesterone 
decreases the inhibitory effect of oestrogen.10 A series of enzymatic processes starts which 
eventually leads to follicle rupture. Ovulation occurs 34-36 hours after the onset of the LH 
surge. LH concentration must be maintained at a certain threshold level for 14-27 hours 
in order to achieve full oocyte maturation. The LH surge initiates the resumption of 
meiosis in the oocyte. In the normal cycle, the time from the LH midcycle surge to 
menses is consistently 14 days, although a luteal phase of between 11-17 days can also be 
considered normal. Wide variability in cycle length between women is due to the varying 
number of days required for follicular growth and maturation in the follicular phase. 
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Subfccundity under natural conditions 
In the developed countries, menarche occurs at around the age of 13 years""'5 and 
menopause at around the age of 51 years.16"21 Menopause occurs because the supply of 
primordial follicles is depleted.22 Follicular growth is then accelerated and fewer follicles 
per cycle grow.22·23 The menstrual interval shows great variation and higher median values 
for seven years after menarche and for eight years before menopause.24 In women with 
regular menstrual cycles who are younger than 20 years, or 40 years and older, decreased 
ovarian function might be expected because of diminished progesterone levels.25 The 
proportion of anovulatory cycles decreases from 60% in women aged 12-14 years, to 5% 
in women aged 26-30 years and increases after the age of 40. The proportion of cycles 
with a shortened luteal phase shows the same trend.26 It is more accurate to study changes 
in ovulatory function in relation to gynaecological age (i.e. years after menarche) than 
calender age. During the first 5 years after menarche, a high incidence of anovulatory 
cycles was observed.27'28 The proportion of anovulatory cycles increased after a 
gynaecological age of about 35 years,27 which is in agreement with the high incidence of 
anovulatory cycles in perimenopausal women who experienced a sudden break in 
menstrual cyclicity after many years of regular cycles.29 
Besides the phases directly after menarche and before menopause, there can be other 
situations during reproductive life in which a woman is in a suboptimal state for 
reproduction. Such phases may occur just after stopping the use of oral contraceptives, just 
after pregnancy, during and after lactation, in relation with an endocrine disease, in the 
case of extreme under- or overweight and with weight changes. 
After discontinuing the use of oral contraceptives, there may be an unintended effect 
in the form of prolonged interference with hormone production by the hypothalamus-
pituitary-ovarian axis during the first few menstrual cycles. Reported consequences are 
anovulatory cycles3031 and a prolonged time to pregnancy.32"34 The delay in conception was 
longer in the women who had used oral contraceptive pills that contained a higher dose 
of oestrogen.34 
In the women who did not breast-feed, ovulation returned 40-50 days postpartum, 
while in the women who did breast-feed, the mean time to the first ovulation was 30-40 
weeks.35 Reproductive problems are also common in situations involving endocrine 
diseases such as diabetes mellitus, thyroid dysfunction and chronically increased or 
decreased gonadotrophin levels.9 Generally, no ovulation occurs in these situations. In 
most of these disorders, reproductive capacity can largely be regained after adequate 
treatment.4 
Ovarian function is also impaired in the case of extreme under- or overweight. In 
12 Chapter 1 
obese women, the androgen:ocstrogen ratio alters, which affects the feedback system, 
increases LH release and results in disrupted follicular maturation and anovulatory cycles.36 
The amount of visceral fat seems to play an important role in this hyperandrogenic 
situation.37 The risk of ovulatory infertility was found to be the highest in obese women 
[Quetelet Index (QI) >27 kg/m2]; it was also slightly increased in moderately overweight 
women (QI 25-26.9 kg/m2) and in underweight women (QI <17 kg/m2).38 Lower luteal 
progesterone levels were even found in women of normal weight who had lost some 
weight by diet changes (on average 1.9 kg/month). According to the authors, this reflected 
a high proportion of anovulatory cycles.39 In another study, normal-weight women had lost 
an average of 2.1 kg after a 3-day fast during the midfollicular phase. However, no 
impaired follicle growth or anovulation were observed by ultrasound, although LH pulses 
and LH production were diminished.40 In normal-weight women who had lost an average 
of 4.9 kg during one menstrual cycle by following a vegetarian diet, ultrasound showed 
an increase in anovulatory cycles. In the diet cycle, LH pulses and concentrations were 
decreased during the follicular phase, while lower levels of oestradiol and progesterone 
were found during the luteal phase.41 
Poor reproductive outcome under natural conditions of subfecundiry 
It has been hypothesized that women with diminished fecundity as in conditions mentioned 
above, have an increased risk of reproductive failures, for example spontaneous abortion, 
stillbirth and congenital malformations.42 Several studies support this hypothesis. For 
instance, more early pregnancy losses,43 spontaneous abortions44"46 and premature infants45 
were found in subfecund women than in fecund women. An increased prevalence of 
infants with a very low birth weight was observed in women of 18 years or younger.47 
Even in a 'low risk group' of women (white, married, with age-appropriate education and 
receiving adequate prenatal care), young maternal age was related to an increase in low 
birth weight, prematurity and small for gestational age infants. The highest risk was found 
in women aged 13-15 years, while even in women aged 18-19 years, the risk was elevated 
in comparison with women aged 20-24 years.48 However, most studies that addressed 
young maternal age and poor reproductive outcome did not show a relationship after 
adjustment for the confounding effects of factors such as socio-economic status and 
smoking.49 In one study, there was no relationship with young reproductive age either after 
adjusting for confounding effects, but it was shown that there might be an increased risk 
of premature delivery in women who conceive within 2 years after menarche.50 In women 
who were inseminated with donor semen, there was not only a decreased probability of 
conception after the age of 31, but also an increased risk of spontaneous abortion.51 A 
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higher risk of spontaneous abortion after achieving a clinical pregnancy was observed with 
increasing age in subfertile women treated with ovulation induction and if necessary, 
inseminated with donor semen.52 The incidence of chromosomal aberrations and genetic 
mutations in oocytes or spermatozoa increased with the age of the woman53 or man.54 Both 
at a young (<20 years) and old (>40 years) maternal age, relatively high prevalences of 
congenital malformations and non-chromosomal congenital malformations in particular, 
were observed in liveborn children.55 Women who were using oral contraceptives during 
pregnancy had an increased risk of chromosomal abnormalities in spontaneously aborted 
fetuses.56,57 However, a meta-analysis did not show an increase in births with congenital 
malformations in women who had used oral contraceptives after their last menstrual 
period.38 
Season as a natural cause of subfecundity 
Another factor that may influence human fecundity is the season.42 Most mammals show 
obvious seasonal variation in reproduction. The mechanism is apparently triggered by 
photoperiodicity. Changes in the photoperiod are registered by the retina and pulses are 
transmitted via the suprachiasmatic nucleus to the pineal gland.59 The pineal gland 
produces melatonin which inhibits or stimulates the hypothalamus to activate ovulation, 
depending on the species. It is unclear whether the pineal gland and melatonin play a role 
in gonadal function in humans.9 Hypothetically, remnants of a seasonal influence can be 
expected to exist in humans. 
Several studies detected seasonal variation in human fecundity by means of measuring 
levels of hormones produced by pituitary and ovary,60"62 menstrual interval length,63 
ovulation,64,65 sperm characteristics,66,67 the probability of becoming pregnant,68,69 the time 
to pregnancy70 and birth rates.7'"73 Seasonal patterns in reproductive failure were also 
detected in the form of early pregnancy loss,74 spontaneous abortions75'78 and congenital 
malformations.79"8' 
Requirements for studies on natural conditions of subfecundity 
Some of the factors mentioned above which influence natural human fecundity have been 
studied extensively, for instance high maternal age, while others have not. New studies 
should focus on the latter factors. Such studies should follow a large population of women 
prospectively starting from the time they start trying to conceive. As the incidence of poor 
reproductive outcome is low, associations can only be discovered if data are obtained from 
a large number of women. If women are enroled in a study after they have started trying 
to conceive, subfecund women will be overrepresented and any early losses may go 
14 Chapter 1 
undetected. A more realistic study design is a case-control study. However, such a study 
will be seriously biased due to a lack of valid data on the determinants, especially if 
weight change is the determinant under study. The effects of a preceding pregnancy and 
lactation on poor reproductive outcome are difficult to study, because most women do not 
want to become pregnant immediately following a pregnancy. The residual effects of oral 
contraceptives have become less relevant, because the dose of hormones has diminished 
over the years. In contrast to the studies on the above-mentioned factors, studies on the 
impact of the season on fecundity might give additional information about the variation 
in human fecundity. The first part of this thesis presents several studies on seasonality in 
human fecundity and reproductive failure. 
In vitro fertilization: The technique 
For a better understanding of human fecundity and to assist decisions on infertility 
treatment, is it worthwhile to investigate the variation in fecundity in situations in which 
explicit attempts are made to increase fecundity, such as during treatment with assisted 
reproductive techniques. In vitro fertilization with embryo transfer (IVF) is one of the 
most widely applied techniques. Data from IVF treatments might help to identify factors 
that have predictive value for fecundity. 
In 1978, the first child was born after IVF.82 Initially, IVF was used in women with 
tubal disease. Later the treatment was also offered to couples with a male infertility factor, 
unexplained infertility, endometriosis and an immunological cause for infertility.83 
However, it has not yet been demonstrated whether IVF is effective in these cases.8"1 In 
an attempt to improve fertilization, various techniques were developed, for example 
subzonal insertion of sperm (SUZI).85 In 1992 anew technique, intracytoplasmalie sperm 
injection (ICSI) was introduced86 with promising results. If necessary, donated spermatozoa 
and oocytes can be used. Other assisted reproductive techniques such as gamete 
intrafallopian transfer (GIFT)87 and zygote intrafallopian transfer (ZIFT)88 have also been 
developed, but are not widely used any more. The choice of technique depends mainly on 
the infertility factors of the couple, the experience of the medical centre and the financial 
cost. 
The IVF treatment method differs between clinics. In general,9,83 IVF treatment starts 
with ovarian stimulation using hormones, to achieve the simultaneous growth of many 
follicles. The natural hormonal production is often suppressed by a gonadotrophin 
releasing hormone agonist (GnRII-a). The dosage and timing of administration vary. 
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Human menopausal gonadotropin (hMG) and/or FSH are often used to stimulate follicular 
growth. When several large follicles are present, human chorionic gonadotropin (hCG) is 
administered to mimic the LH surge. Oocyte retrieval is performed 34-38 hours 
afterwards, mostly transvaginal^ under ultrasound guidance. The oocytes are inseminated 
by a portion of the semen, usually several hours after follicle aspiration. Semen has to be 
prepared in some way before it can be used for insemination. In the case of severe male 
subfertility, ICSI can be used as a fertilization technique. Two or three days after 
insemination, embryos are selected for transfer. The luteal phase can be supplemented with 
progesterone or hCG. A pregnancy test (hCG test) can be performed after 11 days 
following oocyte retrieval. An ongoing pregnancy has been achieved if the pregnancy 
continues to exist for longer than 12 weeks after oocyte retrieval and fetal heart activity 
can be detected by ultrasound. 
Fecundity during treatment with in vitro fertilization 
It is important to be able to predict the success of treatment with in vitro fertilization, 
because the technique is expensive and the emotional and physical demands are high. The 
cost per IVF treatment cycle varies worldwide. In the Netherlands, one IVF treatment 
costs about 3,000 to 3,500 Dutch gilders (i.e. about $ 1,800 to 2,000). The average price 
per IVF cycle in the United Slates of America is about $7,000 to $11,ΟΟΟ.89 Additionally, 
the cost of prenatal care, neonatal care and method of delivery in IVF pregnancies are 
higher than in natural pregnancies, especially because of the higher probability of multiple 
gestations.89"91 The goal of patients who undergo IVF is to achieve a liveborn child. The 
likelihood of achieving this goal should be predicted at the start of treatment and at every 
successive stage during the treatment, e.g. after an unsuccessful cycle. Most studies on the 
success of IVF treatment considered only a few factors at the same time. For instance, 
poor IVF results have been found among older women,92"94 in couples with a male 
infertility factor9395 and in women with a high basal FSH level.96-97 However, various 
factors may have a simultaneous effect on the IVF result. For the clinician who is 
counselling a patient, the univariate relations will not always contribute to a clear 
prognosis. Therefore, to make a reliable prognosis, the predictive value of all factors 
should be considered in one prognostic model. 
In the second part of this thesis, data of IVF treatments since 1989 are used to detect 
factors that have predictive value regarding the success of fertility treatment. Data were 
obtained from three clinics in the Netherlands and one in the United States of America. 
In particular, the effect of the woman's age on IVF outcome is studied, a topic closely 
related to the study of variation in fecundity under natural conditions. 
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Contents of the thesis 
The central goal of this thesis is to study human fecundity. Two different sets of 
circumstances were evaluated: natural conditions and those during medical treatment for 
subfertility. Within this context, specific choices were made. Above, arguments are 
presented for addressing two core questions: 1) Is there seasonal variation in human 
fecundity? and 2) Which combinations of factors are of prognostic significance for the 
results of IVF treatment? 
The first question is addressed in Chapter 2. Several methodological aspects of the 
study on seasonality are described: the choice of a parameter to describe seasonal patterns 
in reproductive outcome, a method to test seasonality and the impact of bias caused by 
seasonality in pregnancy planning on poor reproductive outcome (Chapter 2.1). A study 
on whether there is seasonal variation in the occurrence of ovulatory cycles is described 
in Chapter 2.2. A side step is taken to evaluate seasonal fecundity in the case of IVF 
treatment (Chapter 2.3). Two studies are performed to study seasonal patterns in the time 
to pregnancy (Chapter 2.4). As seasonal influence on hormone production by the 
hypothalamus-pituitary-ovarian axis may lead to problems in the completion of the first 
meiotic division, which occurs just before ovulation, the literature on seasonality in the 
prevalence of Down syndrome at birth is reviewed (Chapter 2.5). 
The studies described in Chapter 3 focus on the second question regarding prognostic 
factors for the results of IVF treatment. In paragraph 3.1, the cumulative pregnancy rate 
after successive treatments with IVF is computed in several ways; this shows the 
importance of the underlying assumptions. Prognostic models for the probability of 
achieving an ongoing pregnancy after IVF treatment are developed and tested 
(Chapters 3.2 and 3.3). Ongoing pregnancy is used as an indicator for the occurrence of 
at least one live birth. There were two reasons for this: the better availability of 
information about ongoing pregnancy in comparison with information at birth and the 
close relationship between the two results. Another study is performed to gain more insight 
into the importance of the woman's age on the success of IVF by using information about 
IVF cycles with donated oocytes (Chapter 3.4). 
In the final chapter (Chapter 4), the information obtained in all the studies described 
in Chapters 2 and 3 is discussed in the light of the core element in this thesis, i.e. human 
fecundity. In addition, potential implications for clinical practice are discussed and 
recommendations for further research are given. The thesis ends with a summary. 
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2.1.1. Comparison of parameters to study seasonality 
in reproductive outcome 
A.M. Stolwijk, G.A. Zielhuis, P.H. Jongbloet 
This report compares validity, precision and convenience of three frequently used 
parameters used to describe seasonality in reproductive outcome: prevalence, index and 
ratio observed versus expected. Each has its advantages and disadvantages; the choice 
of the parameter depends on the aim of the study. It is advisable to report the number 
of cases and referents per month, because all three parameters can be derived from this 
information. 
European Journal of Epidemiology 1995;11:355-358 
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Seasonality in reproductive outcome is a subject of epidemiological research because of 
suspected seasonally-bound etiological factors. The answer to the question of whether 
there is seasonal variation in the occurrence of a specific outcome, for instance births 
with congenital malformations, is only relevant if this seasonal pattern deviates from 
the seasonal pattern in the reference group, e.g. all births. Moreover, one might be 
interested in whether the observed pattern is comparable with the results of other 
studies. 
No consensus exists regarding which parameter should be used to describe 
seasonality in reproductive outcome. Three frequently used parameters are: prevalence 
(for instance by Leek,' McDonald2 and Stark & Mantel3), index (by Huntington4 and 
Jongbloet & Vrieze5) and ratio observed versus expected (by Harlap,6 Leisti et al,7 
Kallén & Mäsbäck8). This paper compares the performance of these parameters to 
describe seasonality in births with congenital malformations (CM). 
The prevalence is expressed as the number of cases born with CM in month m relative 
to the number of births (B) in the same month, per 1,000 births. In order to conclude 
whether the prevalence in a specific month is low or high, this number should be 
compared to the mean CM prevalence (all cases with CM per 1,000 births). 
CM 
"1 1,000 
Bm 
The definition of index of CM is: the number of cases with CM born in each month, 
corrected for the number of days in that month (dm), compared to the average number 
of births with CM a month. This has to be compared with the index of births in the 
same month. 
СЦ, 365 25 
Σ CM
m 
m I 
A common method is to compare the observed number of births with CM in each 
month to the expected number of cases with CM born in the same month. The 
expected number of cases can be computed by multiplying the total number of births 
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with CM by the proportion of all births in the same month in relation to the number of 
births throughout the whole year. 
CM 
'2 в 
Σ СМ.. 
= 1 ' 2 
Σ Β
η , 
m 
Three criteria are used to compare the three parameters: validity, precision and 
convenience. 
Validity and precision of the three parameters were satisfactory because the monthly 
number of births with CM in comparison with the number of all births expressed as 
either a prevalence, or index, or ratio observed versus expected, could easily be 
transformed into each other: 
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Thus, validity and precision are the same for all three parameters. However, 
comparison of the results of other studies which used different parameters can only be 
done if information is available on each component, i.e. the number of births with CM 
and the total number of births in each month. 
A second comparison concerns the convenience of each parameter, i.e. the degree of 
insight that is provided into the results and the statistical properties of the parameter for 
studying seasonal differences. 
Whether the parameters provide insight into the results can be illustrated using the 
data derived from a study on seasonality in Down syndrome (DS) among live births in 
Quebec from 1958 to 1967.2 The number of DS and live births for each month are 
given in the Table 1, together with the computed prevalence, indexes, and ratio 
observed versus expected. 
Table 1. Monthly number of DS and live births* and computed parameters 
Month Number of Number of Prevalence Index Ratio observed 
DS births live births versus expected 
DS births Live births 
1.06 
0.94 
1.10 
1.10 
1.05 
0.91 
1.06 
1.01 
1.07 
0.89 
0.93 
0.89 
0.97 
0.98 
1.04 
1.08 
1.08 
1.07 
1.03 
0.98 
1.03 
0.95 
0.91 
0.88 
1.09 
0.96 
1.05 
1.02 
0.97 
0.85 
1.03 
1.02 
1.04 
0.94 
1.02 
1.02 
1.00 1.00 1.00 
* Data about monthly DS and live births from McDonald.2 
January 
February 
March 
April 
May 
June 
July 
August 
September 
October 
November 
December 
215 
174 
223 
217 
213 
179 
215 
205 
210 
182 
183 
182 
105,858 
97,678 
114,093 
114,625 
118,051 
113,511 
112,819 
107,752 
108,773 
103,792 
96,844 
96,448 
2.03 
1.78 
1.95 
1.89 
1.80 
1.58 
1.91 
1.90 
1.93 
1.75 
1.89 
1.89 
Total 2,398 1,290,244 1.86 
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For descriptive epidemiology, the monthly prevalence can be reported. For 
instance, 'In the month January, on average 2 DS cases were born among 1,000 live 
births in Quebec during the period 1958-1967'. The other two parameters do not have 
any meaning on their own and have to be reported together with the other monthly 
indexes and ratios. 
For revealing the kind and the amount of deviation, the parameters can be criticized 
on the meaning of the figures and on the information after visualization. Monthly DS 
prevalences do not reflect deviations; for that purpose they have to be compared to the 
mean monthly DS prevalence. Monthly indexes can be interpreted as the percentage of 
deviation from the mean. For instance, the DS index in January was 1.06 and can be 
interpreted as a surplus of 6 per cent DS births in comparison with the average number 
of DS births a month. In the same month, the index of live births was 0.97, which 
means a deficit of 3 per cent in comparison with the average number of live births a 
month. Whereas these two indexes have to be compared before it can be concluded 
whether the number of DS births is higher than expected based on the number of live 
births in that month, the ratio observed versus expected reflects this deviation at once. 
In January, the ratio was 1.09 which means that more DS cases were bom in January 
than were expected, based on the number of live births in that month. 
The three parameters over a period of a year are plotted in Figures 1-3. The DS 
prevalence in Figure 1 and the ratio observed versus expected in Figure 3 clearly show 
the month in which DS births were higher or lower than average. In November-
January, March-April and July-September the prevalences were higher than the mean 
prevalence and the ratios observed versus expected were higher than one. In contrast, 
for interpreting the indexes, the two indexes in each month must be compared. During 
the months mentioned above, the indexes of DS were higher than for live births. 
However, an advantage of the indexes (Figure 2) over the other two parameters is that 
seasonality in DS births can be examined together with seasonality in live births. 
The statistical properties of the three parameters differ widely. An advantage of 
prevalence is that confidence limits can be computed for revealing the precision of the 
point estimate. Two monthly prevalences will be different if their confidence intervals 
do not overlap. Furthermore, prevalences per month can be compared between studies 
and pooled prevalences can be computed if several studies have the same design.9 For 
indexes, no statistics are available for comparison within a study or between studies. 
The ratio observed versus expected per month cannot be compared directly between 
studies. However, a chi-square test can be performed to test for differences in 
frequency between months within a study.10 
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Figure 1. Prevalence 
Figure 2. Index 
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Figure 3. Ratio observed versus expected 
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All three parameters allow for adjustment for confounding by means of 
stratification. Moreover, if logistic regression analysis is used to adjust for confounding 
(for instance with the months included into the model as 11 dummy variables), the 
results could be expressed as adjusted prevalences. Such a method of multivariable 
analysis has advantages over stratification, in particular when dealing with small 
numbers per stratum and with many confounders. If some confounders are present in a 
study for seasonality in reproductive outcome, the presentation of stratified crude data 
is recommended, which is a requisite to allow for comparison between studies. 
In this article only three parameters to describe seasonality were compared. The 
choice of a statistical test for studying seasonality is not be discussed here; for an 
overview sec Reijneveld." Moreover, other aspects in studies on seasonality in 
reproductive outcome may be important for the validity of the study. For instance, 
seasonality in a specific type of CM at birth may be observed only because of a 
relation of this type of CM with preterm birth. Also other factors may confound a 
seasonal pattern, for instance if pregnancy planning varies between age groups and 
social economic levels. In addition, a seasonal pattern of CM in births may differ from 
a seasonal pattern of CM when all conceptions are used as reference, because of a 
seasonal pattern in pregnancy loss. A study of the occurrence of CM in conceptions 
must be performed prospectively, testing all women who are trying to become pregnant 
each month as the effect of early pregnancy loss will be underestimated otherwise. 
Detecting CM in aborted fetuses is practically impossible. But even if the presence of 
CM in abortuses can not be determined, the description of seasonality in total 
pregnancy loss can facilitate the interpretation of the pattern of CM at birth. 
In summary, the choice of a parameter to study seasonality in reproductive outcome 
depends on the aim of the study. Monthly prevalences give a direct reflection of reality 
and can be reported in isolation. Prevalences are suitable for comparing data within and 
between studies. The ratio observed versus expected can be used to draw conclusions 
within a study. An advantage of this ratio is that the figure shows the amount and kind 
of deviation in the number of cases in a month. The index is the best parameter only if 
the seasonality in cases as well as the seasonality in the reference group are of interest. 
As all three parameters can be derived from the monthly number of cases and 
referents, it is advisable to report this specific information, instead of the monthly 
parameter alone. 
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2.1.2. Studying seasonality by using a cosine function 
in regression analysis 
A.M. Stolwijk, H. Straatman, G.A. Zielhuis 
A statistical test which allows for adjustment of confounding can be required for the study 
of seasonal patterns. One way to realize this while retaining the information on the 
connection of time periods is by describing the seasonal pattern as a cosine function with 
variable amplitude and shift. After transformation of such a cosine function, it can be 
included into a regression model. The aim of this article is to supply for a detailed 
description of this method. An example of its application is given. 
(submitted) 
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Introduction 
Many studies have been published which concerned seasonal variation, for instance in 
births,' early pregnancy loss,2 and in congenital malformations.3 Whether a seasonal 
pattern exists can be studied in several ways. In this article we demonstrate a method that 
allows for adjustment of confounding. The first part is a general approach of studying 
seasonal patterns. In the second part we show a more detailed description of the method 
by means of mathematical functions. Subsequently, we give an application of this method 
using fictitious data. As an example we use the study of seasonality in fecundity, with 
ovulation as an indicator of fecundity. 
Studying seasonality, a general approach 
To study the seasonal variation in ovulation, data analysis can be performed in successive 
stages. The first step is to calculate and plot the prevalence of fecundity per month. Then 
confidence intervals surrounding the monthly prevalences can be calculated and added to 
the figure. From this information, it can be inferred whether there arc differences in 
fecundity per month and whether there are differences between the months. In the same 
way, clusters of months can be formed and compared to other clusters of months. If 
confounding is presumed to occur, the next step is to adjust for such confounding effects. 
One way to perform this is by means of stratification so that insight can be gained into 
whether prevalences differ between months or clusters of months after adjustment for 
confounding. In this phase, problems may occur if several confounding factors are present. 
Adjustment for their effects simultaneously by means of stratification will often lead to 
small numbers of observations per month and thus to imprecise estimations of the 
prevalences. Nonetheless, these preliminary phases of analysis will provide the first 
indications of whether there is a specific seasonal pattern in fecundity. Rough evidence of 
such a pattern warrants a statistical test. In addition, a method is necessary which allows 
for adjustment of the effects of several confounders simultaneously. 
We focus on the question of whether there is a seasonal pattern in fecundity during 
the course of a year, without paying attention to changes between years. To test for 
seasonality, a χ2 test can be used to detect any departure from a uniform distribution. A 
more specific test should take into account the connection between time periods such as 
months or weeks. The method of Edwards4 tests whether frequencies follow a sine 
function over 12 months. Also adaptations of the Edwards' test are suitable, for instance 
the one of Cave and Freedman5 to test a bimodal seasonal pattern over 12 months, of 
Walter and Elwood6 which can be used in the case of unequal populations at risk, of 
Roger7 for small sample sizes and of Jones et al* for an arbitrary shape of the seasonal 
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effect. The nonparametric Hewitt's test9 or its adaptation for other than 6-months periods 
by Rogerson10 can also be applied, but they are less powerful than parametric tests. A 
Kolmogorov-Smirnov type statistic of Freedman" has a better power than the χ 2 test and 
the Hewitt's test in samples of moderate size. None of these tests allows for adjustment 
of confounding effects, except the method of Jones et al* Moreover, some of them, 
including the latter, require special software. Therefore another test which allows for 
adjustment of confounding and that can be performed by widely available statistical 
computer programs is warranted. 
In epidemiological practice, multivariate analysis techniques are commonly used to 
adjust for confounding. Linear regression analysis is often performed if the dependent 
variable has a normal distribution. In studies on seasonality in fecundity, the dependent 
variable is likely to be dichotomous, for example an ovulation is either present or it is not. 
In such a case, logistic regression analysis can be used. 
To test whether fecundity is seasonally distributed, a cosine function with variable 
amplitude and shift can be introduced into the regression model. Depending on the 
hypothesis being tested, a cosine function with a period of one year, half a year or shorter 
can be included into the model. The maximum likelihood method estimates the regression 
coefficients for the best fitting regression line. The amplitude and the amount of shift of 
the cosine function can be calculated from the regression coefficients. Per time period, the 
probability of fecundity and the odds ratios can be calculated using the logistic regression 
model. 
Detailed description of the method 
A linear regression model can be developed to analyze seasonality in fecundity. Generally 
speaking, such a model will have the following form: 
y = β
η
 + β · season + β.. • С, + .... + β,. • С. 
where ß0 is the intercept and С indicates a confounder; у is a particular parameter for 
fecundity and is normally distributed or can be transformed into such a distribution. An 
example of such a variable is the level of follicle stimulating hormone. In many studies 
on fecundity, the outcome parameter is defined as the probability of fecundity. This 
probability can be modelled in a logistic regression model such as: 
ln( P ) = β,+ β • season + β,. • С, + .... + β,. - С., 
where Ρ is the probability of fecundity, for instance the probability of an ovulatory cycle. 
To define the variable 'season' in these models, it is hypothesized that the seasonal pattern 
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under study to follows a cosine fonction with variable amplitude and horizontal shift. In 
this cosine function, two periods must be defined: (i) the time period which defines the 
measure of fecundity, e.g. 'month' in 'the probability of an ovulatory cycle per month' 
and (ii) the period described by one cosine function. As an example we take 'month' as 
the time period under study, and 'one year' as the period of the cosine function. The 
cosine function can be described as: 
ƒ(*) = a-cos(jc-6) (') 
where: 
π 2π-(/,-1)
 n 
x = — + (in radiais) (¿) 
'„ '. 
t„ = number of time periods described by one cosine function over [0, 2π) (e.g. t„ = 
12 months in Figure 1); 
t, = ith time period (e.g. in Figure 1, for January: i, = 1, for February: t, = 2, etc.); 
α = amplitude, >0; 
θ = horizontal shift of the cosine function (in radiais). 
Thus, the logistic regression model will be as follows: 
l n ( T ^ ) =ßo + a'C0S^-Q) +A', -C> + ••·• +A-/C* 
As θ is unknown, transformation of this cosine function is required before the regression 
analysis can be performed. A rule of goniometry is used for the transformation of formula 
(1) into the next function which can be used in a regression model: 
fix) -jS.-sinW +4·α>8(χ) (3) 
This changes the logistic regression model into: 
Ι η ί - ^ ) =β0 *firsm(x) +jS2-cos(x) +A-/C, + + Л / С * 
With χ as given in formula (2), this leads to: 
l n ( — ) = 
\-P 
, 2π·(/-1)
 π
 2π·(/-1) fi0+ß,-sin[l * y—L] + A-cos [ l + ÍL-L]
 + Д . . С , + . . . . +ß(K-cN 
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Then the probability of fecundity in each time period can be calculated by: 
π 2 π · ( ί - 1 )
 π
 2 π · ( ί - 1 ) A
 + j j,.sin[i + ÍL-1] +ß2-cos[l + iL·-!] +jS(].C, + . Ä„-^v 
Α
 + 4-s in[£ + — 1 L - 1 ] +j»2-cos[^ + — y — ] < Α,-c, + . . . . + A v - r v 
1 + e 
1 
0.5 
0 
-0.5 
Amplitude 
\ / 
π 
/ 2Π 
J F M A M J J A S O N D 
Month 
Figure 1. Twelve months described by one cosine function with amplitude = 1 and shift = 0 radiais 
over [0, 2π) 
Illustration of the transformation of formula (1) into formula (3) and presentation of the 
formulas to calculate the amplitude and the shift of the cosine function 
The season described as formula (1) is the same as formula (3) for a given ß, and ß2, 
which can be illustrated as follows. 
Formula (3) can be rewritten: 
A 
β
χ
 • sin (χ) + β2· cos(x) = yds,2 + β22 • [ 1 · sin(x) + 
νΆ
2 +
л
2
 Λ
2 +
Λ 
cos (χ) ] 
provided that ß, and ß2 are not both zero. 
Define: 
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(6) 
2 
2 
A 
γ. = , (5) 
/A2 + Λ2 
A 
γ = : 
/А2 + Α 
Then formula (3) can be rewritten as: 
α · [γ, · sin(x) + γ 2 · cos(x)] 
As -1 < γ, < 1 and -1 < γ2 < 1 and γ,
2
 + γ2
2
 = 1, this provides a unique θ ε [0, 2π) (see 
Figure 2), this can be written as: 
α · [sin (θ)· sin (χ) + cos (θ)· cos (χ)] 
By using the following rule of goniometry: 
sin(0)· sin(x) + cos(9)· cos(x) = cos(x-0) for all χ 
we have: 
jS, - sin(x) + β2· cos(x) = α · cos(x-0) 
The value of θ can be derived from γ, and γ2 as follows: 
The equation sin(G) = γ, has, in general, two solutions in [0, 2π): 
If γ, > 0, the solutions are: 
Θ, = arcsin(Y,) and Θ* = π-Gj 
If γ, < 0, the solutions are: 
Θ, = 2π + arcsin(y,) and Θ* = π-arcsin(y,) 
The equation cos(9) = γ2 has, in general, two solutions in [0, 2π): 
θ2 = arceos (γ2) and θ 2 = 2π-θ 2 
The value of θ is the one element in the intersection of {θ,, Θ,*} and {θ2, θ2*}, i.e. 
θ = {θ„ θ,*} η {θ2, θ2*}. 
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% 
Χ 
Figure 2. Unity circle, sin(0) = γ„ cos(9) = γ2 
Application to fictitious data 
To study seasonality in the occurrence of ovulation, data are gathered per month. The 
hypothesis to be tested is whether there is a seasonal pattern with one maximum level and 
one minimum level per year. Thus the time period is the 'month' and the period of the 
cosine function is 'one year'. Assume that the following seasonal pattern in the occurrence 
of ovulatory cycles was found by logistic regression analysis and that one confounder, age, 
is present: 
l n ( - ^ - ) = 1.15 + 1.02· sin(x) + 0.34· cos(x) - 0.03· age 
Given the time period 'month' and a cosine function of 1 year, χ [formula (2)] becomes: 
π π · ( ί , - 1 ) 
χ = — + 
12 6 
Incorporation into the formula above results in: 
l n ( — ) = 
1-7» 
1.15 + 1.02· sin[. 
12 
! ] + 0.34· cos í— + 
6 12 6 
] - 0.03 · age 
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Thus ß, = 1.02 and ß2 = 0.34. To describe the seasonal pattern by the cosine function 
given in formula (1), the amplitude and shift have to be calculated. The amplitude is equal 
to [using formula (4)]: 
α = /l.022 + 0.342 = 1.08 
The shift can be calculated using formulas (5) and (6): 
V, = L2? = 0.95 
i/l.022 + 0.342 
and 
0.34 _ „ 
γ, = — = 0.32 
\/l.022 + 0.342 
As γ, > 0, θ, = arcsin(0.95) = 1.25 radiais and θ,* - π - θ, = 1.89 radiais. 02 = 
arccos(0.32) = 1.25 radiais and θ2* = 2π - θ2 = 5.03 radiais. The one element of the 
intersection is the shift, Θ, which is 1.25 radiais. 
Thus the seasonal pattern can be described by: 
1.08· cos(x-1.25) 
The probability of ovulation can be calculated for every month: 
π π- (ί -1)
 π
 π· (ι -1) 
1.15 + 1.02· sin[JL + 1 + 0.34 • cos[_l + 1 - 0.03 · age 1
 12 6 J l 12 6 J * 
p = ? 
π
 π
' (',-!) π π- (/ -1) 
1.15 + 1.02· s i n [ _ + _ .] * 0.34-cos[_l + _! 'l 0.03 · age 
1 + e l 12 6 12 6 
The results are shown in Figure 3. For each month, the probability of ovulation is 
calculated by assuming that the age of the women is 30 years. The probability of ovulation 
in March (i, = 3) is 79% and in September (i, = 9) 31%. If desired, the odds and adjusted 
odds ratios in each month can be calculated. The odds in each month is defined by 
[P/(l-P)], i.e. for March 3.76 and for September 0.44 in 30 year old women. The adjusted 
odds ratio in each month, independent of the effect of age, is calculated using the ratio of 
the odds in one month versus the odds in one reference month. For instance, the odds ratio 
for March is 8.55 if September is taken as the reference month. The amount of variation 
in the occurrence of ovulation explained by the season is expressed in the likelihood ratio 
test result [-21n(L,/L2)], which is the likelihood value from the model without the cosine 
function minus the likelihood value from the model with the cosine function. This value 
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can be compared with to a χ 2 distribution with 2 degrees of freedom to obtain a ρ value. 
A small ρ value indicates that the season makes a statistically significant contribution to 
the variation in fecundity. Whether the season has a biologically significant influence must 
be inferred from the prevalences. 
Odds, OR 
100 
Figure 3. Probability of ovulation (P), odds and odds ratio (OR, with September as reference month) 
per month 
Final remarks 
One cosine function with variable amplitude and shift is a way of describing a seasonal 
pattern. However, a seasonal pattern might deviate greatly from such a cosine function. 
Then an analysis that uses one cosine function to test for seasonality may erroneously 
leads to the conclusion that there is no seasonal pattern. To determine whether another 
seasonal pattern is apparent, a mixture of cosine functions with different periods can be 
included into the model. 
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2.1.3. Seasonality bias in poor reproductive outcome 
A.M. Stolwijk, H. Straatman, G.A. Zielhuis 
Epidemiology 1996;7:561-562 (letter) 
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Recently Basso et α/1 warned about bias in studies of seasonality in poor reproductive 
outcome, stemming from a seasonal variation in pregnancy planning. Such variation in 
pregnancy planning was found in a survey in five European countries during the 1970s 
and 1980s. For the same reason, bias can be expected in studies of seasonally-bound 
exposure and poor reproductive outcome. Examples of these forms of exposure are the use 
of pesticides and herbicides, the occurrence of influenza, exposure to sunlight, and the 
consumption of vitamin C. Bias will occur if (i) the exposure has a seasonal distribution, 
and (ii) the proportion of conceptions that end as a poor reproductive outcome varies 
throughout the season because of seasonal variation in pregnancy planning (as illustrated 
by Basso et at). The result can be a spurious relation between exposure and reproductive 
outcome, or, in the case of a real effect of exposure, over- or underestimation of the 
strength of the relation. 
We studied the impact of this kind of bias in the association between exposure and 
poor reproductive outcome by means of a simulation study. Using the data presented by 
Basso et al, we defined three subpopulations, which differed in probability of conception 
and probability of spontaneous abortion (Table 1). We defined the distribution of the 
proportion of women who started per month as a cosine function with a period of 1 year 
and a shift of 7.5 months. This definition resulted in a seasonal pattern in pregnancy 
planning, with a maximum probability of 16.6% for starting in August to try to conceive 
and a minimum of 2.7% for starting in February. For simplicity, we used the moment of 
conception as the etiologic moment for spontaneous abortion. To maximize the 
overestimation, we defined the seasonal pattern in the probability of exposure as a cosine 
function with a period of 1 year and a shift of 3 months. We set the proportion of women 
exposed at 10%. These assumptions led to variation in the probability of exposure, with 
a maximum of 22.6% for conceptions in March and April and a minimum of 4.1% for 
conceptions in September and October. Note that the probability of exposure did not vary 
among the three subpopulations and thus was not related to the degree of fecundity, nor 
to the probability of spontaneous abortion. The simulation was based on 100,000 women 
per year who planned to become pregnant and continued for a period of 20 years. As the 
model was not stable during the first years of simulation, we analyzed only the results of 
the last 10 years. 
The results are shown in Table 1. Model 1 used the data presented by Basso et al and 
resulted in a relative risk of spontaneous abortion for exposed vs. unexposed women of 
1.03 [95% confidence interval (CI) = 1.01-1.05]. We found the largest bias when we 
defined a large fecund population (Subpopulations 1 and 2 combined) with extreme 
variation in the probabilities of spontaneous abortion (Model 3). This model resulted in 
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a relative risk of 1.10 (95% CI = 1.08-1.12). In all of the simulations, we found the 
highest probability of spontaneous abortions after conceptions in March or April and the 
lowest after conceptions in September. 
We conclude that bias in the relation between a seasonally-bound exposure and poor 
reproductive outcome does occur because of seasonal variation in pregnancy planning, but, 
for practical purposes, this bias will be negligible. 
Table 1. Simulations of seasonality in spontaneous abortion (SAB) risk due to exposure to X in a 
population with variation in distributions of fecundability and abortion risk (conditional on 
the null hypothesis of no real effect of X on abortion risk) 
Model Subpopulation 
1: Fecund, 2: 3: Subfecund, 
low risk SAB Intermediate high risk SAB 
p * p + P P Ρ Ρ 
' С
 Г 5 А В ' Г С r SAB Г С r SAB 
1. Basso et al1 36Л 6~3 2\Л 8 І 92 R 5 
2. More variation 36.7 3.1 21.7 8.8 9.2 29.1 
in PSAB 
3. Large fecund 36.7 3.1 36.7 3.1 9.2 29.1 
population 
* Р
г
 = probability of conception per month (in percentages). 
t PSAB = probability of spontaneous abortions per month (in percentages). 
% RR = relative spontaneous abortion risk for exposure to X, relative to non-exposed. 
Reference 
1. Basso O, Olsen J, Bisanti L, Juul S, Boldsen J, and the European Study Group on Infertility and 
Subfecundity. Are seasonal preferences in pregnancy planning a source of bias in studies of seasonal 
variation in reproductive outcomes? Epidemiology 1995;6:520-524. 
RRJ (95% CI) Range 
of SAB/ 
month (%) 
1.03(1.01-1.05) 9.5-10.8 
1.06(1.04-1.08) 12.5-16.5 
1.10(1.08-1.12) 10.2-15.7 
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2.2. Is there seasonality in human ovulation? 
A.M. Stolwijk, F.J.H. Aarts, C.J.C.M. Hamilton, P.H. Jongbloet, G.A. Zielhuis 
To study seasonality in human ovulation in a direct way, we measured the occurrence 
of ovulation in infertile patients with spontaneous menstrual cycles (<6 weeks) who 
visited the fertility clinic at the University Hospital Nijmegen in the Netherlands for the 
first time in 1991 or 1992 (N = 407). Ovulation was detected using serial transvaginal 
ultrasound and midluteal progesterone measurement and was performed during one 
screening cycle. The frequency of ovulatory cycles per month varied from 73% to 93% 
(not statistically significant). No seasonal pattern in ovulation was found in subfecund 
Dutch women with spontaneous menstrual cycles. This finding was not confounded by 
the effects of age of the women, body mass index, or disorders that could influence 
ovulation. 
Human Biology 1996;68:563-571 
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Introduction 
Seasonality of births is found throughout the world.'"3 Such a birth pattern can be 
influenced by social and cultural factors, but biological factors also may be involved.2'' 
For instance, decreased ovarian function was measured in women younger than 25 
years and in women older than 35 years and in women with decreased energy intake or 
increased energy expenditure.4 In several populations the changes in energy balance 
show seasonal variation.5"7 Seasonal reproduction is common in mammals. For 
example, in rhesus monkeys seasonal variation in ovulation has been found.8 
A mechanism that may cause seasonality in ovulation, other than influencing 
energy balance, is photoperiodicity. The information from the retina about light and 
darkness is transported by way of the suprachiasmatic nucleus in the hypothalamus to 
the pineal gland. The pineal gland produces melatonin from serotonin during darkness.9 
In humans, however, the role of the pineal gland and melatonin is still unclear.10 
It is unknown whether birth seasonality in humans is caused by seasonal variation 
in ovulation. Indications of seasonal patterns of ovulation were found by Timonen et 
alu and Rameshkumar et al}2 In Finland Timonen et al found less cystic glandular 
hyperplasia during the light season than during the dark season (30.1% vs. 34.6%) in 
9750 endometrial biopsies. This finding indicated more ovulatory cycles during the 
light season (i.e., the months surrounding June). In contrast, an increase in anovulatory 
cycles was observed from May to July in the endometrial biopsies of 1036 women 
living in India.12 In that study a negative correlation was found between the percentage 
of ovulatory cycles and the environmental temperature, whereas in Finland Timonen et 
alu found no relation between these two factors. Possibly, ovulation was suppressed 
because of low energy intake in India during spring and summer. Because these results 
are contradictory and based on indirect measurement of ovulation, we studied 
seasonality in human ovulation directly in a population with rather constant energy 
balance and moderate environmental temperature throughout the year. The convenient 
method of serial measurements of salivary progesterone cannot reliably discriminate 
between ovulatory and anovulatory cycles;4 therefore we used the laborious method of 
serial transvaginal ultrasound and midluteal serum progesterone measurement. 
Materials and Methods 
In 1991 and 1992, 1021 couples visited the fertility clinic of the University Hospital 
Nijmegen, the Netherlands, for the first time. At the time of their first visit a detailed 
reproductive history was taken. The standard infertility workup consisted of a semen 
analysis, ultrasonographic ovulation detection during one cycle, assessment of cervical 
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mucus quality, and a timed postcoital test. The luteal phase was assessed by midluteal 
progesterone level seven days after follicular rupture and length of the luteal phase. 
The tubal status was determined by hysterosalpingography and/or laparoscopy. 
Hormonal screening was performed based on the menstrual history or if the history or 
clinical exam suggested an endocrine disturbance. Ultrasonographic ovulation detection 
was performed only in women with menstrual cycles shorter than 6 weeks (N = 422). 
Women with amenorrhea or oligomenorrhea (i.e., a menstrual cycle of 6 weeks or 
longer) were not screened because they were expected to have anovulatory cycles. In 
addition, women were not screened if they had been referred to the fertility clinic for 
specific treatments, such as in vitro fertilization or microsurgery. In this study 
retrospective data were used for the 422 women with spontaneous menstrual cycles less 
than 6 weeks. 
The first transvaginal ultrasound scan was performed on cycle day 10 or, if the 
cycles were much shorter or longer than 28 days, 18 days before the expected onset of 
the next menstrual period. Scans were repeated on alternate days or daily, according to 
the follicular size. An ovulatory cycle was defined according to the ultrasonographic 
criteria of follicular rupture, that is, the observation of considerable loss of volume in a 
preexisting follicle, as described by Wetzels and Hoogland,13 in combination with a 
midluteal progesterone level above 20 nmol/L. Luteinized unruptured follicle syndrome 
was diagnosed if the dominant follicle did not rupture but instead showed rapid growth 
after reaching a diameter of about 22 mm and remained a cystic structure throughout 
the luteal phase.14 
Three groups of women at a higher risk for anovulatory cycles were distinguished 
on the basis of the following criteria: (i) age 35 years or older, (ii) body mass index 
(BMI) less than 20 kg/m2 or more than 27 kg/m2, and (iii) a disorder that could 
influence ovulation. BMI is defined as weight (kg)/height2 (m2). The cutoff point of 27 
kg/m2 was used because this is the criterion for obesity.15 We use the general term 
'disorders' to mean disorders that could influence ovulation, specifically, endocrine 
disorders (e.g., polycystic ovary syndrome, hyperprolactinemia), endometriosis, or 
cervical mucus disturbance. For the analyses concerning such disorders couples with 
unexplained infertility were excluded. Furthermore, a group of women at higher overall 
risk was formed from the women who met one or more of the three criteria. 
To study seasonality, we used the month of the first day of the last menstrual 
period preceding the screening. Percentages of women with ovulatory cycles were 
computed for each month. Using logistic regression analysis, we studied whether these 
percentages differed between months and whether the seasonal variation followed a 
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pattern that could be described by a sine function with a unimodal or bimodal pattern. 
Therefore the months were entered into a logistic model as a sine function with a 
period of 0.5 year or 1 year and with variable amplitude and horizontal shift. 
Likelihood ratio test results gave information about the effects of including the season 
in the model on the explanation of the variation in ovulatory cycles. Furthermore, we 
studied whether the seasonal effect was more obvious in any of the groups of women 
at higher risk because of an interactive effect. Next, we performed logistic regression 
analysis for studying whether confounding by other risk factors influenced the relation 
between season and ovulation. Finally, logistic regression analysis was used to test 
whether the low percentage of women with ovulatory cycles found in a cluster of 
months differed from that in the rest of the year and if this difference remained after 
adjusting for confounding by other risk factors. We computed odds ratios with 95% 
confidence intervals for comparing the proportions of ovulatory cycles in the high- and 
low-risk groups. 
To determine whether we could find a seasonal pattern with the available data, we 
calculated the power of the study. Because no standard formula for power calculation 
for seasonal variation is available, we used simulations for both a unimodal seasonal 
pattern (with the peak in June because of a possible influence of the photoperiod) and a 
bimodal seasonal pattern (with the peaks in June and December because of possible 
negative feedback mechanisms during the dark period). 
Results 
Four hundred twenty-two women were screened for ovulation. Most of the cycles were 
ovulatory (n = 354, 84%), but 53 (13%) were anovulatory (including 7 cycles with 
luteinized unruptured follicles). In 15 women the outcome of the screening was 
unknown because the screening cycle was incomplete or the ultrasonographic picture 
was ambiguous. These women were excluded from further analyses. 
Characteristics of the remaining 407 women are given in Table 1. The youngest 
woman was 19 years old and the oldest was 45 years old; 15% of the women (n = 62) 
was 35 years or older. The BMI ranged from 16 kg/m2 to 45 kg/m2. Seventeen percent 
of the women (n = 60) had a BMI below 20 kg/m2 and 10% (n = 35) a BMI above 27 
kg/m2. No data about height or weight were available for 55 women. Forty-three 
percent of the women (n = 132) had a disorder that could influence ovulation. In 98 
couples the cause of infertility was unknown. 
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Table 1. Characteristics of the 407 women with 
Age (years) 
BMI (kg/m2) 
Weight (kg) 
Length (m) 
Primary infertility 
Age <35 years 
Age >35 years 
BMI <20 kg/m2 
BMI >27 kg/in2 
Disordert 
Overall riskf 
Min. 
19 
16 
42 
1.48 
η 
272 
345 
62 
60 
35 
132 
227 
Max. 
45 
45 
126 
1.89 
ovulatory or anovulatory cycles 
Mean 
30.5 
22.8 
64.1 
1.68 
Unknown 
0 
0 
0 
55 
55 
98 
93 
SD 
4.3 
3.9 
11.7 
0.07 
Median 
31 
22 
62 
1.68 
%* 
67 
84 
15 
17 
10 
43 
72 
Percentage of the women with known values. 
Women with an endocrine disorder, endometriosis, or a cervical mucus disturbance (98 women 
with unexplained infertility were excluded). 
Defined as high if a woman met one or more of the following criteria: (i) 35 years of age or 
older, (ii) BMI less than 20 or greater than 27 kg/m2, (iii) disorder. 
In Table 2 the percentages of women with ovulatory cycles per month are given for 
the total population and for the groups of women at higher and lower risk; odds ratios 
are included. Although not statistically significant, the women aged 35 years or older 
had more ovulatory cycles than the women younger than 35 years. When 5-year age 
groups were distinguished, the group of 25-29-year-olds showed the fewest ovulatory 
cycles (82%) (Table 3). An ovulatory cycle was found in 78% of women with a BMI 
below 20 kg/m2, in 90% of women with a BMI of 20-27 kg/m2 and in 83% of women 
with a BMI above 27 kg/m2 (Table 3). The women with a low or high BMI had fewer 
ovulatory cycles than those with an optimal BMI. Women with a disorder that could 
influence ovulation showed fewer ovulatory cycles than those without a disorder (Table 
2). The group of women with one or more risk factors showed fewer ovulatory cycles 
than those with no risk factor (Table 2). 
The percentages of ovulatory cycles throughout the year are shown in Figure 1. 
There were troughs in December-February, April, and September. The difference in the 
percentages of ovulatory cycles between months was not statistically significant. The 
season did not contribute to the explanation of the variation in ovulation: The pattern 
did not fit a model with the months included as 11 dummy variables or as a sine 
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% Ovulatory cycles 
F M A M J J A S O N D 
Month of last menstrual period 
Figure 1. Percentage of women with ovulatory cycles per month (N = 407) 
Table 3. Women with ovulatory cycles differentiated by age and BM1 
% 
Age (years) 
19-24 
25-29 
30-34 
35-39 
40-45 
Body mass index (kg/m2) 
16-19 
20-27 
28-45 
26 
106 
164 
49 
9 
47 
231 
29 
90 
82 
88 
94 
90 
78 
90 
83 
function with a period of 0.5 year or 1 year (p value of the likelihood ratio tests was 
always greater than or equal to 0.59). No interactive effects of the risk factors and 
season were found (Table 2). Moreover, the pattern was not masked by the effects of 
age, BMI, and disorders or by the effect of overall risk (p value of the likelihood ratio 
tests for the effect of season was always greater than or equal to 0.51). In addition, we 
tested whether the low percentage of women with ovulatory cycles during the period 
December-February (80%) was different from the percentage found in the rest of the 
year (89%). The crude analysis showed an odds ratio of 0.52 (95% confidence interval. 
0.27-1.00), but after adjusting for the effects of age, BMI. and disorders, this difference 
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in ovulatory cycles disappeared considerably (odds ratio of 0.73; 95% confidence 
interval, 0.29-1.86). 
If seasonal variation exists, with the given number of screenings per month we 
would have been able to detect a difference of about 10% in ovulatory cycles per 
month between the extremes of the sine function with α = 0.10 and a power of 70%. 
Discussion 
This study did not reveal a seasonal pattern in ovulatory cycles of subfecund Dutch 
women in 1991-1992. The number of women in the study was rather small, resulting in 
a rather low power; therefore minor seasonal variation in ovulation might have been 
missed. The absence of a statistically significant seasonal variation in ovulation was not 
explained by confounding effects of age, BMI, and disorders. 
The study population was highly selected. All the women had a history of 
infertility. The women with primary or secondary amenorrhea or with oligomenorrhea 
were not screened for ovulation and therefore were excluded from the study. The 
ovulation frequency in this study population does not represent the frequency in the 
general Dutch female population. However, seasonality itself is not likely to have 
influenced the selection process. Therefore, if seasonality in ovulatory frequency as a 
biological phenomenon does occur in the general population, such a pattern almost 
certainly would also appear in this selected study population, at least to a certain 
extent. 
Ultrasonography in combination with serum progesterone measurement one week 
after follicle rupture is a reliable method for ovulation detection.13 In 15 women we 
could not determine retrospectively whether or not ovulation had occurred, partly 
because of incomplete data in the patient dossiers. In January a relatively large number 
of screening results were inconclusive (4 out of 30 screenings), so the percentage of 
ovulatory cycles in that month would be at most 77%, that is, still one of the lowest 
percentages during the year. The inconclusive screening cycles change the results only 
slightly. 
To study seasonality in ovulation, it is not necessary to follow women for several 
menstrual periods. In clinical practice (using the reliable method of serial transvaginal 
ultrasound in combination with midluteal serum progesterone measurements) following 
women for more than one period is even undesirable because the screening method is 
too cumbersome for the patients. Measurements during one menstrual cycle per woman 
give the same answer to the question so long as the women are equally distributed 
throughout the year for the known risk factors for anovulatory cycles and so long as 
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unknown risk factors are randomly distributed throughout the year. We presume that 
these assumptions are met because the fertility clinic did not change its procedure 
during the year. Moreover, we adjusted for possible confounding effects of age, BMI, 
and disorders. Thus this method was appropriate to study seasonality in ovulation. 
The results of this study do not confirm the results of Timonen et al] ' in Finland or 
those of Rameshkumar et aln in India. The ovulation patterns found in those two 
studies were compatible with the results of Roenneberg and Aschoff,3 who found a 
negative correlation between temperature and conceptions in equatorial regions with hot 
summers and a positive correlation in regions with cold winters and moderate 
summers. However, photoperiodicity and variation in environmental temperature are 
not the only features of seasonal influence; variation in energy intake and expenditure 
also matter. Therefore another explanation might be the decreased energy intake during 
spring and summer in India; Ellison16 noticed decreased luteal function in that situation. 
No large seasonal variation in energy balance is expected in the Netherlands. Therefore 
in this study any influence of the season might be due to photoperiodicity and changes 
in environmental temperature. Because in the Netherlands (which is situated between 
50° and 54° latitude) heterogeneity in photoperiodicity and temperature during the year 
is less than that in Finland, seasonal variation in ovulation may not be detectable. 
In short, we conclude that no overt seasonality in human ovulation was present in 
these subfecund Dutch women with menstrual cycles shorter than 6 weeks. 
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2.3. Seasonality in the results of in vitro fertilization 
A.M. Stolwijk, M.J.C.M. Reuvers, C.J.C.M. Hamilton, P.H. Jongbloet, 
J.M.G. Hollanders, G.A. Zielhuis 
Seasonal variation has been found in various reproductive outcomes. As known causes 
for reducing the rate of success of in vitro fertilization (IVF) cannot explain all the 
variation in IVF results, we studied whether the season had any additional explanatory 
power. The study population consisted of 1126 women who were treated for the first 
time with IVF at the University Hospital in Nijmegen, the Netherlands, between 1987-
1993. Only first IVF cycles were analysed. After adjusting for confounding by the age 
of the woman, type of infertility, indication for IVF and year of aspiration, some 
seasonal variation was observed in the fertilization rate, embryo quality, pregnancy rate 
and birth rate. 
Human Reproduction 1994;9:2300-2305 
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Introduction 
Seasonal patterns have been found in various reproductive outcomes: in births 
throughout the world,1"3 in stillbirths4 and in spontaneous abortions.4"* These may be 
caused by seasonal variations in ovulation and sperm characteristics. Evidence to 
support such seasonality has been found for ovulation7,8 and sperm characteristics.9 It 
has been suggested that the season not only influences the number of ovulations but 
also the quality of the oocyte,10 possibly by mediating gonadotrophins. Despite the fact 
that endogenous gonadotrophin secretion is suppressed by the hormonal therapy given 
during in vitro fertilization (IVF) treatment, it is still of interest to look for seasonality 
in the success rate of IVF. 
Several factors are known to reduce the rate of success of IVF, e.g. advanced age 
of the woman,""14 the presence of primary infertility of the female,14 the presence of 
male infertility13,14 or multiple infertility factors.13 However, these factors cannot 
explain the entire range of IVF results. The aim of this study was therefore to 
investigate whether season has any additional explanatory power. As the seasonal effect 
can be attributed to characteristics of the oocyte or spermatozoon, we studied the 
seasonal influence on the ovarian response to ovulation induction, the number of 
oocytes retrieved, fertilization rate, embryo quality, pregnancy rate and birth rate. 
Materials and Methods 
The study population consisted of all the women who were treated with IVF for the 
first time at the University Hospital Nijmegen, the Netherlands, between February 1987 
and August 1993, for whom data had been recorded (N = 1154). In 1987 and the first 
half of 1988, data on only an aselect proportion of the women had been recorded. A 
group of 28 women were excluded from the analyses because their treatment cycle was 
cancelled for reasons other than poor response. 
The season was expected to influence the oocyte during its development at the time 
of IVF treatment and the spermatozoon during its development before sperm collection 
on the day of oocyte aspiration. Therefore, to study seasonality, the date of aspiration 
was taken as an approximation of the moment of aetiological impact. In the treatment 
cycles which were cancelled because of low ovarian response to ovulation induction, 
the date of aspiration was approximated by adding 16 days to the first day of the last 
menstrual period because for the other women the median interval between the first 
day of the last menstrual period and aspiration was 16 days. 
Successful IVF results were defined as: (i) sufficient ovarian response to ovulation 
induction, (ii) one or more fertilized oocytes, (iii) one or more transferred embryos of a 
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(fairly) good quality (i.e. greater than or equal to six cells on day 3, round embryo, 
<10% cytoplasmatic fragmentation and/or >90% equal blastomeres), (iv) pregnancy and 
(v) birth. Furthermore, differences in the number of oocytes retrieved were studied. 
Only the results of the first IVF treatment cycles were included in this study. Excluded 
were the results of cryopreserved embryos. 
Potential confounding variables were considered to include the age of the woman, 
the type of infertility (primary or secondary) of the woman and indication for IVF, 
which consisted of a total of eight categories of combinations of tubal pathology, 
cervical factor or endometriosis and male infertility (while no donor spermatozoa were 
used) and unexplained infertility. Seven couples who were treated with IVF because of 
male infertility only and who used donor spermatozoa were excluded from the analyses 
which differentiated between the categories of indication. Furthermore, the year of 
aspiration was considered to be a potential confounding factor because the IVF 
treatment changed over the years [most important changes were the administration of 
gonadotrophin-rcleasing hormone (GnRH) agonist and the optimization of the time of 
aspiration]. 
The relationships between IVF results and the month of aspiration, age of the 
woman, type of infertility and indication for IVF were tested by χ2 tests. Whether there 
were differences in the number of oocytes retrieved between the various categories was 
tested with the Wilcoxon-Mann-Whitney test or the Kraskall-Wallis one-way analysis 
of variance by ranks test. The association between the age of the woman and the 
number of oocytes retrieved was assessed by the Spearman correlation coefficient. The 
relationship between IVF results and the month of aspiration was corrected for the age 
of the woman, type of infertility, indication for IVF and year of aspiration by logistic 
regression. As a reference group the month of aspiration with the best IVF result was 
taken (provided that the number of IVF treatments in that month was relatively large). 
The results of the logistic regression analysis were expressed in odds ratios. The 
likelihood ratio test was used to examine whether a logistic regression model which 
included the month of aspiration and the confounding variables could explain more of 
the variation in the IVF results than a model with only the confounding variables. 
Results 
Almost two thirds of the women (712/1126) had a history of primary infertility. The 
age of the women varied from 20 to 47 years; half of the women were >33 years. 
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Table 1. Number and percentages of women with successful in vitro fertilization results per 
month of aspiration 
Month of Total Response* >1 >1 >1 'good' Pregnancyt Birtht 
aspiration oocyte fertilized embryot 
oocytet 
January 
February 
March 
April 
May 
June 
July 
August 
September 
October 
November 
December 
η 
65 
132 
129 
94 
168 
112 
13 
26 
103 
130 
125 
29 
I2 df=l 1 (p) 
η 
61 
122 
122 
91 
162 
106 
12 
22 
92 
117 
108 
26 
% 
94 
92 
95 
97 
96 
95 
92 
85 
89 
90 
86 
90 
19.89 (0.05) 
η 
56 
111 
119 
88 
152 
99 
10 
20 
73 
105 
95 
23 
η 
51 
95 
100 
76 
132 
81 
8 
14 
59 
92 
84 
20 
% 
91 
86 
84 
86 
87 
82 
80 
70 
81 
88 
88 
87 
9.38 (0.59) 
η 
39 
71 
65 
61 
95 
60 
6 
7 
43 
59 
60 
16 
14.78 
% 
70 
65 
55 
69 
63 
61 
60 
35 
60 
57 
63 
73 
;ο.ΐ9) 
η 
12 
31 
27 
18 
30 
21 
1 
3 
10 
25 
26 
7 
10.03 
% 
21 
28 
23 
21 
20 
21 
10 
15 
14 
24 
28 
32 
0.53) 
η 
9 
21 
14 
9 
23 
14 
0 
0 
7 
20 
17 
5 
% 
17 
19 
12 
11 
15 
14 
0 
0 
10 
19 
18 
23 
14.25 (0.22) 
Total 1126 1041 92 951 812 85 582 62 211 22 139 15 
* Calculated as part of the total number of women. 
t Calculated as part of the number of women with one or more oocytes retrieved. 
% Women 
100 
80 
60 
'l F M A M J J A S O N D 
Month of aspiration 
Figure 1. In vitro fertilization results per month of aspiration. Calculated as part of the total group 
of women (N = 1126): • Response. Calculated as part of the women with >1 oocyte 
retrieved (n = 951): * >1 fertilized oocyte, * >1 'good' embryo, • Pregnancy, χ Birth. 
_ 1 3L· Ji^. 
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Figure 1 and Table 1 present the response to the hormone treatment by month of 
aspiration. Of all the women treated, 8% did not respond to the hormone treatment. 
The poorest responses were observed during the second half of the year. As there were 
some differences in the response among women according to age group, primary or 
secondary infertility and category of indication (Table 2), and because the distribution 
of women in these categories over the year was unequal, logistic regression was 
performed to adjust for confounding. In addition the year of aspiration was considered 
to be a confounder: the mean response before 1990 was 87% whereas in 1990-1993 
this was 95%. Furthermore, before 1990 56% of the IVF treatments were performed 
from July to December, whereas in 1990-1993 only 29% were performed in the second 
half of the year. After adjusting for confounding by age, type of infertility, indication 
for IVF and year of aspiration, no differences were found in the response between 
months (see Figure ЗА). 
Number of oocytes 
1 4 - г 
12 - τ τ τ 
1 0 - τ 
8 - ι τ 
Il II 
б - и n u n II II 
1 I I 
4 - 1 1 1 
2 - 1 1 
„Li 1 1 1 1 1 1 1 1 1 1 1_ 
J F M A M J J A S O N D 
Month of aspiration 
Figure 2. Number of oocytes retrieved per month of aspiration (25th, 50th and 75th percentile and 
Kruskall-Wallis χ2, df = 11). 1 P25-P75; • P50; χ2 = 32.69 ρ < 0.000. 
Information on the number of oocytes retrieved in each month is presented in 
Figure 2. In the group of 1126 women, the median number of oocytes was seven. No 
oocytes could be retrieved in 175 women: in 85 there was no ovarian response, in 84 
aspiration was not performed because ovulation occurred after a luteinizing hormone 
(LH) peak and in six women aspiration was performed but no oocytes could be 
retrieved. The number of oocytes varied per month of aspiration (Figure 2), per year of 
aspiration (Kruskall-Wallis χ2 = 103.93, df = 6, ρ < 0.001) and in indication for IVF 
(Kruskall-Wallis χ2 = 14.08, df = 7, ρ = 0.05). The number of oocytes was negatively 
correlated with the age of the woman (Spearman r = -0.15, ρ = 0.03). The number of 
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oocytes in women with primary and secondary infertility did not differ (Wilcoxon Ζ = 
-0.76, ρ = 0.45). After adjusting for the age of the woman, type of infertility, 
indication for IVF and year of aspiration, the proportion of women from whom more 
than seven oocytes could be retrieved, i.e. above the median number, was higher in 
March than in September (p < 0.05; Figure 3B). 
Differences in subsequent IVF results were studied conditional on the retrieval of 
one or more oocytes. Figure 1 and Table 1 show these results per month of aspiration. 
The proportion of women with one or more fertilized oocytes was the highest during 
April-May and October-February. In April-May and November-February the frequency 
of women with one or more embryos of (fairly) good quality was relatively high. The 
pregnancy rate was the highest for women with oocyte aspiration during February-
March and October-December. The birth rate was the highest for women with oocyte 
aspiration in October-February. However, these differences in IVF results between 
months of aspiration were not statistically significant. 
As could be expected, there were some differences in the results of IVF between 
the women with primary or secondary infertility, and between the categories of 
indication (Table 2). The women with secondary infertility had more success than the 
women with primary infertility. The indication for IVF seemed to influence the 
fertilization of the oocytes and the quality of the embryos. Couples who were treated 
with IVF exclusively because of male infertility had the least success. If one or more 
oocytes were retrieved, the age of the woman did not seem to have much influence on 
the subsequent IVF results (Table 2). Furthermore, in general, the IVF results up to 
1990 were inferior to those in later years (data not shown). 
To test whether there were monthly differences in the IVF results, it was 
considered appropriate to adjust for confounding in logistic regression models. On the 
condition that at least one oocyte was retrieved, the fertilization of one or more oocytes 
occurred more often in January than in August (p < 0.05; Figure 3C). The quality of 
the embryo was better in January than in March (p < 0.05; Figure 3D). The pregnancy 
rate was higher for women with oocyte aspiration in February than in September (p < 
0.05; Figure 3E), and the birth rate was higher for women with oocyte aspiration in 
February than in April (p < 0.05; Figure 3F). 
In testing whether the season was related to the response to hormonal treatment, 
number of oocytes retrieved, fertilization rate, quality of the embryo, pregnancy rate 
and birth rate for each of these IVF results, the logistic model with the month of 
aspirations and confounding variables was compared with the model with only the 
confounding variables. The log-likelihood ratio test was not statistically significant for 
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any of the IVF results, indicating that adding season to the model did not improve the 
explaining power of the variation in any of the IVF results. 
Table 2. Number and percentages of women with successful in vitro fertilization results per age 
group, type of infertility and category of indication 
Age (years) 
20-24 
25-29 
30-34 
35-39 
>40 
χ
2
 df=4 
(P) 
Type of infertility 
Primary 
Secondary 
χ
2
 df=i 
(P) 
Indication J 
Tubal pathology 
Cervix/endometriosis 
Tubal+cervix/endom. 
Male infertility 
Male+tubal 
Male+cervix/endom. 
Male+tubal+cervix/endom. 
Unexplained 
f df=7 
(P) 
Total 
Total 
η 
14 
194 
558 
313 
47 
712 
414 
298 
96 
66 
190 
155 
132 
55 
109 
1126 
Response* 
η 
14 
187 
523 
273 
44 
% 
100 
96 
94 
87 
94 
19.13 
(0.001) 
655 
386 
92 
93 
0.58 
(0.45) 
280 
88 
59 
172 
143 
121 
53 
103 
94 
92 
89 
91 
92 
92 
96 
95 
4.98 
(0.66) 
1041 92 
>1 
oocyte 
η 
13 
164 
482 
251 
41 
600 
351 
243 
82 
52 
162 
130 
113 
49 
98 
951 
>1 
fertilized 
oocytet 
η % 
11 85 
137 84 
418 87 
211 84 
35 85 
1.50 
(0.83) 
502 84 
310 88 
3.84 
(0.05) 
225 93 
73 89 
49 94 
113 70 
110 85 
90 80 
43 88 
91 93 
53.87 
(0.001) 
812 85 
>1 
'good' 
embryot 
η % 
8 62 
98 60 
302 63 
148 59 
26 63 
1.63 
(0.80) 
350 59 
232 66 
5.45 
(0.02) 
182 75 
53 65 
35 69 
64 40 
75 58 
64 58 
32 67 
63 64 
54.21 
(0.001) 
582 62 
Preg-
nancyt 
η % 
3 23 
36 22 
111 23 
54 22 
7 17 
1.02 
(0.91) 
122 21 
89 26 
3.15 
(0.08) 
59 25 
17 21 
13 25 
23 14 
32 25 
22 20 
12 25 
22 22 
8.03 
(0.33) 
211 22 
Birtht 
π % 
2 15 
21 13 
75 16 
37 15 
4 10 
1.62 
(0.81) 
76 13 
63 18 
5.11 
(0.02) 
39 17 
11 13 
8 16 
15 9 
21 16 
14 13 
9 19 
15 15 
5.64 
(0.58) 
139 15 
* Calculated as part of the total number of women. 
t Calculated as part of the number of women with one or more oocytes retrieved, 
t Excluding 18 couples who were treated with IVF for other reasons and seven couples who were 
treated with IVF on the indication of male infertility only and who used donor spermatozoa. 
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A. Responset 
Odds ratio 
J F M A M 5 J J A S O N D 
Month of aspiration 
B. >7 Oocytes retrievedf 
Odds ratio 
"J F MS A M J J A S O N D 
Month of aspiration 
C. >1 Fertilized oocytej 
Odds ratio 
" J S F M A M J J A S O N D 
Month of aspiration 
D. >1 'Good' embryo} 
Odds ratio 
J S F M A M J J A S O N D 
Month of aspiration 
E. PregnancyJ 
Odds ratio 
0.8 
0.6 
0.4 
0.2 
0 
7Д 
J F 5 M A M J J A S O N D 
Month of aspiration 
F. Birtht || 
Odds ratio 
1 
0.8 
0.6 
0.4 
0.2 
r 
J F J M A M J J A S O N D 
Month of aspiration 
Figure 3. Odds ratios for each in vitro fertilization (IVF) result per month of aspiration, adjusted 
for age of the woman, type of infertility, indication for IVF and year of aspiration. § = 
Reference month (i.e. the month with the best results, provided that the number of IVF 
treatments in that month was relatively large). * = ρ < 0.05 as compared to the reference 
month, t = Calculated as part of the total group of women (N = 1126). % = Calculated 
as part of the women with >1 oocyte retrieved (n = 951). || = For July and August no 
odds ratio could be computed because there were no births. 
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Discussion 
This study shows that seasonal differences in the results of IVF do occur, but some of 
the variation can be explained by age of the woman, primary or secondary infertility, 
indication for IVF and year of aspiration. This means that there is some random 
variation in the monthly distribution of the women by age, type of infertility and 
indication for IVF. In addition there is a year effect, as most of the relatively 
unsuccessful treatments before 1990 were performed in the second half of the year, 
whereas in 1990-1993 most of the treatments were carried out in the first half of the 
year and were more successful. Furthermore, as the number of IVF cycles per month 
was rather small, the estimates were not very precise. This was especially the case in 
July and August in which the IVF team had the summer recess. The tendency towards 
inferior results in these months may be due to imprecise estimates or to the recess 
itself. However, this was contradicted by the adjusted effects on the IVF results in the 
surrounding months, which also tended to be less successful than in the period 
November-February. This stability in results suggests a real effect of season with more 
favourable circumstances in the period November-February. 
For the fertilization rate, the quality of the embryos and the pregnancy rate, it 
seemed appropriate, based on the pattern of Figure 3, to perform logistic regression 
models including the confounding variables and a cosine function of months [a 
cos(x-9); χ = π/12+ π(/Μ-1)/6; where a = amplitude > 0; θ = horizontal shift of the 
cosine function]. From these models it appeared that the best results were found in the 
period November-February for the fertilization rate [log-likelihood ratio test 
(-21n(L,/L2)) = 4.77, df = 2, ρ = 0.09], for one or more 'good' embryo [-21n(L,/L2) = 
2.40, df = 2, ρ = 0.30] and for the pregnancy rate [-21n(L,/L2) = 4.52, df = 2, ρ = 
0.10]. As the numbers were rather small, it was not possible to perform these analyses 
on subsets, e.g. different periods, for looking at consistencies. 
The biological mechanism through which the season may influence human 
reproduction is not clear. Melatonin, a hormone produced during darkness, may be one 
of the factors which influences gonadal function.15 It should be emphasized that the 
hypothalamic-pituitary function of the woman is suppressed during the IVF procedure. 
It is therefore remarkable that there was still some seasonal difference in the number of 
oocytes retrieved which could not be explained by the age of the woman, type of 
infertility, indication for IVF and year of aspiration. Conditional on the retrieval of one 
or more oocytes, some seasonal differences in the subsequent results were still 
observed. This must have been related to either the inferior quality of the oocyte or the 
spermatozoon, or to diminished receptivity of the endometrium. A seasonal effect on 
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the spermatozoa may be most likely. In a review of seasonal variation in sperm 
characteristics, it was shown that the total spermatozoa per ejaculate and the sperm 
concentration were highest in the winter and spring and lowest in the summer, and the 
percentage of motile spermatozoa was highest in the spring.9 Sperm characteristics may 
deteriorate through the influence of environmental temperature, which is highest during 
the summer months. As the production of spermatozoa takes -74 days,16 inferior 
spermatozoa may be found up till October. Analogous with this view, Paraskevaides et 
αϊ,
17
 showed that the conception rate was highest during October-March in women who 
underwent artificial insemination by donor. In that study maximum sperm counts 
occurred between February and May. However, no clear seasonal variation was found 
in the sperm characteristics of the partners (or the sperm donors) of the 951 women 
from whom one or more oocytes could be retrieved in our study. 
In conclusion, seasonal variation was present, although some of the variation could 
be explained by the women's age, type of infertility, indication for IVF and year of 
aspiration. After correction, some monthly differences in the IVF results remained, 
with a tendency for better results following oocyte retrieval during the period 
November-February. As seasonal impact was not large, there seems no reason yet to 
take the season into account in IVF clinical practice. 
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2.4.1. Seasonal variation in the time to pregnancy: 
A secondary analysis of three Danish databases 
A.M. Stolwijk, J. Olsen, I. Schaumburg, P.H. Jongbloet, G.A. Zielhuis 
Three Danish databases were reanalysed to investigate seasonal variation in the time to 
pregnancy. Information was available on cohorts of women selected on the basis of 
union membership or residence in a given area: textile workers in Denmark (with 1,053 
first and 1,771 second pregnancies), pharmacy assistants in Denmark (with 734 first 
and 725 second pregnancies) and pregnant women in the 36th week of pregnancy in 
two Danish cities (with 3,657 first and 3,526 second pregnancies). The influence of 
the season was of primary interest, because it is presumed to cause impaired ovarian 
function and hence a prolonged time to pregnancy. Furthermore, we studied whether 
the waiting time was prolonged in other situations with possibility of decreased ovarian 
function: in young and older women. In general, seasonality in the time to pregnancy 
based on the time of conception was found with a higher chance of a prolonged 
waiting time before conceiving in February-April and a lower chance of a prolonged 
waiting time before conceiving in August-October. This association was not distorted 
by the age of the women or diabetes mellitus. A prolonged time to pregnancy was 
found in women of 30 years or older. Women of 20 years or younger did not have a 
prolonged waiting time, but most of them were well beyond the age of menarche and 
thus beyond the period of impaired ovarian function. On a population level, there was 
evidence for seasonality in the time to pregnancy, which is compatible with seasonal 
variation in pregnancy planning as well as with biological influences. 
European Journal of Epidemiology 1996;12:437-441 
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Introduction 
The time necessary to achieve a clinically recognizable pregnancy varies considerably 
between couples. This time to pregnancy can be considered as a measure of 
fecundability.1 The variation in the time to pregnancy may partly be explained in the 
literature by a variety of biological and environmental factors, such as: maternal age,2 
parity,3 recent use of oral contraceptives,4,5 smoking,6,7 caffeine consumption8 and 
occupational exposure to heat, noise, textile dyes, lead, mercury and cadmium.9 In 
addition, median waiting times which preceded pregnancies ending in spontaneous 
abortions were 1.68 times longer than those in pregnancies resulting in live births.10 
We hypothesize that impaired ovarian function is one underlying cause for a 
prolonged time to pregnancy. Impaired ovarian function is assumed to occur just after 
the menarche, before the menopause, after birth or abortion, after the use of oral 
contraceptives and in endocrine disorders such as diabetes mellitus. In these situations, 
more anovulatory cycles occur and consequently a prolonged time to pregnancy is 
expected. Anovulation in humans due to impaired ovarian function has also been 
hypothesized to vary with the season as a remnant of seasonal reproduction in 
mammals." Indications for seasonality in human reproduction have been found for 
ovulation,12,13 early pregnancy loss14 and births.I5"17 The main theme of this study is 
whether seasonality in the time to pregnancy exists. Additionally, diminished ovarian 
function is studied by answering the question of whether in young and older women 
there is a prolonged time to pregnancy. We addressed these questions in a secondary 
analysis on three databases about specific Danish populations. 
Methods 
Three Danish databases were available, comprising information on female textile 
workers, pharmacy assistants and pregnant women in Aalborg and Odense. In this 
secondary analysis, only the information about the first and second pregnancies were 
used. Women who became pregnant despite contraception and women who reported 
fertility examinations or treatments were excluded from the study. 
A. Textile workers 
The first population consisted of all female textile, clothing and footwear workers in 
Denmark, who were members of a union in 1985 (N = 18,658).'° By means of a postal 
questionnaire, these women were asked about all their pregnancies during 1979-1984. 
Response was 70.3%. For each pregnancy, information about the time to pregnancy 
was obtained by asking: 'For how long had you been trying to become pregnant before 
you succeeded? (Had regular intercourse without the use of any contraception)'. 
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Answer categories were: became pregnant despite contraception, 0-6 months, 7-12 
months, 13-24 months, 25-36 months, more than 3 years and do not know. Questions 
about age at each pregnancy and about diabetes mellitus were included in the 
questionnaire. A total of 1,053 first and 1,771 second pregnancies met the criteria for 
analysis (Table 1). 
B. Pharmacy assistants 
The information in the second database was obtained in a study on 4,924 female 
pharmacy assistants in Denmark, who were members of a union at some time during 
1979 to 1984.18 The women were asked about all their pregnancies in the period 
1979-1984 by means of a postal questionnaire; 92% responded. A total of 2,557 
pregnancies were reported. As in the former paragraph, for each pregnancy, 
information was obtained about the time to pregnancy, age at conception and diabetes 
mellitus. No information was available about fertility examinations or treatments. The 
734 first and 725 second pregnancies are shown in Table 1 according to age at 
conception, occurrence of diabetes mellitus and waiting time. 
C. Pregnant women 
The information in the third database was based on a questionnaire which was sent to 
all women in two cities in Denmark (Odense and Aalborg) who were in the 36th week 
of pregnancy between April 1984 and April 1987.8 A total of 11,888 women 
participated in the study and completed the questionnaire (86%). Time to pregnancy 
was obtained by the question: 'For how many months had you and your partner been 
attempting to achieve conception; that is, how much time elapsed from when you 
stopped using contraception until you became pregnant?'. Answer categories were: 0-6 
months, 7-12 months and 1 year or longer. Furthermore, information was available 
about diabetes mellitus. There were 3,657 first and 3,526 second pregnancies (Table 1). 
For each database and for the first and second pregnancies separately, seasonality in 
the time to pregnancy was studied based on the time of conception. The seasonal 
influence would be the most obvious during the first menstrual cycles after the onset of 
trying to achieve a pregnancy, because long intervals will dilute the influence of the 
season. Given the information in the databases, we defined prolonged time to 
pregnancy therefore as a time to pregnancy of more than 6 months. Logistic regression 
models were created and likelihood ratio tests were performed to study whether adding 
the season to the model increased the explanation of the variance in the time to 
pregnancy. The season was included in the model as a cosine function with a period of 
one year and variable amplitude and horizontal shift. To adjust for confounding, age 
and diabetes mellitus were included in the model. Odds ratios per month of conception 
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Table 1. Distribution (percentages) of female textile workers, pharmacy assistants and pregnant 
women according to age, diabetes mellitus and time to pregnancy (TTP) 
Characteristics 
TTP >6 months 
Age at conception 
<20 years 
21-29 years 
>30 years 
Diabetes mellitus 
Total (n) 
Textile workers 
1st 
pregnancy 
25.1 
36.4 
59.7 
4.0 
0.3 
1053 
2nd 
pregnancy 
20.0 
19.0 
72.8 
8.2 
0.4 
1771 
Pharmacy 
1st 
pregnancy 
29.2 
37.8 
60.1 
2.1 
0.4 
734 
assistants 
2nd 
pregnancy 
20.3 
15.2 
78.5 
6.4 
0.6 
725 
Pregnant 
1st 
pregnancy 
25.6 
16.9 
75.6 
7.5 
0.4 
3657 
women 
2nd 
pregnancy 
22.7 
5.2 
74.3 
20.6 
0.4 
3526 
were calculated, expressing for each month the ratio of the number of women with 
time to pregnancy of more than 6 months to the number of women with a time to 
pregnancy <6 months, compared to that ratio in a reference month. As reference month 
was chosen the month with the highest proportion of women with a prolonged time to 
pregnancy. To study the effect of age on the time to pregnancy, women who were 20 
years or younger or 30 years or older at the beginning of the waiting time were 
compared to women of 21-29 years old. This was expressed in the form of odds ratios. 
Results 
Seasonal variation in the time to pregnancy was found in all three populations, both in 
the first and second pregnancies (Figure ΙΑ-C). A relatively high proportion of the 
pharmacy assistants and the pregnant women had a long waiting time if they had 
conceived in February-April and a short waiting time if they had conceived in August-
October. Almost the same pattern was observed in the textile workers as far as their 
first pregnancy was concerned. However, roughly the opposite pattern was found in the 
second pregnancies of the textile workers: a relatively high proportion had a long time 
to pregnancy if they had conceived in October-December and a short time to 
pregnancy if they had conceived in April-June. The seasonal variation in the textile 
workers was much smaller than in the other study populations; odds ratios varied from 
0.9 to 1.1 in the textile workers, whereas in the pharmacy assistants and the pregnant 
women odds ratios varied from about 0.3 to 1.0 and 0.7 to 1.0, respectively. None of 
these patterns was confounded by the effects of age or diabetes mellitus. 
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% Women with a TTP >6 months OR % Women with a ITP >6 months OR 
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Month of conception 
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Month of conception 
C. Pregnant women§ 
% Women with a TTP >6 months 
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Figure 1. 
Percentages of women with a time to 
pregnancy (TTP) of >6 months per month 
of conception, separated into first and 
second pregnancies. Odds ratios (OR) per 
month, expressing the ratio of the number 
of women with a time to pregnancy of >6 
months to the number of women with a 
time to pregnancy of <6 months compared 
to that ratio in the reference month. The 
reference month is the month with the 
highest percentage of women with a time to 
pregnancy of >6 months. • % Women 1st 
pregnancy; * % Women 2nd pregnancy; 
Odds ratio 1st pregnancy; 
Odds ratio 2nd pregnancy. 
t First pregnancies: unadjusted -21n(L,/L2) = 0.84 (df = 2, ρ = 0.66), adjusted for age and 
diabetes mellitus -2ln(L,/L2) = 21.90 (df = 2, ρ = 0.000); second pregnancies: unadjusted 
-21n(L,/L2) = 0.33 (df = 2, ρ = 0.85), adjusted for age and diabetes mellitus -2ln(L,/L2) = 55.06 (df 
= 2, ρ = 0.000). 
J First pregnancies: unadjusted -21n(L,/L2) = 11.34 (df = 2, ρ = 0.003), adjusted for age and 
diabetes mellitus -2ln(L,/L2) = 10.75 (df = 2, ρ = 0.005); second pregnancies: unadjusted 
-2ln(L,/L2) = 19.19 (df = 2, ρ = 0.000), adjusted for age and diabetes mellitus -21n(L,/L2) = 16.86 
(df = 2, ρ = 0.000). 
§ First pregnancies: unadjusted -21n(L,/L2) = 7.21 (df = 2, ρ = 0.03), adjusted for age and 
diabetes mellitus -21n(L,/L2) = 7.29 (df = 2, ρ = 0.03); second pregnancies: unadjusted -21n(L,/L,) 
= 7.38 (df = 2, ρ = 0.03), adjusted for age and diabetes mellitus -2ln(L,/L2) = 6.95 (df = 2, ρ = 
0.03). 
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The odds ratios for the age categories are presented in Table 2. In the first 
pregnancies, the women of 20 years or younger conceived more quickly than the 
women aged 21-29 years. The results were less consistent in the second pregnancies: 
more young textile workers and pregnant women had a prolonged time to pregnancy 
than the women aged 21-29 years in the same populations. However, the confidence 
interval included unity. In each population, more of the women aged 30 years or older 
had a prolonged waiting time than those aged 21-29. 
Table 2. Odds ratios (and 95% confidence intervals) for the women with a time to pregnancy of 
>6 months versus <6 months according to age 
Age at conception 
<20 versus 21-29 
Age at conception 
>30 versus 21-29 
Textile workers 
1st 2nd 
pregnancy pregnancy 
0.67 1.11 
(0.49-0.91) (0.82-1.50) 
1.74 1.79 
(0.91-3.35) (1.22-2.64) 
Pharmacy assistants 
1st 2nd 
pregnancy pregnancy 
0.43 1.00 
(0.30-0.62) (0.59-1.69) 
1.61 3.16 
(0.57-4.51) (1.69-5.93) 
Pregnant women 
1st 2nd 
pregnancy pregnancy 
0.71 1.21 
(0.57-0.88) (0.85-1.74) 
1.58 1.81 
(1.22-2.06) (1.50-2.17) 
Discussion 
This analysis revealed a prolonged time to pregnancy in the women who conceived in 
February-April and a shorter time in those who conceived in August-October. This 
pattern was not found in the second pregnancy in the group of textile workers. 
It should be noted that only women who had been or were pregnant were included 
in the three databases. Subfecund women with a longer time to pregnancy will have 
been under-represented in the study populations, especially in the group of pregnant 
women. As subfecund women have a higher probability of impaired ovarian function, 
selection might have led to underestimation of the effects of the season and age on the 
time to pregnancy. 
The evidence for seasonal variation in the time to pregnancy found in this study 
may be the consequence of seasonal influences on the biological mechanism, for 
instance, a reaction of the pineal gland and melatonin to changes in the duration of 
light and darkness during the year,19 or other seasonal changes in various types of 
exposure which are associated with low fecundity. Furthermore, the seasonal variation 
in the time to pregnancy may be the result of social factors. During the study period, 
the number of births in Denmark was relatively low during November-January and 
relatively high during March-July. As the use of contraceptives makes it possible to 
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plan pregnancies and as most women have a short time to pregnancy,20 the birth pattern 
may be an indication for months that are less and more favoured for conceiving. This 
would lead to a relatively high percentage of women with a prolonged time before 
conceiving in February-April and a relatively low percentage of women with a 
prolonged time before conceiving in June-September. It is possible that this was 
applicable to our study. Thus, not only biological factors, but also a seasonal variation 
in pregnancy planning may have influenced the seasonal pattern in the time to 
pregnancy. 
Unfortunately, the time to pregnancy was measured fairly roughly and recorded on 
the basis of the time of conception. Therefore we could not study seasonal variation in 
the time to pregnancy per month based on the precise starting date of the waiting 
period. A prospective study which includes all women at the start of their waiting time 
to pregnancy, whether they become pregnant or not, would give more insight into the 
biological role of seasonality in the time to pregnancy. 
Waiting times were prolonged in the women older than 30 years. This is in 
accordance with our hypothesis of impaired ovarian function as cause for prolonged 
time to pregnancy and with the findings of others.2 Results were not as clear for the 
youngest age group. In the first pregnancies, the youngest group of women conceived 
more quickly than the women aged 21-29 years; in the second pregnancies, there was 
some evidence of an opposite pattern, but this could be explained by chance, or it 
could be due to the selection of only pregnant women in the study sample. We had 
expected that a prolonged time to pregnancy would occur more often in young women, 
because after the menarche ovarian function is suboptimal. As most of the women aged 
<20 years fell outside this range, the fact that the young women did not have a 
prolonged time to pregnancy was probably due to the age classification itself. The 
number of women who conceived within three years after the menarche was too small 
to draw any conclusions. However, it should be noted that more of the second 
pregnancies in the women of 20 years or younger were preceded by still birth or 
spontaneous abortion than those in the older women (in the population of pregnant 
women in Aalborg and Odense: the ratio spontaneous abortions and still births versus 
live births in women <20 years was 0.70, in women 21-29 years 0.15 and in women 
>30 years 0.08). The occurrence of still births and spontaneous abortions may reflect 
decreased ovarian function in the youngest age group. 
In conclusion, seasonality in the time to pregnancy based on the time of conception 
was found in the three databases. This is compatible with differential pregnancy 
planning as well as with biological influences. 
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2.4.2. Seasonal variation in the time to pregnancy: 
Avoiding bias by using the date of onset 
A.M. Stolwijk, H. Straatman, G.A. Zielhuis, P.H. Jongbloet 
To study seasonality in human fecundability, measured indirectly by time to the first 
pregnancy, we used data from 18,970 French-Canadian women who married for the 
first time during the 17th or 18th century. The time to pregnancy was approximated by 
the interval between marriage and first birth minus 38 weeks. We used the week of 
marriage and the week of conception as references to study seasonality. We found a 
minor seasonal pattern in time to pregnancy when using the week of marriage as a 
reference. The proportions of women with a short time to pregnancy were highest 
during December-January and June-July, indicating that these may be the most fecund 
periods. In contrast, we found an obvious seasonal pattern when using the date of 
conception as a reference. This pattern can be largely explained by a strong seasonal 
pattern in pregnancy planning (in this case, in marriages). When studying seasonal 
variation in the time to pregnancy, the date of onset of the time to pregnancy should be 
used as reference, not the date of conception. Otherwise, results will be biased owing 
to seasonality in pregnancy planning. The same is true for studies on seasonally bound 
exposures in relation to time to pregnancy. 
Epidemiology 1996;7:156-160 
82 Chapter 2.4.2 
Introduction 
Seasonal reproduction is a common phenomenon in many animals. In humans, seasonal 
variation can also be observed for several reproductive factors, for instance, 
ovulation,12 spermatozoa concentration,3 pregnancy after artificial donor insemina-
tion,4'7 early pregnancy loss,8 and birth.9"" A seasonal pattern may be caused by 
photoperiodicity, which influences gonadal function. Information about the gonadal 
function of women can be derived from gonadal hormone production and ovulation. 
This information is difficult to gather, however. A more convenient, although indirect, 
measure of gonadal function is fecundability. The time to pregnancy can be considered 
as an indication of fecundability.12 
For studying seasonality in the time to pregnancy, a date of reference should be 
defined. Either the date of the onset of the time to pregnancy (that is, the first day of 
refraining from any kind of contraceptive method because of pregnancy wish) or the 
date of the end of the time to pregnancy (that is, the date of conception) can be used. 
In this study, we used proxies for both definitions. 
This article addresses the question of whether there is seasonal variation in the time 
to pregnancy. Data were obtained from a historical cohort of women who lived in 
Quebec during the 17th and 18th centuries. As contraceptive methods were not 
accessible in those days (with the exception of total abstinence from sexual 
intercourse), the date of marriage can be used as the date of the onset of the time to 
the first pregnancy. We approximated the end of the time to pregnancy by the date of 
the first birth minus 38 weeks for the gestational period. In addition, we studied the 
occurrence of bias related to the choice of the date of reference in studies on variation 
in the time to pregnancy. 
Subjects and Methods 
Family reconstitutions of the early French-Canadians are being compiled in the form of 
a population register called 'Le registre de la population de Québec ancien' by the 
Programme de recherche en démographie historique at the University of Montreal.13 
The register covers the entire population from the arrival of the first settlers in the 
early part of the seventeenth century to 1765, after the British takeover. This 
population can be considered to have lived in conditions of 'natural fertility,' that is, 
free from any contraceptive practice.14 
In this study we used the interval between the date of marriage and the date of 
birth of the first child minus 38 weeks as a proxy for the time to pregnancy. We 
included women in the study if the dates of their marriage and first birth were known 
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and if the interval between their marriage and first birth was at least 240 days and, at 
most 1,096 days. We used the lower limit of 240 days because children bom within a 
shorter interval had presumably been conceived before marriage. The upper limit was 
necessary because long intervals have often been found to correspond with a birth in 
the family that was missed by the registry. Because of the lower limit of 240 days, the 
time to pregnancy was below zero in some cases. 
To study seasonality, we used both the week of marriage and the week, of 
conception (approximated by the week of the first birth minus 38 weeks) as the date of 
reference. For reasons of simplicity, marriages or births on the 29th of February or on 
the 31st of December were excluded from the analyses based on the week of marriage 
or the week of conception, respectively (leading to exactly 52 weeks per year). 
As seasonal influence would be the most obvious during the first menstrual cycles 
after marriage, because long intervals will dilute the influence of the season, we 
performed analyses to detect seasonal patterns in the time to pregnancy of <0, <1, <2, 
or <3 months. The weeks were entered into a logistic regression model as a sine 
function with a period of 26 weeks or 52 weeks with variable amplitude and shift. We 
chose the best fitting model as the one with the highest likelihood ratio. Additionally 
we calculated the deviance to determine whether the observed proportions of pregnant 
women per week were equal to the expected proportions when using the model with 
the best fitting sine function. We also used logistic regression analysis to correct for 
possible confounding effects of the woman's age at marriage (in three age groups) and 
the calendar year (in categories of 10 years and, in one case of small numbers, in a 
20-year period). 
Results 
Data were available from 20,888 women. Only the first marriage was included in the 
analysis (N = 18,970). The age of the women at first marriage varied from 11 to 46 
years. Half of the women married before the age of 21. Their marriages had taken 
place between 1634 and 1762. 
Half of the women conceived within 3 months. The time to pregnancy varied with 
the age of the women: the youngest women (18 years or younger) and the oldest 
women (34 years or older) had the longest time to pregnancy. Moreover, the time to 
pregnancy tended to be the longest during the first decennia of French settlement in 
Canada. 
The proportions of women with a time to pregnancy of <0, <1, <2, and <3 months 
per week of marriage and the best fitting sine functions are shown in Figure 1. A sine 
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function with a period of 26 weeks fitted better than one with a period of 52 weeks. 
There was only small variation in the proportions of women who became pregnant 
within 0, 1, 2, or 3 months: for <0 months from 4.5 to 6.4%, for <1 month from 22.9 
to 27.3%, for <2 months from 38.9 to 45.0, and for <3 months from 51.6 to 54.8%. 
Because of the large number of observations, these seasonal patterns in the time to 
pregnancy deviated from a uniform distribution (p < 0.002 in most cases). Peaks in the 
bimodal curves were found during weeks 50-2 (December-January) and weeks 24-28 
(June-July). The deviance (df = 49) was 76.97 for <0 months (p = 0.01), 69.09 for <1 
month (p = 0.03), 58.93 for <2 months (p = 0.16), and 40.65 for <3 months (p = 
0.80). These results indicated that the proportions of pregnant women per week of 
marriage could be predicted well with the sine function models with a period of 26 
weeks. Adjustment for the effects of age at the time of marriage and the calendar 
period did not change the results to any substantial extent. 
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Figure 1. Percentages of women with a time to pregnancy of <0, <1, <2, or <3 months, per week 
of marriage; crude data and best fitting sine function (excluding marriages on the 29th of 
February or the 31 st of December). 
* = weeks with fewer than 50 marriages. 
In contrast, when we used the week of conception as the date of reference, an 
obvious unimodal seasonal pattern was observed in the time to pregnancy (Figure 2). A 
sine function with a period of 52 weeks fitted better than a sine function with a period 
of 26 weeks. The deviance for the proportion of women with a time to pregnancy of 
<0, <1, <2, or <3 months was 312.12, 698.75, 248.92, and 106.63, respectively (df = 
49, ρ < 0.0001). Thus, although the model with a sine function with a period of 52 
% Women pregnant 
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weeks explained much of the variation in the distribution of the time to pregnancy 
throughout the year (likelihood ratio test result in all cases ρ < 0.0001), it did not 
predict the observed proportions very well. Moreover, the seasonal patterns in the time 
to pregnancy per week of conception remained after adjustment for confounding by age 
and calendar period. 
% Women pregnant 
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5 10 15 20 25 30 35 40 45 50 
Week of conception 
Figure 2. Percentages of women with a time to pregnancy of <0, <1, <2, or <3 months, per week 
of conception; crude data and best fitting sine function (excluding births on the 29th of 
February or the 31 st of December) 
Thus, the results of the two approaches for studying seasonality in the time to 
pregnancy differed considerably. The reason for this can be found in a seasonal pattern 
in marriages (Figure 3). The majority of women married during weeks 1-8 and 41-48 
(that is, January-February and October-November). Because half of the women 
conceived within 3 months after marriage, a peak of conceptions followed during 
weeks 45-10 (November-mid-March) (Figure 4). The expected number of conceptions 
per week with a time to pregnancy of <0, <1, <2, or <3 months could be estimated by 
using the number of marriages per week (Figure 3) and the distribution of the time to 
pregnancy in the population. It appeared that the high proportion of women with a 
relatively short time to pregnancy after having conceived during the weeks 45-10 
(Figure 2) was explained to a large extent by the distribution of marriages during the 
year. [For the four curves shown in Figure 2, the model χ 2 (df = 51) decreased from 
values of higher than 355, when assuming a uniform distribution, to values of 99 or 
less, when taking into account the distribution of marriages (Figure 3) and the time to 
pregnancy.] 
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# Marriages per week 
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Week of marriage 
Figure 3. Number of marriages per week (excluding marriages on the 29th of February or the 31st 
of December) 
# Conceptions per week 
5 10 15 20 25 30 35 40 45 50 
Week of conception 
Figure 4. Number of conceptions per week (excluding births on the 29th of February or the 31 st 
of December) 
Discussion 
As seasonal changes in, for instance, the photoperiod may cause a seasonal pattern in 
gonadal function and thus in fecundability, we focused on the question of whether 
there was a seasonal pattern in the time to pregnancy. The season was defined in two 
ways, that is, by the onset and by the end of the time to pregnancy. Although almost 
no seasonal pattern was observed in the time to pregnancy when the date of onset was 
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used as the point of reference, we found a striking seasonal pattern when the end of the 
time to pregnancy, that is, the week of conception, was the reference point. In this 
case, the seasonal variation in the time to pregnancy was explained by the seasonal 
pattern in marriages. Because 53% of the women became pregnant within 3 months, 
the marriage pattern almost dictated the conception pattern and thus the relation 
between the time to pregnancy and the date of conception. 
We found the highest proportions of women with a short time to pregnancy among 
those who married in December-January or in June-July. This finding may indicate that 
gonadal function is optimal during these periods. With a part of the same database used 
here (N = 5,194), Nonaka et alÌS found that marriages in August-October resulted in a 
lower percentage of immediate conceptions (8-10 months after marriage) than in other 
seasons. Although this finding agrees with our results, Nonaka et al did not find a 
bimodal pattern. A possible explanation for the difference is that we used a database 
three times as large and studied seasonality in weeks instead of in 3-month periods. In 
Finland, Timonen et α/1 found the highest proportion of ovulations during the 'light 
season,' that is, around June. Rameshkumar et al,2 in contrast, found the highest 
proportion of anovulations during the same period in India. These conflicting patterns, 
however, may be explained by the influence of both the photoperiod and temperature." 
Spermatozoa concentration was found to be the highest during February and March and 
almost as high in November; other semen characteristics did not reveal a seasonal 
pattern.3 In ovulating women who underwent artificial insemination by donor, the 
highest conception rates were found during October-March in England4 and in October-
January in Finland.5 Unfortunately, the proportion of ovulating women per month were 
not reported in these two studies. In another Canadian study, Henderson-Toth et af 
found the highest pregnancy rate after artificial insemination during November-
December and February; they did not mention whether they excluded anovulatory 
cycles. Thus, although none of these other studies found a bimodal pattern, the 
indication in our study for a peak in fecundability during June-July was in agreement 
with the ovulation pattern found in Finland by Timonen et al,1 whereas the peak in 
fecundability during December-January was in agreement with observations found in 
sperm concentration and after artificial insemination by donor. 
A factor that possibly influences the seasonal pattern in the time to pregnancy 
might be seasonal variation in pregnancy loss. We lacked information to evaluate this 
issue. Several other studies found seasonality in spontaneous abortions when using 
births as a reference.'6"'8 As seasonal variation in abortions can influence the number of 
births, the results of those studies may be biased. Two prospective studies provide 
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further insight. Weinberg et α/8 found peaks in the risk of early pregnancy loss (within 
6 weeks after the last menstrual period) in 221 women with a positive pregnancy test 
result after having conceived in early September to early December. Nakamura et α/19 
observed 11 spontaneous abortions in 519 women who had undergone ultrasonographic 
examination for confirmation of pregnancy. The last menstrual periods were more 
frequent during July-December (8/328) than during the first half of the year (3/189). 
The relatively high probability of pregnancy loss at the end of the year in these two 
studies seems to contradict the high proportion of women with a short time to 
pregnancy around December-January in our study. This discrepancy may indicate that 
the seasonal pattern in the time to pregnancy found in our study was not caused by a 
seasonal pattern in pregnancy loss. 
To study a biological phenomenon that influences fecundability, it is correct to use 
the date of the onset of the time to pregnancy as a reference. In this case, the impact of 
a seasonal pattern in marriages or in pregnancy planning in general can be found only 
in the precision of the measured time to pregnancy per week of marriage; it cannot 
lead to bias. An important consequence of seasonality in pregnancy planning is the 
potential for biased results in studies on a seasonally bound exposure (for example, in 
an occupational setting) in relation to the time to pregnancy. This bias may occur if the 
exposure status is measured at the date of conception instead of at the onset of the time 
to pregnancy. This type of 'time bias' differs from the one discussed by Weinberg et 
^ 20,21 ^ 0 r eja t e cj ¡t to changes in exposure status over calendar time. 
To overcome bias because of pregnancy planning, the onset of the time to 
pregnancy should be used as the date of reference. The best information would be 
obtained from a prospective study, in which women are enrolled in the study before 
they begin their time to pregnancy. This type of study, however, would have to cope 
with considerable practical problems connected with the large number of women who 
should be followed for a long period. An alternative is a retrospective study in which 
the date of the onset of the time to pregnancy is known. With such a study, the bias of 
pregnancy planning can be resolved. Unfortunately, if women are enrolled in the study 
while they are pregnant or after delivery, the date of the onset of the time to pregnancy 
and the date of conception will often be unknown and subfecund women will be 
underrepresented. The result will be underestimation of the strength of the relation, but 
no change in the direction of the effect estimators. In this study, the date of marriage 
was a reliable proxy for the onset of the time to pregnancy, because contraceptive 
methods were not accessible in the 17th and 18th centuries. Moreover, bias because of 
missing data of marriages or births is not likely, because the register is nearly 
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complete, and the population was essentially closed.13 
We conclude that the impact of a biological factor in causing seasonal variation in 
the time to pregnancy and thus in fecundability, is small; the most fecund periods seem 
to be December-January and June-July. Moreover, to study this correctly, the onset of 
the time to pregnancy should be used as the date of reference, not the date of 
conception. 
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2.5. Seasonal variation in the prevalence of Down syndrome 
at birth: A review 
A.M. Stolwijk, P.H. Jongbloet, G.A. Zielhuis, F.J.M. Gabreëls 
Study objective: Many studies on seasonality in Down syndrome (DS) have been 
performed, leading to different results. It is hypothesized that seasonal variation in the 
hormone production by the hypothalamus-pituitary-ovarian axis just before ovulation 
leads to seasonality in conception rates of DS. The aim of this study is to determine 
whether there is seasonal variation in the prevalence of DS at birth as a proxy for 
seasonality in DS at conception. Design: We reviewed all the English and Dutch 
articles on this topic. Articles published between 1966 and January 1996 were traced 
by Medline, and by the reference lists. Main results: Twenty articles met the criteria for 
inclusion in this review. Although seven of these studies reported seasonality in DS 
prevalence, no consistent seasonal pattern was found in DS at birth in these seven 
studies, or in the other thirteen studies. A seasonal pattern could not have been masked 
by the effects of maternal age, induced abortions, shortened gestation or 
misclassification of DS. Conclusion: Seasonality in the prevalence of Down syndrome 
at birth does not exist. Thus, we found no support for the hypothesis that DS 
occurrence is related to seasonality in hormone production. 
Journal of Epidemiology and Community Health (in press) 
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Introduction 
It has been shown conclusively that the prevalence of DS at birth in any given 
population is related only to the maternal age of the childbearing population and to the 
use of prenatal diagnosis with subsequent termination of affected pregnancies.' The 
underlying mechanism for the higher prevalence of DS with advancing maternal age is 
not yet clear. 
The most common hypothesis for the maternal age effect is ageing of the ovum 
itself.2 Another hypothesis, the so-called compromised microcirculation hypothesis 
proposed by Gaulden,3 states that hormonal imbalance causes a less-than-optimal 
microvasculature to develop around the maturing and mature follicles. This would 
result in an oxygen deficit and consequently in a decrease in the intra-cellular pH of 
the oocyte. The consequence would be a smaller size of the spindle, followed by 
displacement and nondisjunction of a chromosome. A more general hypothesis was 
proposed by Jongbloet4 and presumes that hormonal imbalance may suppress the 
maturation of the oocyte during the follicular phase, which may be expressed, amongst 
others, by nondisjunctions. Both hypotheses about hormonal imbalance causing 
nondisjunctions may apply to seasonal influence. 
It has been hypothesized that there is seasonal variation in human reproduction as 
most mammals show a seasonal pattern in reproduction. This pattern may be dictated 
by photoperiodicity which regulates the production of melatonin and inhibits or 
stimulates the production of gonadal hormones.5 It has been hypothesized that remnants 
of such a seasonal reproduction pattern may still be present in humans and may cause 
seasonal variation in reproductive errors.4 Seasonal variation in human reproduction has 
been observed in ovulations,6,7 in sperm production,8 in early pregnancy loss,9 in 
spontaneous abortions10"12 and in births.13"15 As a consequence of seasonal variation in 
hormone production by the hypothalamus-pituitary-ovarian axis, a seasonal pattern in 
the prevalence of Down syndrome at birth can be expected. 
For this article, we reviewed studies on seasonality in Down syndrome. As it is 
presumed that the etiologic moment occurs just before ovulation, our main interest was 
DS of maternal origin, preferably originating during first meiosis. Almost all DS cases 
(95 per cent) have free trisomy 21, which is a consequence of nondisjunction during 
meiosis one or two.16 About 95 per cent of these extra chromosomes 21 are of maternal 
origin'718 and about 77 per cent of DS cases of maternal origin result from 
nondisjunction during the first meiosis.19 Based on these arguments, seasonality in DS 
can be studied without making any distinction between the type of DS, parental origin 
or meiotic nondisjunction. As it is not possible to study the occurrence of Down 
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syndrome at conception, we reviewed articles about the occurrence of Down syndrome 
at birth. A consistent seasonal pattern in Down syndrome at birth will support our 
hypothesis that seasonality in Down syndrome occurs as a consequence of a seasonally-
bound influence on the hormone production of the hypothalamus-pituitary-ovarian axis. 
However, if a seasonal pattern in Down syndrome is not obvious, this review cannot 
reject the hypothesis, as selective spontaneous abortions might have made such a 
pattern disappear. 
Methods 
A computerized literature search was performed by means of Medline. All the English 
and Dutch articles were selected which contained the words 'Down syndrome', 
'Down's syndrome' or 'trisomy 21' in combination with 'season*' and were registered 
in the volumes published between 1966 and January 1996. Additionally, studies were 
traced via the reference lists of the articles. Unpublished work was not reviewed. 
Studies were only included if they contained more than 50 DS cases, presented 
monthly results of DS prevalence at birth, and used a comparison group of total or live 
births in the corresponding period and area. Only original studies were included. 
As photoperiodicity may influence hormone production and consequently the 
occurrence of nondisjunctions, the overview of seasonal patterns is arranged according 
to the latitude of the location of the study population. If a seasonal pattern exists, we 
expect to find a consistent seasonal pattern on the northern hemisphere and the 
opposite pattern on the southern hemisphere and that this pattern might be transient 
from the poles to the equator. 
As in the original studies seasonality is analysed and interpreted in various ways, 
we used in this review the crude data of each study, i.e. the monthly DS rate compared 
to the average DS rate. As large differences existed in the overall DS prevalence 
between studies, presumably because of differences in maternal age, induced abortions 
after prenatal diagnosis and in registration, DS prevalence per month was not compared 
and clearly could not be pooled. Moreover, exact numbers were not always presented 
in the studies. 
Results 
In total, 53 English and Dutch publications were traced via Medline; only 13 of them 
met all the criteria for inclusion in this review. In Table 1 the main reason for 
exclusion is mentioned for each study. In addition, seven studies which met the criteria 
were found via reference lists. 
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Table 1 Main reason for excluding publications from this review 
Reason Publication 
Not about seasonality in DS 
Kessler & Lilienfeld (Advances in Cancer Research 1969,12 225-302) 
Chen & Woolley (Journal of Medical Genetics 1971,8 153-159) 
Kenna et al (Quarterly Journal Medicine 1975,44 17-44) 
Safra et al (Teratology 1976,14 143-149) 
Ikeda et al (Journal of Mental Deficiency Research 1977,21 139-151) 
Paradise (Pediatrics 1980,65 917-943) 
Klein et al (Journal of Pediatric Surgery 1984,19 370-374) 
Jongbloet et al (Diabetes Research 1988,9 51-58) 
Not an original study 
Pergament (The Chigaco Medical School Quarterly 1969,28 57-67) 
Jongbloet (The Lancet 1970,2 1317-1318) 
Lowe (British Medical Journal 1972,3 515-520) 
Hecht (In Hook & Porter (Eds ) Population cytogenetics Studies in 
humans New York Academic Press, Ine, 1977, 237-250) 
Stark & White (In Hook & Porter (Eds ) Population cytogenetics Studies 
in Humans New York Academic Press, Ine, 1977, 275-283) 
Ament (American Journal of Epidemiology 1976,103 342-343) 
Rothman (American Journal of Epidemiology 1976,104 585-586) 
Janerich & Jacobson (The Lancet 1977a, 1 515-516) 
Janench & Jacobson (The lancet 1977b,I 1004-1005) 
Robinson (Advances in Pathobiology 1977,6 214-226) 
Robinson & Puck (The Lancet 1977,2 981-982) 
Sever (The Lancet 1977,1 754) 
Mikkelsen (Human Genetics 1981,2 (suppl) 211-226) 
Jongbloet (The Lancet 1983,2 347-348) 
Anonymus (The Lancet 1983,1 1312-1313) 
ICPEMC (Mutation Research 1986,175 263-266) 
Other publication on (almost) 
the same population included Nielsen et al (Humangenetik 1973,19 67-74) 
in this review Nielsen et al (Annales de Génétique 1981,24 212-215) 
Less than 50 DS cases 
Robinson & Puck (American Journal Human Genetics 1967,19 112-129) 
Haynes et al (Neurology 1974,24 691-700) 
Seifert & Sommer (American Journal of Diseases of Children 
1986,140 822-824) 
Drugan et al (Fetal Therapy Clinical Advances 1989,4 195-199) 
No DS prevalence per month 
Leek (The Lancet 1966,2 457-460) 
Halevi (British Journal of Prevention and Social Medicine 1967,21 66-77) 
Baird & Miller (British Journal of Prevention and Social Medicine 
1968,22 81-85) 
Hook et al (The Lancet 1974,1 566-567) 
Iselius & Lindsten (Human Genetics 1986,72 133-139) 
No DS prevalence at birth 
Jongbloet (Clinical Genetics 1971,2 315-330) 
Jongbloet (In Blandau (Ed ) Aging Gametes Basel S Karger AG, 1975, 
300-329) 
Pun & Singh (Br J Clin Pract 1995,49 129-130) 
Not compared to total or live 
births in corresponding 
period and place 
Jongbloet et al (Human Genetics 1982,62 134-138) 
Jongbloet & Vneze (Human Genetics 1985,71 241-248) 
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In Table 2, an overview is given of the remaining 20 studies on seasonality in DS. 
Because of the influence of photoperiodicity on hormone production, the studies are 
listed by latitude. If two studies were performed at the same latitude, the one with the 
largest number of DS cases is mentioned first. The authors of 13 studies concluded that 
no relation was present between the month of birth and DS prevalence20"32. Seven 
studies33"39 reported seasonality in DS prevalence. 
These seven studies33"39 were not a selective group in the number of DS cases, the 
prevalence of DS or latitude. Their numbers of DS varied from 103 to 2,469, and in 
the other 13 studies from 139 to 3,810. The prevalence of DS was in the range from of 
0.88 to 2.4 per 1,000 in the seven studies, and from 0.43 to 1.86 per 1,000 in the other 
studies. The seven studies were located between Scotland and Victoria, Australia. 
Overall, no consistent pattern was found in seasonal variation in these seven studies 
that reported a seasonal pattern, or in the trends reported in the other studies. An 
unexplained cluster of relatively high prevalences of DS births might be apparent in 
November/December at the extreme end of the northern hemisphere,21,24'26'27·29,36,38 but in 
the other months there was no consistent pattern. As the studies with a low number of 
DS cases may have missed a seasonal pattern, we focused on studies with more than 
1000 DS births which gave information on the monthly prevalence of 
Qg 21,24,25,28,29,33,35.38,40 j n m ¡ s s e i e c t ¡ v e group of studies, no comparable seasonal pattern 
was found in DS at birth. They showed the same direction in prevalence of DS in 
comparison with the average prevalence per month only in two single months. There 
was a relatively high prevalence of DS births during August and a relatively low 
prevalence during June in the northern hemisphere, while the opposite pattern was 
observed in the southern hemisphere. During the other months, some of these nine 
studies reported a relatively high prevalence of DS, whereas the others showed a 
relatively low prevalence. 
Discussion 
In this review, no obvious seasonal pattern was found in DS prevalence at birth. Some 
factors can influence the DS prevalence at birth: maternal age, induced abortions after 
prenatal diagnosis41 and shortened gestation.42 Maternal age can only confound the 
relation between the season and the occurrence of Down syndrome if pregnancy 
planning during the year differs according to woman's age. As this is not apparent, 
confounding by maternal age is not expected. If there is a seasonal pattern in DS at 
conception, induced abortions after prenatal diagnosis might have weakened this 
pattern, but would not have changed the positions of the peaks and troughs of a 
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seasonal pattern at birth. Although a seasonal pattern in preterm birth may exist,43 it 
would only cause a minor shift in a seasonal pattern for DS. Thus, it is unlikely that 
these factors would have masked a seasonal pattern in DS at birth. Moreover, some 
misclassification of Down syndrome might have occurred. Only 8 studies24"28'31'38'39 
mentioned the number of karyotyped cases of Down syndrome, the percentage of 
karyotyped cases varied from 15% to 100%. However, we do not expect that 
misclassification of Down syndrome was seasonally-bound and thus it can not have 
masked any association between season and the prevalence of Down syndrome at birth. 
Another source of bias could be a seasonal pattern in spontaneous abortions. In 
their review, Hassold & Jacobs44 reported that approximately 2.3 per cent of all 
spontaneous abortions, 1.3 per cent of all stillbirths and 0.13 per cent of all live births 
have trisomy 21. They estimated that trisomy 21 occurs in almost 0.45 per cent of all 
recognized pregnancies and that only 23.8 per cent of all conccptuses with trisomy 21 
survive to term. As far as we know, there is only one article in which seasonality in 
DS was studied before birth. In that study, no seasonal variation was found in DS 
among 5,292 samples for prenatal diagnosis.45 However, as there were only 45 DS 
cases, the results were not very reliable. 
In brief, we have to conclude that there is no seasonal pattern in DS at birth. Thus 
we cannot support the hypothesis that the season influences the hormone production 
which results in Down syndrome. We cannot exclude the possibility, however, that a 
seasonal pattern in DS may exist at the time of conception, but disappears because of 
selective spontaneous abortions. To answer this question, a study using a very large 
number of prenatal karyotypes from an aselect group of women may provide more 
insight, especially if the nondisjunctions during the first meiosis of maternal origin are 
considered separately. 
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3.1. A more realistic approach to the cumulative pregnancy 
rate after in vitro fertilization 
A.M. Stolwijk, C.J.C.M. Hamilton, J.M.G. Hollanders, L.A. Bastiaans, 
G.A. Zielhuis 
As most studies overestimate the cumulative pregnancy rate, a method is proposed to 
estimate a more realistic cumulative pregnancy rate by taking into account the reason 
for an early cessation of treatment with in vitro fertilization (IVF). Three methods for 
calculating cumulative pregnancy rates were compared. The first method assumed that 
those who stopped treatment had no chance at all of pregnancy. The second method, 
the one used most often, assumed the same probability of pregnancy for those who 
stopped as for those who continued. The third method assumed that only those who 
stopped treatment, because of a medical indication, had no chance at all of pregnancy 
and that the others who stopped had the same probability of pregnancy as those who 
continued treatment. Data were used from 616 women treated at the University 
Hospital Nijmegen, Nijmegen, the Netherlands. The cumulative pregnancy rates after 
five initiated IVF cycles for the three calculation methods were in the ranges from 
37-51% for the positive pregnancy test result, 33-55% for a clinical pregnancy and 
30-56% for an ongoing pregnancy. As expected, the first method underestimated the 
cumulative pregnancy rate and the second overestimated it. The third method produced 
the most realistic cumulative pregnancy rates. 
Human Reproduction 1996;11:660-663 
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Introduction 
Information about the probability of pregnancy after successive treatments with in vitro 
fertilization (IVF) is important for candidate patients and for the physicians who are 
counselling them. Several authors have reported cumulative pregnancy rates and 
recognized the importance of the variation in patient populations and treatment, 
including age, type of infertility and ovulation stimulation regimen, on the cumulative 
pregnancy rates.'"6 Far less attention has been paid to the impact on cumulative 
pregnancy rated of the reason for early cessation of IVF treatment.7"9 
As it is neither ethical nor practical to force patients to continue IVF treatments 
until pregnancy or for a fixed number of treatments (e.g. at least five), the real 
cumulative pregnancy rate after five IVF cycles for a specific population cannot be 
calculated. Therefore, to estimate the cumulative pregnancy rate, assumptions are 
necessary about the probability of the occurrence of pregnancy for those who 
discontinue treatment without achieving pregnancy. Most studies assume implicitly that 
all the patients who stop treatment early have the same probability of pregnancy as 
those who continue.'"610 Haan et alu noted the importance of selective early cessation 
but compared the cumulative rate based on the assumption that the pregnancy rate of 
the first IVF treatment held good for the following IVF treatments with the cumulative 
rate based on the assumption that the same chance of pregnancy could be applied to 
women who stopped treatment early compared with those who continued treatment. 
Both of these methods will overestimate the real probability of pregnancy after 
successive IVF treatments. The other extreme, i.e. assuming that the women who stop 
IVF treatment early will never become pregnant, will obviously underestimate the 
cumulative pregnancy rate. The examples below show how large the bias can be. 
Recently Tan et аІъ presented a cumulative live birth rate of 68.6% after five IVF 
treatments in women who had previously achieved an IVF live birth. A life-table 
analysis was used because it takes into account the experience of the entire cohort by 
using all the treatment cycles. However, this method implicitly assumes that the women 
who stopped IVF treatment early (in this case before the fifth treatment) had the same 
probability of having a live birth as those who continued treatment. Using the number 
of women per IVF treatment and the cumulative live birth rates, the calculated number 
of live births following each of the five IVF treatments were 21 live births in 105 
women after the first treatment, six in 48 after the second, one in 30 after the third, 
one in 14 after the fourth and four in eight after the fifth. If we assume that none of 
the women who stop treatment early will ever achieve a live birth, the cumulative live 
birth rate would be 31 %. The actual rate would be higher of course, but certainly not 
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as high as the 68.6% presented by Tan et al. 
In the same manner, Guzick et α/' calculated the cumulative rates for clinical 
pregnancy in treatments where oocyte retrieval was performed, excluding couples in 
whom the male partner had poor semen characteristics. They reported a cumulative 
pregnancy rate after six cycles of 59.6%. Furthermore, they predicted the cumulative 
pregnancy rates after nine and 12 cycles to be 75% and 84%, respectively. As all these 
calculations implicitly assumed the probability of pregnancy for those who stopped 
treatment early to be the same as for those who continued treatment, these rates are 
overestimated. Here, the assumption that those who stopped treatment early would not 
become pregnant leads to a cumulative pregnancy rate of 27% after six cycles. The 
actual rate would be between 27% and 59.6%, analogues to the first example. 
More precise estimates of the cumulative pregnancy rates can be made if the reason 
for the early cessation of treatment is known. If, for instance, women stop treatment 
for financial or emotional reasons, they can be expected to have a higher probability of 
achieving a pregnancy than those who stop treatment because of poor IVF results such 
as low fertilization rates and poor embryo quality. To illustrate the importance of the 
assumption underlying the estimation of the cumulative pregnancy rates, here 
cumulative pregnancy rates have been calculated for patients of the University Hospital 
Nijmegen, the Netherlands during 1988-1993. Estimations assuming a difference in the 
probability of pregnancy for specific reasons for the discontinuation of treatment, were 
compared to those based on more extreme assumptions. 
Materials and methods 
At the University Hospital Nijmegen, the Netherlands, 872 women were treated for the 
first time with IVF between the August 1, 1988 and January 1, 1993. In this study only 
women were included who were treated with human menopausal gonadotropin in 
combination with a long protocol of gonadotrophin-releasing hormone agonist, with or 
without oral contraceptives during the preceding menstrual cycle, and who did not use 
donor spermatozoa (N = 616). Only the results of the first five initiated IVF treatments 
were analysed (whether or not oocyte aspiration and embryo transfer were performed). 
Three definitions of pregnancy were used: (i) positive pregnancy test result, measured 
16 days after embryo transfer; (ii) clinical pregnancy — a positive pregnancy test result 
and ultrasonographic evidence of at least one gestational sac 4 weeks after embryo 
transfer; and (iii) ongoing pregnancy — a pregnancy continuing for >12 weeks after 
embryo transfer. To calculate the cumulative rates for each of these types of 
pregnancy, only the data up to the first pregnancy in question were included in the 
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analysis. To be clear, data were also included if women did not achieve pregnancy 
during the first five treatments. 
Three assumptions were used to deal with the effect of the early cessation of IVF 
treatment (i.e. before a woman became pregnant): assumption I, women who stopped 
treatment had no chance of becoming pregnant; assumption II, women who stopped 
treatment had the same probability of becoming pregnant as those who continued; and 
assumption III, only the women who stopped treatment because of a medical indication 
had no chance of becoming pregnant, while the women who stopped treatment for 
other reasons had the same probability of pregnancy as those who continued treatment. 
A medical indication for stopping further IVF treatment was assumed to include: (i) a 
previous treatment with a fertilization rate of <10%, despite the presence of more than 
three large follicles (>15 mm) on the day of human chorionic gonadotrophin (HCG) 
administration and the performance of oocyte aspiration, or (ii) three or less large 
follicles during two previous treatments. 
The cumulative pregnancy rate after χ initiated treatments was calculated as 
follows:12 [1 - Π (1 - number of pregnant women in treatment χ I number of women 
at risk in treatment x)] · 100%. In this formula, Π indicates the product of the terms 
specified within the parentheses for each of the χ treatments. 
Results 
The number of women who achieved pregnancy per IVF treatment and who stopped 
after each treatment without becoming pregnant are shown in Table 1. Note, that the 
number of women who stopped treatment after a specific IVF cycle was the highest for 
the calculation of ongoing pregnancy, then for clinical pregnancy, and the lowest for 
the positive pregnancy test result. This was because all women who stopped treatment 
before achieving an ongoing pregnancy were also included in the numbers of those not 
achieving a positive pregnancy test result or a clinical pregnancy. The reverse situation 
did not apply. After the first IVF treatment, 42 women were advised to stop further 
treatment because of a medical indication; the corresponding figures were 58, 39 and 
15 after the second, third and fourth treatments respectively. 
The results of the calculations of the cumulative rates for a positive pregnancy test 
result, clinical pregnancy and ongoing pregnancy based on each of the three 
assumptions are shown in Figures ΙΑ-C and Table 1. As expected, the cumulative 
pregnancy rates were the lowest with assumption I, highest with assumption II and 
intermediate with assumption III (Table 1). The cumulative pregnancy rates after five 
successive IVF treatments ranged from 37 to 51% for a positive pregnancy test result, 
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Table 1. Cumulative pregnancy rates for successive in vitro fertilization (IVF) treatments 
calculated on the basis of three assumptions 
IVF No. of 
treatment women who 
became 
pregnant 
No. of 
women who 
stopped 
treatment* 
Positive pregnancy test result 
1 131 
2 56 
3 34 
4 5 
5 0 
Clinical pregnancy 
1 112 
2 56 
3 33 
4 4 
5 1 
Ongoing pregnancy 
1 94 
2 49 
3 33 
4 3 
5 3 
120 
102 
133 
31 
123 
105 
140 
37 
127 
109 
148 
42 
No. of 
Alti 
616 
485 
429 
395 
390 
616 
504 
448 
415 
411 
616 
522 
473 
440 
437 
women at riskt 
AII§** 
616 
365 
207 
40 
4 
616 
381 
220 
47 
6 
616 
395 
237 
56 
11 
A I I l | | t t 
616 
407 
307 
179 
158 
616 
423 
320 
186 
160 
616 
437 
337 
195 
165 
Cumulative 
pregnancy rate 
AI All 
21.3 
30.4 
35.9 
36.7 
36.7 
18.2 
27.3 
32.6 
33.3 
33.4 
15.3 
23.2 
28.6 
29.1 
29.5 
21.3 
33.3 
44.3 
51.3 
51.3 
18.2 
30.2 
40.7 
45.7 
54.8 
15.3 
25.8 
36.1 
39.5 
56.0 
(%) 
АШ 
21.3 
32.1 
39.6 
41.3 
41.3 
18.2 
29.0 
36.3 
37.7 
38.1 
15.3 
24.8 
32.1 
33.2 
34.4 
* Women who stopped after this treatment without becoming pregnant. 
t Number of women who did not become pregnant in the previous IVF treatment(s). 
Î Assumption I (Al): women who stopped treatment had no chance of becoming pregnant. 
§ Assumption II (All): women who stopped treatment had the same probability of pregnancy as 
those who continued. 
|| Assumption III (AHI): women who stopped treatment because of a medical indication had no 
chance of becoming pregnant, while those who stopped treatment for other reasons had the 
same probability of pregnancy as those who continued. 
TI Women included who stopped treatment after the foregoing IVF treatment(s) without 
becoming pregnant. 
** Women excluded who stopped treatment after the foregoing IVF treatment(s) without 
becoming pregnant, 
t t Women who stopped treatment because of a medical indication included; women who stopped 
treatment for other reasons excluded (in comparison with those at risk in the case of 
assumption II, for IVF treatment 2, +42; for treatment 3, +100; for treatment 4, +139; and for 
treatment 5, +154). 
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A. Positive pregnancy test result 
% Pregnant women 
60 
50 
40 
30 
20 
10 
0 
0 1 2 3 4 5 
IVF treatment 
B. Clinical pregnancy 
% Pregnant women 
60 
SO 
40 
30 
20 
10 
0 
0 1 2 3 4 S 
IVF treatment 
С. Ongoing pregnancy 
% Pregnant women 
60 
SO 
40 
30 
20 
10 
0 
0 1 2 3 4 S 
IVF treatment 
Figure 1. Cumulative rates for a positive pregnancy test result (A), clinical pregnancy (B) and 
ongoing pregnancy (C) for successive in vitro fertilization (IVI·) treatments calculated on 
the basis of three assumptions: ( ) assumption I, women who stopped treatment had 
no chance of becoming pregnant; ( ) assumption II, women who stopped treatment 
had the same probability of pregnancy as those who continued; ( ) assumption III, 
women who stopped treatment because of a medical indication had no chance of 
becoming pregnant, while those who stopped for other reasons had the same probability 
of pregnancy as those who continued treatment. 
Cumulative pregnancy rate 109 
from 33 to 55% for a clinical pregnancy and from 30 to 56% for an ongoing 
pregnancy. The cumulative pregnancy rates calculated by taking into account the 
reason for early cessation were 41% for a positive pregnancy test result, 38% for a 
clinical pregnancy and 34% for an ongoing pregnancy. 
Discussion 
In most of the studies that present cumulative pregnancy rates, the implicit assumption 
is that the women who stop IVF treatment before the occurrence of pregnancy have the 
same probability of becoming pregnant as those who continue. The consequence is an 
overestimation of the cumulative pregnancy rates, especially at higher IVF treatment 
numbers where many women stop further treatment. More realistic cumulative 
pregnancy rates can be estimated by incorporating the reason for early cessation of the 
IVF treatment in the assumption. Cumulative pregnancy rates based on the third 
assumption, which takes into account a medical indication for cessation of IVF 
treatment, will be the most reliable. However, as the probability of pregnancy in those 
with a medical indication for stopping treatment is assumed to be zero, it is reasonable 
to expect the cumulative pregnancy rate to be slightly underestimated. In particular, at 
higher treatment numbers this assumption will result in a slight underestimation, as 
women who received a medical indication for stopping further treatment only after the 
third or fourth cycle had reasonable results in at least one treatment cycle. 
The deviations in the cumulative pregnancy rates found when using the different 
assumptions arc highly dependent on the number of women who discontinued treatment 
before the occurrence of pregnancy. The overestimation of the real cumulative 
pregnancy rate by a life-table analysis (which uses the assumption that those who stop 
treatment have the same probability of becoming pregnant as those who continue) will 
be particularly large in clinics with a high percentage of patients for whom the IVF 
procedure is mainly performed for diagnostic purposes before a final decision is made 
to continue IVF treatment, e.g. in case of severe male infertility, unexplained infertility 
problems or a high level of follicle stimulating hormone in young women. In those 
cases, the method for the calculation of the cumulative pregnancy rate by taking into 
account whether or not one stopped treatment because of a medical indication 
(assumption III) is highly recommended. 
In a recent study, Alsalili et aln calculated cumulative pregnancy rates by using a 
life-table analysis. They discussed the importance of the underlying assumption that the 
probability of pregnancy is the same for those who continue and those who discontinue 
treatment. They state that: 'The two factors, prognostic information ... ' (which is used 
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to decide whether or not to continue treatment) '... and successive cycle reduction in 
fertility, work in opposite directions on the assumption that pregnancy rates are 
constant for treated and non-treated individuals. Acknowledging its limitations, life-
table analysis remains the conventional method for assessing IVF success and 
comparing results from different IVF centres.' Their argument for the two factors 
working in opposite directions is, however, incorrect. This can be explained by 
considering that those who stop treatment because of poor prior results (i.e. prognostic 
information) would have had a lower probability of pregnancy than those women who 
continued treatment, even if it is assumed that those who continued treatment would 
have a lower chance of pregnancy than in their previous cycle (i.e. successive cycle 
reduction). It seems that the authors confused the assumption made in life-table 
analysis: the probability of pregnancy for those who continue and those who 
discontinue treatment is not assumed to be the same at every cycle but in fact it applies 
to a specific cycle. Thus, the overestimation when using life-table analysis remains. 
One result that might seem strange is that the estimated cumulative pregnancy rate 
after five treatments was higher for ongoing pregnancy than for clinical pregnancy and 
lowest for a positive pregnancy test result when using assumption II (i.e. women who 
stopped treatment had the same probability of pregnancy as those who continued), as 
shown in Table 1. However, this can be explained by looking at the denominator, i.e. 
the number of women at risk. All women who had not yet achieve a pregnancy but had 
stopped treatment are excluded from the denominator. As for the calculation of 
cumulative rates per type of pregnancy, women should only be included if they did not 
achieve that particular kind of pregnancy; notice that the numbers of women included 
at the fifth cycle are not the same for the three definitions of pregnancy. From Table 1 
it can be inferred that only 11 women received a fifth IVF treatment because they had 
not achieved an ongoing pregnancy in the previous four cycles. Only six of them had 
not achieved a clinical pregnancy and four did not even have a positive pregnancy test 
result. As three and two of the women who were excluded from the calculation of the 
cumulative rate for a positive pregnancy test and clinical pregnancy after the fifth 
cycle, respectively, achieved an ongoing pregnancy during the fifth cycle, the 
cumulative pregnancy rate after the fifth cycle was higher for an ongoing pregnancy 
than for a clinical pregnancy or a positive pregnancy test result. 
Comparison of the cumulative pregnancy rates between clinics and between types 
of assisted reproductive techniques can be very misleading. Reasons for this are not 
only the use of different definitions of pregnancy and the kind of assumption used to 
calculate the cumulative pregnancy rates, but also differences in the characteristics of 
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the populations (e.g. age, type of infertility, reproductive history), the characteristics of 
treatments (e.g. type of ovulation stimulation protocol, experience of the IVF clinic) 
and the number of and reason for couples discontinuing treatment before the 
occurrence of pregnancy. Caution is thus required when calculating, interpreting and 
comparing cumulative pregnancy rates. The figures presented here are only valid for 
the IVF clinic in Nijmegen, the Netherlands, between 1988 and 1993. 
Multivariable prognostic models are necessary to take into account the influence of 
patient and treatment characteristics. In these models, the reason for cessation, i.e. a 
medical indication or another reason, should also be considered when calculating the 
cumulative pregnancy rate for specific patients. Only in that case can the cumulative 
pregnancy rate give reliable information for the candidate IVF patients. 
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3.2. Prognostic models for the probability of achieving 
an ongoing pregnancy after in vitro fertilization and 
the importance of testing their predictive value 
A.M. Stolwijk, G.A. Zielhuis, C.J.C.M. Hamilton, H. Straatman, J.M.G. Hollanders, 
H.J.M. Goverde, P.A. van Dop, A.L.M. Verbeek 
The aim of this study was to create reliable models to predict the probability of achieving 
an ongoing pregnancy during in vitro fertilization (IVF) treatment: model A, at the start 
of the first treatment, model B, at the time of embryo transfer, and model C, during the 
second treatment at the end of the first IVF treatment. Prognostic models were created 
using data from the University Hospital Nijmegen (Ν = 757) and applied to the data from 
the Catharina Hospital Eindhoven (N = 432), the Netherlands, to test their predictive 
performance. The predictions of model В (made at time of embryo transfer) were fairly 
good (c = 0.672 in the test population). For instance, 93% of the patients who had a 
predicted probability of achieving an ongoing pregnancy of <10% did not achieve an 
ongoing pregnancy. However, the predictions of the other two models (A and C) for 
Eindhoven were less reliable. The predictive value of model С was fairly high in 
Nijmegen (с = 0.673). Its poor performance in the test population may be explained partly 
by differences in effectiveness of the ovulation stimulation protocols and the decision 
about when to discontinue the cycle. Thus, before using prognostic models at an IVF 
centre, their reliability at that specific centre should be tested. 
Human Reproduction 1996;11:2298-2303 
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Introduction 
The probability that a patient will achieve an ongoing pregnancy should be evaluated as 
accurately as possible before a patient enters a programme for in vitro fertilization (IVF) 
and during the course of her treatment with IVF. In addition to the age of the woman and 
the aetiology of infertility (the standard indicators for success), better rules would be 
welcome for physicians when counselling a patient. Potential predictors of IVF success 
are: patient characteristics at entry to the programme, characteristics of the treatment itself 
and during treatment, and the intermediate results. 
Most studies on factors that may predict pregnancy after treatment with IVF have 
investigated only a few indicators, for instance age and the type of infertility,'"3 baseline 
follicle stimulating hormone (FSH), luteinizing hormone (LH) and oestradiol 
concentrations,4 ovulation stimulation treatment and ovarian response,5 endometrium 
thickness and uterine artery flow,6 sperm characteristics7 and age, oestradiol concentration, 
number and quality of oocytes and embryos.8 However, various simultaneous factors may-
influence the probability of achieving an ongoing pregnancy after IVF. It would therefore 
be desirable to create a model to predict the probability of achieving an ongoing 
pregnancy which includes all the relevant factors. Until now, only a few attempts have 
been made to do this for IVF910 and other assisted reproductive techniques."12 In the study 
by Hughes et al,9 age and failed fertilization due to poor sperm quality had a predictive 
value for success in subsequent IVF cycles. Haan et α/10 found that the probability of 
achieving an ongoing pregnancy after IVF treatment was increased by the presence of 
idiopathic infertility and decreased by the presence of a male factor, one ovary, the 
woman's age >36 years, primary infertility of at least 5 years duration and by a higher 
number of previous IVF treatments. Multivariate prognostic models should not be 
confused with explanatory models such as recently published by Roseboom et α/.'3 They 
discussed a multivariate model to explain the variation in the probability of pregnancy 
after embryo transfer. The variation was explained by the woman's age, average embryo 
morphology score, number of transferred embryos and an interaction term between tubal 
pathology and the woman's age. However, exclusion of the main effect of tubal pathology 
in the model makes a meaningful interpretation of the multivariate model difficult14 and 
may cause bias.15 Moreover, their statement in the results section '... with a 1 year increase 
of age, the probability of pregnancy for non-tubal patients decreased by 21%...' is 
obviously mistaken as a result of a wrong interpretation of the odds ratio in their study. 
Critical remarks can also be made about the methods used in the other four studies 
mentioned above.9"'2 All the cycles were combined, irrespective of the number of previous 
IVF treatments and the number of treatments per patient. Some studies based the inclusion 
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of factors on statistical significance of the relationship in univariate analyses, which can 
be influenced by other factors, instead of on the increase in the predictive power in 
multivariate models. Moreover, the predictions of these models were never tested in other 
populations. Thus, the validity of these prognostic models when used at other IVF centres 
can be questioned. 
The purpose of this study is to create reliable models to predict the probability of 
achieving an ongoing pregnancy during the first or second treatment cycles with IVF. We 
used data from the University Hospital Nijmegen, the Netherlands, to develop the models, 
and data from another centre to test their predictive value. 
Materials and methods 
To develop the prognostic models, data were used from couples who were treated by IVF 
for the first time in the period March 1991 to January 1995 at the University Hospital 
Nijmegen, the Netherlands. During this period IVF treatment hardly changed. To test these 
models, data were used from the Camarina Hospital, Eindhoven, the Netherlands. 
Guidelines on indications for IVF treatment in the Netherlands have been described by 
Jansen.16 In short, couples are only offered IVF treatment in case of bilateral 
tubapathology, in cases of unilateral tubapathology, male factor, endometriosis or cervical 
factor when other infertility treatments had not resolved the problem, and in case of 
idiopathic infertility after an infertility duration of at least 3 years. For both populations 
data were only included if the complete IVF treatment had been carried out at that 
particular IVF centre, no donor oocytes had been used and no intra-cytoplasmatic sperm 
injection (ICSI) had been performed. Patient characteristics prior to treatment are given 
in Table 1. 
Ongoing pregnancy was defined as a pregnancy which continued for longer than 12 
weeks after embryo transfer. To predict the probability of achieving an ongoing 
pregnancy, three models were developed that employed different moments of prediction. 
To predict the probability of achieving an ongoing pregnancy during the first IVF 
treatment, model A was made at the start and model В at the time of embryo transfer. For 
the prognosis of achieving an ongoing pregnancy during the second IVF treatment, model 
С was created at the end of the first IVF treatment. Table 2 presents the number of 
patients and pregnancies at each prediction moment. 
Model A 
This model was based on predictions made at the start of the first IVF cycle regarding the 
probability of achieving an ongoing pregnancy during the first IVF cycle. To develop this 
model, data were available from 757 couples whose first IVF cycle took place in 
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Table 1. Patient characteristics of the populations at the start of the first in vitro fertilization (IVF) 
cycle 
Woman's age (years) 
Duration of infertility (years)* 
Basal FSH (IU/1) 
Min. 
22 
0 
<0.6 
Nijmegen (Ν 
Max. Mean 
47 32.9 
20.5 4.4 
23 6.1 
η 
= 757) 
SD Median 
4.0 
2.8 
2.8 
%t 
33 
4.0 
5.7 
Min. 
21 
0 
§ 
Eindhoven (N 
Max. 
43 
20.5 
η 
Mean 
31.8 
3.7 
= 432) 
SD Median 
4.1 32 
2.7 3.5 
%i 
>1 Preceding gestations 
>1 Preceding spontaneous abortions 
>1 Preceding ectopic pregnancies 
>1 Preceding deliveries 
Indication for IVF 
Tubal exclusively 
Tubal and other(s) 
Male factor exclusively 
Male factor and other(s) 
Endometriosis exclusively 
Endometriosis and other(s) 
Cervical factor exclusively 
Cervical factor and other(s) 
Idiopathic infertility 
Two ovaries 
Sperm characteristics 
>20 * 106/ml 
>60% Normal forms 
>50% Motile 
Quality of motility >4** 
Anti-sperm antibodies, S or $ 
In sperm 
In woman's serum 
Use of donor spermatozoa 
256 
126 
62 
138 
168 
137 
133 
190 
44 
119 
27 
91 
138 
708 
630 
433 
416 
660 
66 
38 
29 
0 
33.8 
16.6 
8.2 
18.2 
22.2 
18.1 
17.6 
25.1 
5.8 
15.7 
3.6 
12.0 
18.2 
93.7 
83.2 
57.2 
55.0 
87.2 
8.7 
5.0 
3.8 
0.0 
162 
29 
23 
50 
147 
42 
941| 
34Ц 
34 
33 
1 
1 
96 
395 
§ 
§ 
§ 
§ 
10 
§ 
§ 
4 
37.5 
8.3 
6.6 
14.2 
34.6 
9.9 
22.1 
8.0 
8.0 
7.8 
0.2 
0.2 
22.6 
93.4 
2.3 
0.9 
* Number of missing values for duration of infertility in Nijmegen η = 374. 
t Number of missing values in Nijmegen: for two ovaries η = 1, anti-sperm antibodies $ or Ç, 
and in sperm η = 2. 
% Number of missing values in Eindhoven: for >1 preceding spontaneous abortions, ectopic 
pregnancies, deliveries, respectively η = 81, 81, 80, for the indications of IVF η = 7, for two 
ovaries η = 9. 
§ No information available. 
|| Donor spermatozoa was used for three patients. 
\ Donor spermatozoa was used for one patient (the other indication for IVF was tubal factor). 
** On a scale from 1 (worst) to 5 (best). 
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Nijmegen. To induce ovulation, all the patients received a long protocol of gonadotrophin-
releasing hormone (GnRH) agonist (usually Leuprolide; Abbott B.V., Amstelveen, the 
Netherlands or Suprefact; Hoechst Holland N.V., Amsterdam, the Netherlands) that was 
started on day 21 of the previous cycle and human menopausal gonadotrophin (HMG, 
Humegon; Organon Int. B.V., Oss, the Netherlands). Additionally, from August 1991 to 
January 1994, all the patients received oral contraceptives during the cycle that preceded 
the IVF cycle. To improve synchronization of follicle growth, some women received oral 
contraceptives before or after this period. To test the model, data were available from 432 
couples from Eindhoven who underwent their first IVF treatment between January 1990 
and June 1995 (another five couples were excluded from this population because 
information about the occurrence of an ongoing pregnancy was lacking). In this test 
population, the type of ovulation induction used most often (92.2%) was a short protocol 
of GnRH agonist (usually Suprefact; Hoechst Holland N.V.) and HMG (Humegon; 
Organon Int. B.V.) in a few cases supplemented by progestins in the preceding cycle. 
Table 2. Number of patients and ongoing pregnancies 
At start of first IVF 
At embryo transfer of first IVF 
At start of second IVF 
N 
757 
604 
454 
Nijmegen 
Pregnancies 
η 
88 
88 
61 
% 
11.6 
14.6 
13.4 
Ν 
432 
300 
275 
Eindhoven 
Pregnancies 
η % 
46 10.6 
46 15.3 
29 10.5 
Potential prognostic factors for the model that employed the onset of the first IVF 
cycle as the moment of prediction could only consist of information known at that 
moment, i.e. patient characteristics: age, period of infertility, reproductive history, basal 
FSH, indication(s) for IVF treatment, one or both ovaries present, sperm characteristics, 
anti-sperm antibodies in the woman or man, and information about the treatment protocol 
being used at that time: type of hormonal ovulation stimulation, maximum number of 
embryos that would be transferred, timing of human chorionic gonadotrophin (HCG) 
administration and type of culture medium. In Nijmegen, data on the duration of infertility 
were only available from patients who started IVF treatment between 1993-1994. 
Therefore the effect of the duration of infertility could only be estimated using the data 
from these 383 couples. Donor spermatozoa had not been used in Nijmegen, but it had 
been used in the test population in four and six patients during the first and second IVF 
cycles, respectively. If donor spermatozoa had been used, the sperm characteristics were 
considered to be good and the indication for IVF 'male factor' was considered to be 
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absent. We disregarded the results of cryopreserved embryo transfer. 
Model В 
Based on predictions made at the time of embryo transfer regarding the probability of 
achieving an ongoing pregnancy during the first IVF cycle. Only the data from couples 
who underwent embryo transfer during the first cycle were used to develop this model. 
Data were available from 604 (79.8% of the 757) couples from Nijmegen. To test the 
model, data could be used from 300 (69.4% of the 432) couples from Eindhoven. At this 
moment, information was added about preceding events during the cycle as potential 
prognostic factors, i.e. quality and number of oocytes retrieved, number of oocytes 
fertilized, quality and number of embryos transferred and whether the transfer had been 
uncomplicated as indicated by the use of a Wallace catheter, because in difficult cases a 
stiffer, Frydman catheter was used. In addition, information was known about the 
experience of the physician who performed the puncture and transfer; this could be used 
as a potential prognostic factor. Again, the results of cryopreserved embryo transfer were 
disregarded. 
Model С 
Based on predictions made at the end of the first IVF cycle regarding the probability of 
achieving an ongoing pregnancy during the second IVF cycle. To create this model, data 
were used from couples who did not have an ongoing pregnancy after the first IVF cycle 
or after a transfer of cryopreserved embryos and who started a second IVF cycle. In 
Nijmegen and in Eindhoven, 454 and 278 couples started a second IVF cycle, respectively. 
In Eindhoven, information about ongoing pregnancy was lacking for three couples during 
the second cycle, so the data from 275 couples could be used for the test. In addition to 
the factors mentioned above, the pregnancy test result after the first IVF cycle was a 
potential prognostic factor in this model. 
Statistical analysis 
Models were developed by using logistic regression analysis. The first step was to develop 
a prognostic model based on patient characteristics and, if appropriate, the intermediate 
IVF treatment results. The second step was to evaluate whether treatment characteristics 
added any prognostic value to the model. The third step was to test the model. 
Criteria for accepting variables as predictive factors in the model were based on 
statistical significance and added prognostic value, evaluated by using the с index [i.e. 
(number of concordant pairs + 0.5 * the number of tied pairs)/ total number of pairs] . ' 7 ' 8 
The с can be interpreted as the probability of a correct prediction for a random pair of a 
woman with an ongoing pregnancy and a women without a pregnancy. It is equal to the 
area under a receiver operating characteristic (ROC) curve.19 For the development of a 
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prognostic model, the erroneous exclusion of any prognostic factors (because of too little 
power) would be more deleterious than including too many factors. Therefore these criteria 
were given a high and low cut-off point, respectively; Ρ value < 0.10 and с > 0.005. The 
variables were selected according to a method akin to a stepwise selection method. Here, 
the selection criteria is based not only on a Ρ value (<0.10), but also on a change in с 
(>0.005). Special attention was given to multicollinearity. If this was present, only the 
variable with the highest predictive power was included in the multivariate model. If a 
variable did not meet the criteria in a univariate analysis, it thus could still be included in 
the prognostic model if the variable met the criteria when it was included in a multivariate 
model, i.e. after taking into account the prognostic value of other variables. In addition, 
a variable was omitted from the model if another factor was a stronger predictor and 
showed no additional predictive value. For sperm characteristics combined variables were 
created and their predictive value was evaluated against that of the separate sperm 
characteristics. 
To test the predictive validity of the models, the data from the other centre were 
applied. As the data from Nijmegen contained more potential predictors than the data from 
Eindhoven, the models selected as the best predictive could not always be fully tested. If 
a specific variable was lacking, the model was modified, if possible, by exchanging it with 
a similar variable, or otherwise by excluding the variable. To evaluate the reliability of the 
model, the с was calculated. If the model had reasonable prognostic value, the predicted 
probability and the observed result of IVF were compared. 
Results 
The models for predicting the probability of achieving an ongoing pregnancy, developed 
with the data from Nijmegen and tested with the data from Eindhoven, are presented in 
Table 3. 
Model A 
During the first IVF cycle, 88 (11.6%) out of the 757 women from Nijmegen and 46 
(10.6%) out of the 432 women from Eindhoven achieved an ongoing pregnancy. The only 
factors that had predictive value were a previous gestation and the woman's age. During 
testing, this model did not show any predictive value when applied to the data from 
Eindhoven (c = 0.497). 
Model В 
Embryo transfer was performed in 604 (79.8%) out of the 757 couples from Nijmegen in 
the first IVF cycle. In Eindhoven, embryo transfer was performed in 300 (69.4%) out of 
the 432 couples. The ongoing pregnancy rate per transfer was 14.6% in Nijmegen and 
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Table 3. Prognostic models for the probability of achieving an ongoing pregnancy (P) during the first 
in vitro fertilization (IVF) cycle or second IVF cycle 
Model 
A 
"в 
"c 
I л [P/(l-P)] = 
- 0.3350 
+ 0.8151 * >1 preceding gestation 
- 0.0620 * woman's age (years) 
~7.2(J34 
+ 0.5290 * >1 preceding gestation 
+ 0.0630 * no. fertilized oocytes 
+ 0.3464 * no. transferred embryos 
+ 0.4377 * no. transferred embryos of at 
least good quality 
""-7.0236 
+ 0.9886 * woman's age <30 years 
+ 0.6001 * woman's age 31-35 years 
- 0.8412 * idiopathic infertility 
+ 1.8638 * embryo transfer during first IVF 
cycle 
SE(ß) 
0.9503 
0.2349 
0.0297 
—5Г5399-
0.2422 
0.0260 
0.1711 
0.1297 
~Ь~І \2~ 
0.4146 
0.3886 
0.4537 
0.7336 
-2ln(L,/L2) 
df 
ρ value 
14.04 
df=2 
p=0.0009 
48.96~ 
df-4 
p=0.0001 
2Ö.88-
df=4 
p-0.0003 
Nijmegen 
at 
development 
N* с 
757 0.612 
"YÓ3~0J2Ï 
"
_4~54-"о!б73 
Eindhoven 
at testing 
N* с 
431 0.497 
17~1 Ö~672~ 
~2~7~1 Ö7528-
* Patients with missing values on one or more of the variables were excluded, i.e. for Nijmegen 0, 
1 and 0, and for Eindhoven I, 129 and 4 for models A (prediction at start of first IVF cycle 
regarding probability during first cycle), model В (prediction at embryo transfer regarding 
probability during first cycle) and model С (prediction at end of first IVF cycle regarding 
probability during second cycle), respectively. 
15.3% in Eindhoven. The prognostic model included the factors: at least one preceding 
gestation, the number of fertilized oocytes, the number of transferred embryos and the 
number of transferred embryos of at least good quality. The probability of achieving an 
ongoing pregnancy increased if there had been a preceding gestation and the higher the 
numbers. During the test, this model showed good predictive value (c = 0.672) and good 
predictive performance, as shown in Table 4. For instance, 93% of the women with a 
predicted probability of achieving an ongoing pregnancy of <10% did not achieve an 
ongoing pregnancy after embryo transfer. 
Model С 
To predict the probability of achieving an ongoing pregnancy during the second IVF cycle, 
only the data from the couples who received a second treatment could be used. Of the 454 
couples who received a second IVF treatment in Nijmegen, 61 (13.4%) achieved an 
ongoing pregnancy. In Eindhoven this occurred in 29 (10.5%) out of the 275 couples who 
underwent a second IVF treatment. The best prognostic model is shown in Table 3. Of 
prognostic value were: the woman's age in age-groups, the presence of idiopathic 
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infertility and embryo transfer during the first IVF cycle. However, this model did not 
show any predictive value in the test population (c = 0.528). 
Table 4. Predicted and observed percentages and numbers of women with an ongoing pregnancy 
during the first in vitro fertilization (IVF) treatment at the time of embryo transfer in 
Eindhoven 
Observed 
Percentage ongoing pregnancy 
No. women pregnant 
Total number of women 
0-<5 
0 
0 
16 
5-<10 
8 
5 
60 
Predicted probability (%) 
10-<15 15-<20 20-<25 
16 19 23 
6 6 3 
37 31 13 
25-<30 
25 
2 
8 
>30 
50 
3 
6 
Total 
15 
25 
171* 
* No prediction could be made for 129 women, because no information was available about the 
number of transferred embryos of at least good quality. 
Discussion 
This study showed that models for prediction of ongoing pregnancy due to IVF treatment 
can be developed with a fairly high prognostic value. However, this does not imply that 
the same models are predictive for patients treated at another clinic or even at the same 
clinic. Of the three models, only the one that made a prediction at the time of embryo 
transfer was fairly reliable in the other population. The other two models that made 
predictions at the start of treatment or after the first IVF cycle, however, seemed to be of 
little value when used in Eindhoven. Although model B, which predicts at time of embryo 
transfer, is of little clinical importance, it gives information about the reasons for the 
inadequacy of the prediction at the start of the cycle. For the two models at the start of 
the cycle, the ovarian response and oocyte aspiration are very important, but cannot be 
included as prognostic factors in the models because this information is not available at 
the start of the treatment. Whereas in the model that made a prediction at time of embryo 
transfer, the number and quality of the retrieved oocytes are potential prognostic factors. 
Therefore, one explanation for the poor reliability might be differences in the effectiveness 
of the ovulation simulation protocols, the long protocol of GnRH agonist in Nijmegen and 
the short protocol in Eindhoven. No oocyte aspiration was performed during the first IVF 
treatment in 7.4% (56 out of the 757) and 21.8% (94 out of the 432) of the women from 
Nijmegen and Eindhoven, respectively. During the second IVF treatment, these 
percentages were 4.6% (21 out of the 454) and 15.3% (42 out of the 275), respectively. 
Not only might the effectiveness of the ovulation stimulation protocol have influenced the 
cancellation rate, but also the timing of this decision differed between the two centres. 
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During the first IVF cycle, the percentage of cancelled cycles for the reason of too many 
follicles was only 1.8% in Nijmegen, but was as high as 31.5% in Eindhoven. This 
decision was made in Nijmegen if >25 follicles were present in combination with an 
oestradiol concentration of >20,000 pmol/1, whereas in Eindhoven, cycles were cancelled 
when >20 follicles were present. Whether the models developed in Nijmegen can make 
more accurate predictions if they are applied to an IVF centre that uses a long protocol 
of GnRH agonist and with fewer cancelled cycles remains to be seen. 
The present models were adapted to make testing possible, given the information 
available in the test population. The changes were negligible. Models A and С were not 
changed at all. In model В the number of follicles >15 mm was initially included in the 
model, but because of lack of this information in the Eindhoven population, it was 
exchanged with the number of fertilized oocytes. Moreover, in model В the sperm 
characteristics <60% normal forms and/or <20*106 spermatozoa per ml added minor 
predicting value, and were excluded from the model. Note that basal FSH had no 
additional predictive value, nor had the indications for IVF, except for idiopathic infertility 
in model C. 
For prognosis, the predictive value of a positive test and of a negative test are of more 
practical value than the sensitivity and specificity of a test. The predictive value of a 
positive test is the proportion of patients with a positive test who achieve an ongoing 
pregnancy, and the predictive value of a negative test is the proportion of the patients with 
a negative test who do not achieve an ongoing pregnancy. Thus, they illustrate whether 
the prognosis was right. Whereas the sensitivity and specificity of a test indicate whether 
the patients who achieved an ongoing pregnancy were classified well by the test. All these 
measures can be easily calculated using the data of Table 4. For instance, assume the cut­
off point for the test to be a predicted probability of 5%; the test is positive if the 
predicted probability is >5% and negative if <5%. The positive predictive value of this test 
is 16% (25/155) and the negative predictive value is 100% (16/16). This demonstrates that 
the test can indicate patients who do not achieve an ongoing pregnancy after IVF, but 
cannot predict who achieves an ongoing pregnancy. The sensitivity and specificity of this 
test are 100% (25/25) and 11% (16/146), respectively. 
Obviously, clinicians select their patients before treatment with IVF. If the study 
populations had included more extreme groups, those with a very high or a very low 
probability of success, then the reliability of the prognosis would have been better. The 
models we created only apply to populations that lie within the range of the characteristics 
presented in Table 1. As women of 40 years of age or older were poorly represented in 
Nijmegen (η = 34), the models may not be valid for them. In addition, information on the 
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duration of infertility was only available from 383 patients in Nijmegen. The potential 
prognostic effect of the duration of infertility might not have been detected because of too 
few observations. 
As the data were gathered retrospectively, it was not always possible to obtain full sets 
of information from the two databases. In some cases data were missing, or they were not 
present in the desired form. Moreover, the two hospitals had their own method of 
performing IVF and the patient populations might have differed on other aspects than 
those studied. Therefore it was more difficult to create a model that would make reliable 
predictions than if the data had been gathered in a standardized way for the purpose of 
prognostic studies at hospitals which use the same treatment protocols and the same 
definitions for each variable. To make it possible to create reliable prognostic models, we 
recommend setting up uniform national registries which also contain information about the 
basic fertility workup. 
The importance of testing prognostic models is evident. Untested prognostic models 
can be worthless when used for prediction at another (or possibly even the same) IVF 
clinic. Before a model can be used by another IVF centre, it should be tested with 
retrospective data from that centre, to establish whether it is a predictive model in that 
centre. Even before a model is implemented in the centre were it was developed, it should 
be tested with an entirely separate set of data from the same centre before one can rely 
on its predictive properties. 
References 
1. Piette C, De Mouzon J, Bachelot A, Spira A. In-vitro fertilization: influence of women's age on 
pregnancy rates. Hum Reprod 1990;5:56-59. 
2. Hull MGR, Eddowes HA, Fahy U, et al. Expectations of assisted conception for infertility. Br 
Med J 1992;304:1465-1469. 
3. Check JH, Lurie D, Dietterich C, Callan С, Baker A. Adverse effect of a homogeneous 
hyperechogenic endometrial sonographic pattern, despite adequate endometrial thickness on pregnancy 
rates following in-vitro fertilization. Hum Reprod 1993;8:1293-1296. 
4. Padilla SL, Bayati J, Garcia JE. Prognostic value of the early serum estradiol response to 
leuprolide acetate in in vitro fertilization. Fértil Steril 1990;53:288-294. 
5. Dor J, Seidman DS, Ben Shlomo I, Levran D, Karasik A, Mashiach S. The prognostic importance 
of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro 
fertilization (IVF) treatment. J Assist Reprod Genet 1992;9:228-232. 
6. Spernol R, Hecher K, Schwarzgruber J, Szalay S. Doppler-Flow-Messungen in der Atería uterina. 
Ein Prognosefaktor für den Erfolg bei der Behandlung durch 1VF? Ultraschall Med 1993;14:175-177. 
7. Enginsu ME, Pieters MH, Dumoulin JC, Evers JL, Geraedts JP. Male factor as determinant of 
in-vitro fertilization outcome. Hum Reprod 1992;7:1136-1140. 
8. Fluker MR, Siu CK, Gunby J, Daya S. Cycle characteristics and outcome in relation to ovarian 
response during in vitro fertilization. J Assist Reprod Genet 1993;10:504-512. 
124 Chapter 3.2 
9. Hughes EG, King C, Wood EC. A prospective study of prognostic factors in in vitro fertilization 
and embryo transfer. Fértil Steril 1989;51:838-844. 
10. Haan G, Bemardus RE, Hollanders JMG, Leerentveld RA, Prak FM, Naaktgeboren N. Results of 
IVF from a prospective multicentre study. Hum Reprod 1991;6:805-810. 
11. Guzick DS, Balmaceda JP, Ord T, Asch RH. The importance of egg and sperm factors in 
predicting the likelihood of pregnancy from gamete intrafallopian transfer. Fértil Steril 
1989;52:795-800. 
12. Nelson JR, Huppert L, Corson SL, et al. Predicting success of gamete intrafallopian transfer. Fértil 
Steril 1993;60:116-122. 
13. Roseboom TJ, Vermeiden JPW, Schoute E, Lens JW, Schats R. The probability of pregnancy after 
embryo transfer is affected by age of the patient, cause of infertility, number of embryos transferred 
and the average morphology score, as revealed by multiple logistic regression analysis. Hum Reprod 
1995;10:3035-3041. 
14. Breslow NE, Day NE. Statistical methods in cancer research. Volume 1 - The analysis of 
case-control studies. Lyon: International Agency for Research on Cancer; 1980. 
15. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologie research. Principles and quantitative 
methods. New York: Van Nostrand Reinhold Company; 1982. 
16. Jansen CAM. Indicaties voor in vitro fertilisatie. Nederlands Tijdschrift voor Obstetrie & 
Gynaecologie 1993;106:35-36. 
17. Harrell FE, Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. 
JAMA 1982;247:2543-2646. 
18. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, 
evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15:361 -387. 
19. Hanley JA, McNeil BJ. The meaning and use of the area under a Receiver Operating 
Characteristic (ROC) curve. Radiology 1982;143:29-36. 
Externally valid prognostic models 125 
3.3. The search for externally valid prognostic models for 
ongoing pregnancy after in vitro fertilization 
A.M. Stolwijk, H. Straatman, G.A. Zielhuis, C.A.M. Jansen, D.D.M. Braat, 
P.A. van Dop, A.L.M. Verbeek 
This study aimed to make reliable prognostic models for predicting ongoing pregnancy 
after the first and second in vitro fertilization (IVF) cycles. Models were developed 
using data from the University Hospital Nijmegen 1991-1994 and tested using data 
from Nijmegen 1995-1996 and two other centres. The internal validity was estimated 
by bootstrapping. Predictions were calibrated by shrinkage and prior probability. 
Discrimination was studied by the с index and observed proportions of women with a 
low predicted probability. Models, whether or not after shrinkage, did not discriminate 
well. Calibration by prior probability did not show any advantage. Nevertheless, 
specific situations seemed to exist in which the model for ongoing pregnancy during the 
second IVF cycle was reliable. The predictions were inaccurate in the Nijmegen 1995-
1996 population because of too small numbers of patients with a low probability. In 
general, the prognostic models should not yet be implemented in clinical practice. 
Further development and testing of the models is warranted. 
(submitted) 
126 Chapter 3.3 
Introduction 
Prognostic models can facilitate decision-making for patients and physicians and are 
therefore becoming increasingly popular. Important prerequisites for the 
implementation of these models in clinical practice are that they not only have 
adequate internal validity, but also show high external validity. Testing the internal 
validity using, for instance, the split-half method, gives only an indication of the 
amount of overfitting of the model to the data at hand. Whether an internally valid 
model will predict well in another population, thus whether it is externally valid, is still 
the question. To examine this, a model should be applied to other data than those on 
which the model was based. The predictive accuracy of a prognostic model can be 
expressed by calibration and discrimination. ' Calibration refers to the amount of bias in 
the predictions, while discrimination refers to the ability to separate patients with 
different outcomes. Unfortunately, prognostic models for the probability of pregnancy 
presented in the literature have not been validated at all2"5 or only their internal validity 
has been checked.6,7 The conclusions based on these studies are not always in line with 
the uncertainty still present in the models, however. For instance, Collins et al1 
estimated only the internal validity of their model, but concluded that the model 
predicted sufficiently accurately to be useful in the clinical management of infertility. 
Hughes et al3 concluded that their prognostic model '... provides patients with a more 
accurate prognosis before treatment', although their model was not even internally 
validated. Nelson et al5 based their conclusions regarding the correctness of the 
predictive performance of their model on a comparison between the observed outcomes 
and predicted outcomes in the same - total - population. Appropriately, Eimers et at 
mentioned that their model should be applied to an external population to check its 
validity. Nevertheless, they concluded that '...the chance to conceive spontaneously can 
be predicted.' 
Recently, we have developed two models to predict the probability of achieving an 
ongoing pregnancy during the first and second in vitro fertilization (IVF) cycles.8 The 
actual moments of prediction were the start and the end of the first cycle, respectively. 
We used data from one centre for developing the models and data from another centre 
for testing them. The models did not predict well at the test centre. The aims of this 
study were to determine whether this was just bad luck or a real reflection of low 
validity, and to explore possible ways of increasing the validity of these prognostic 
models for ongoing pregnancy after IVF treatment. To achieve these goals, we tested 
the original models using data from two other populations. Corrections were made for 
obvious differences between protocols for cancelling treatment by means of restriction. 
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Moreover, we studied whether the two developed models were overfitted because of 
the inclusion of too many potential prognostic factors. Internal validity was further 
evaluated by bootstrapping. Shrinkage was used to calibrate the predictions in order to 
avoid the effects of overfitting of the model. Further calibration was performed by 
taking the prior probability into account. 
Materials and Methods 
Two prognostic models were developed: Model I for predicting the probability of 
achieving an ongoing pregnancy during the first IVF treatment, and Model II for 
predicting the probability of achieving an ongoing pregnancy during the second IVF 
treatment; the first prediction was made at the start of the first IVF treatment, the latter 
at the end of the first treatment. Ongoing pregnancy was defined as a pregnancy which 
continued for longer than 12 weeks after embryo transfer. To develop and test the 
prognostic models, data from patients were only included if the complete IVF 
treatment had been carried out at that particular IVF centre, hormonal ovulation 
induction had been performed, no donor oocytes had been used and no intra-
cytoplasmatic sperm injection had been performed. In addition to these criteria, which 
were also employed in our previous study, we excluded any cycles in which donor 
sperm had been used and defined a stricter criterion for idiopathic infertility (excluding 
patients who underwent IVF treatment only because of hormonal dysfunction or 
unsuccessful intrauterine insemination by donor sperm). To develop Model II, for 
predicting an ongoing pregnancy during the second treatment, only data from patients 
were included who underwent a second IVF cycle after an unsuccessful first IVF 
treatment. The results of cryopreserved embryo transfer were disregarded. Four 
databases were available from Dutch IVF centres: 
1. University Hospital Nijmegen, 1991-1994 
Data from this population were used to develop the prognostic models described 
previously. The population consisted of 757 couples who were treated for the first time 
with IVF. Data from 454 of them could be used for predicting ongoing pregnancy 
during the second IVF cycle. 
2. University Hospital Nijmegen, 1995-1996 
After the development of the prognostic models, new data from the same IVF centre 
became available. These concerned data from 208 patients who underwent IVF for the 
first time and 127 patients who underwent their second IVF cycle during this period. 
3. Camarina Hospital Eindhoven 
Data from patients in Eindhoven were used to test the models developed in our 
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previous study. Data were available from 428 couples who underwent their first IVF 
treatment between 1990 and 1995 and from 268 couples who underwent a second 
treatment. 
4. Diaconessenhuis Voorburg 
Data were available from 1424 patients who underwent IVF treatment for the first time 
and from 1014 patients who underwent a second IVF treatment during the period 
1989-1994. 
The observed probabilities of achieving an ongoing pregnancy during the first and 
second IVF for each population are presented in Table 1. 
Table 1. Number of patients and ongoing pregnancies 
Nijmegen Nijmegen Eindhoven Voorburg 
1991-1994 1995-1996 
N Pregnancies N Pregnancies N Pregnancies N Pregnancies 
η % η % η % η % 
First IVF cycle 757 88 ГПб 208 34 16.3 428 46 ÌOJ 1424 236 \6І 
Second IVF cycle 454 61 13.4 127 22 17.3 268 28 10.4 1014 149 14.7 
Before starting to improve the prognostic models developed earlier on the basis of data 
from the Nijmegen 1991-1994 population, we studied whether the poor predictions in 
the Eindhoven population were due to chance. Therefore, we tested the models on data 
from another two populations: Nijmegen 1995-1996 and Voorburg. Moreover, as the 
criteria to cancel a cycle because of too many large follicles were wider in Eindhoven 
than in Nijmegen, we also tested the models on a selection of patients from Eindhoven 
after excluding any couples who discontinued the first IVF cycle because of too many 
follicles. 
If the number of variables that can be included into a prognostic model is large in 
comparison with the number of ongoing pregnancies, the model will be overfitted.' The 
consequence is low predictive performance in other populations. In this study, the 
number of variables considered for each model was fairly large: in Model I, the patient 
characteristics known at the start of treatment, and in Model II, the former 
characteristics plus the results of the first IVF treatment cycle. To decrease the number 
of potential prognostic factors and thereby the possibility of overfitting, new models 
were developed in which only variables were allowed that showed in any of the four 
populations: (i) nearly complete information (i.e. less than 2% missing values) and (ii) 
reasonable distribution (i.e. for dichotomous variables a smallest proportion of more 
than 5%, on the condition that it was not known beforehand that the variable was a 
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strong predictor). Logistic regression analysis was used to develop a prognostic model 
for the Nijmegen population of 1991-1994, by employing a stepwise selection method 
with a ρ value of 0.10 and a change in с index of 0.005 as inclusion and exclusion 
criteria. 
Next, bootstrapping was used to gain insight into the internal validity of the model 
and thus into the amount of overfitting of the model using the data from the Nijmegen 
1991-1994 population. For bootstrapping various samples are drawn with replacements 
from the original population. A new prognostic model is developed for each sample 
and applied to the original population to estimate the с index. We used 100 samples. 
For each bootstrap sample, logistic regression analysis was performed using a stepwise 
selection method, with as sole inclusion and exclusion criterion a ρ value of 0.10, 
because the selection criterion of the change in с index could not be operated 
automatically in SAS. The result of bootstrapping is a nearly unbiased estimation of the 
optimism of the model and thus of the internal validity of the model. 
Shrinkage is a calibration method that can be used to correct for overfitting. A 
heuristic shrinkage estimator was applied to the standardized independent variables. 
This shrinkage estimator is defined as (modelx2 - p) / modety2, where modelx2 is the 
likelihood ratio [-21n(L,/L2)] of the model with all the potential prognostic factors, 
based on the development population and p, the number of all potential prognostic 
factors.' To calculate the standardized independent variables, the mean and standard 
deviation were taken from the variable distribution in the development population. The 
result of shrinkage is that the predicted probabilities move towards the average 
probability. After application of the shrinkage estimator, the intercept was adjusted so 
that the observed and predicted numbers of pregnancies in the development population 
were equal. Subsequently, the models were tested again using the data from the other 
three populations. 
If the overall probability of achieving an ongoing pregnancy in the development 
population is considerably different from that in the test population and this is not due 
to the characteristics of the population, the predictions for the test population will 
systematically be too high or too low. The probabilities of achieving an ongoing 
pregnancy in the overall test populations were used to correct for these differences in 
prior probabilities, so that the total predicted and observed numbers of ongoing 
pregnancies in the test population matched. Observed and expected numbers of women 
with an ongoing pregnancy in each 5% probability category, if appropriate, were 
compared by determining the Hosmer-Lemeshow goodness-of-fit statistic for external 
validation (C
v
 which is distributed as χ2 with df = number of categories for the original 
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and shrunken model, and df — number of categories - 1 for the models which are 
calibrated by prior probability).'0 The effect of each of the strategies to improve 
validity, i.e. calibration by prior probability, shrinkage and a combination of these two 
methods, was evaluated on the basis of ρ values. 
The discriminative performance of a model was evaluated by calculating the overall 
discrimination and assessing the predictive value of a negative test. The overall 
discriminative performance is expressed in the с index [i.e. (number of concordant 
pairs + 0.5 * number of tied pairs) / total number of pairs].1" The с index can be 
interpreted as the probability of a correct prediction for a random pair that comprises a 
woman with an ongoing pregnancy and a woman without an ongoing pregnancy. The 
value of the с index is equal to the area under the Receiver Operating Characteristic 
(ROC) curve.12 As it is of clinical importance to identify couples who have a low 
probability of achieving an ongoing pregnancy during IVF treatment, the emphasis is 
put on the discriminative performance of the models to detect couples who have a 
probability of achieving an ongoing pregnancy of at the most 5% or 10%. This is 
equivalent to the evaluation of the predictive value of a negative test with a cut-off 
point of 5% and 10% predicted probability, respectively. Their complements, i.e. the 
proportions of women who achieved an ongoing pregnancy in the group of women 
with a predicted probability of 0-5% or 0-10%, have been presented with mid-p exact 
95% confidence intervals (CI).13 The probability of achieving an ongoing pregnancy 
after one IVF treatment is at best expected to match the natural fecundity in fertile 
couples, which is about 30% per cycle. Therefore, the predictive value of a positive 
test is expected to be low and cannot be used as a criterion to determine the 
discriminative ability of a prognostic model. 
Results 
The distributions of the patient characteristics, i.e. the potential prognostic factors 
present at the start of the first treatment to be used in Model I, in each of the four 
populations are shown in Table 2. In addition to patient characteristics, the results of 
the first IVF treatment are potential prognostic factors in Model II. The distributions of 
these factors in the couples who were included in the populations for developing and 
testing Model II are shown in Table 3. Testing of the models developed with data from 
the Nijmegen 1991-1994 population with data of the other populations seemed 
appropriate, because the ranges of the values of the potential prognostic variables in 
Nijmegen 1991-1994 were comparable with those in the other populations. 
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Table 4. Prognostic models for the probability of achieving an ongoing pregnancy (P) during the 
first IVF cycle or second IVF cycle 
Type of 
model*: 
Model 14 
Model II.§ 
Ln [P/(l-P)] = 
- 0.3350 
+ 0.8151 * >1 preceding gestation 
- 0.0620 * woman's age (years) 
- 1.1507 
- 0.0708 * woman's age (years) 
- 0.7478 * idiopathic infertility 
+ 1.8674 * embryo transfer 
during 1st IVF cycle 
SE(ß) 
0.9503 
0.2349 
0.0297 
1.3907 
0.0372 
0.4528 
0.7328 
-2ln(L,/L2) 
df 
ρ value 
14.042 
df=2 
p=0.0009 
18.068 
df=3 
p=0.0004 
N 
757 
454 
Nijmegen 1991-1994 
at development 
С С Shrink-
index index age 
adj.t (%) 
0.612 0.584 60.64 
0.669 0.603 49.84 
* For the dichotomous variables: value 1 if present, 0 if not present. 
t С index adjusted for the optimism calculated by bootstrapping. 
J Prediction at start of 1st IVF cycle regarding probability of achieving an ongoing pregnancy during 1st 
cycle. 
§ Prediction at end of 1st IVF cycle regarding probability of achieving an ongoing pregnancy during 2nd 
cycle. 
Table 4 describes the models developed using data from the Nijmegen 1991-1994 
population. The probability of achieving an ongoing pregnancy decreased with 
increasing age of the woman and increased if the woman had experienced gestation 
before IVF treatment. The с index at development was 0.61. Table 5 presents the 
results of testing this model using data from the Nijmegen 1995-1996, Eindhoven and 
Voorburg populations. The с indexes for Model I were 0.61, 0.50 and 0.55, 
respectively. Only one or two women in each population had a predicted probability of 
0-5%. The proportion of women with a predicted probability of 0-10% who became 
pregnant ranged from 9-16%. The description of Model II in Table 4 shows that the 
probability of achieving an ongoing pregnancy during the second IVF treatment 
decreased with increasing age of the woman and when idiopathic infertility was an 
indication for IVF, and increased if embryo transfer had been performed during the 
first IVF treatment. The с index of Model II at development was 0.67. After testing 
this model using data from the Nijmegen 1995-1996, Eindhoven and Voorburg 
populations, the с indexes were 0.58, 0.50 and 0.53, respectively (Table 5). The 
proportion of women with a predicted probability of 0-5% who achieved an ongoing 
pregnancy varied from 10-12%, while the proportion with a predicted probability of 
0-10% who became pregnant varied from 10-13%. 
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As the Eindhoven centre cancelled IVF treatment on the basis case of too many 
large follicles more readily than the Nijmegen centre, 29 couples whose first IVF 
treatment had been cancelled because of too many follicles (26 of them had a second 
IVF treatment) were excluded from the Eindhoven test population. Forty-six out of the 
remaining 399 women (11.5%) achieved an ongoing pregnancy during the first IVF 
cycle, while 21 out of the 242 women (8.7%) became pregnant during the second IVF 
cycle. Testing the models using data from this restricted Eindhoven population resulted 
in с indexes of 0.50 for Model I and 0.61 for Model II. The proportion of women with 
a predicted probability of 0-10% who became pregnant was 10% for Model I (Table 
5). For Model II, one third of the couples had a predicted probability of 0-10% and the 
observed proportion of women who achieved an ongoing pregnancy in this group was 
4% (Table 7). 
It was also studied whether cancellation formed an explanation for the poor 
predictive performance of the models on the Voorburg population. In Voorburg, 
however, IVF cycles were never cancelled because too many follicles were present. 
When we only considered the women who had undergone embryo transfer during the 
first IVF cycle, the probability of achieving an ongoing pregnancy during the first IVF 
treatment could be predicted accurately at the moment of embryo transfer with a model 
described in our previous study.8 The с index was 0.84 and the proportion of women 
with a predicted probability of 0-5% that became pregnant was 1.7% (95% CI 
0.8-3.0%). Such a low predicted probability occurred in 60% of the patients for whom 
information was available about prognostic factors: prior gestation and numbers of 
fertilized oocytes, embryos transferred and good quality embryos transferred. The 
proportions of first IVF cycles in which no oocyte aspiration was performed were 
comparable between Voorburg and Nijmegen 1991-1994 [9.6% (137 out of the 1424 
women) and 7.4% (56 out of the 757 women), respectively]. In Nijmegen and 
Voorburg, this part of the IVF treatment, between the start of the first IVF cycle and 
embryo transfer, differed only in the ovulation stimulation protocol: in Nijmegen a 
long protocol of gonadotrophin-releasing hormone agonist was used, whereas in 
Voorburg, in general, no agonist was used. This resulted more often in premature 
luteinizing hormone (LH) peaks in women in Voorburg than in Nijmegen (absolute 
numbers are unknown), with as consequence less follicles available for aspiration 
because of ovulations. However, when only women without a premature LH peak were 
considered at the Voorburg centre, both prognostic models did not predict any better. 
Thus the differences in type of stimulation protocols seemed not to be an explanation 
for the poor performance of the models in Voorburg. 
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Table 6. Shrinkage of the prognostic models for the probability of achieving an ongoing 
pregnancy (P) during the first IVF cycle or second IVF cycle 
Type of 
model*: 
Model I.f 
Model H.t 
Ln [P/(l-P)] = 
- 2.0533 
+ 0.3859 * 0.6064 
- 0.2458 * 0.6064 
- 1.9138 
- 0.2698 * 0.4984 
* (>1 preceding gestation -
0.33818)/0.47340 
* [woman's age (years) -
32.8666] / 3.96605 
* [woman's age (years) -
33.0419]/3.8083 
SE(ß) 
0.1200 
0.1112 
0.1177 
0.1700 
0.1415 
-21n(L,/L2) 
df 
ρ value 
14.042 
df=2 
p=0.0009 
18.068 
df=3 
p=0.0004 
Nijmegen 
1991-1994 
at development 
N 
757 
454 
С index 
0.611 
0.669 
- 0.2838 * 0.4984 * (idiopathic infertility - 0.1719 
0.17401)/0.37954 
+ 0.6790 * 0.4984 * (embryo transfer during 1st 1VF 0.2665 
cycle-0.84361)/0.36362 
* For the dichotomous variables: value 1 if present, 0 if not present. 
t Prediction at start of 1st IVF cycle regarding probability of achieving an ongoing pregnancy during 1st 
cycle. 
X Prediction at end of 1st IVF cycle regarding probability of achieving an ongoing pregnancy during 2nd 
cycle. 
Restriction of model development to variables with less than 2% missing values 
and at least a 5% proportion of dichotomous variables in any of the four populations 
(see Tables 2 and 3) led to the exclusion of the following potential prognostic factors 
for Model I: the duration of infertility, basal FSH, preceding spontaneous abortions, 
ectopic pregnancies and deliveries, cervical factor, number of ovaries, sperm 
characteristics and anti-sperm antibodies in the male or female. In addition, the 
following were excluded for Model II: the number of follicles, the number of 
transferred embryos of at least good quality and a positive pregnancy test result. 
Despite these restrictions, the models developed now were exactly the same as the 
original ones (see Table 4). Accordingly, the test results presented in Table 5 applied to 
this first attempt to increase internal validity. 
Bootstrapping, using the variables selected above, showed an optimism of 0.03 for 
Model I and 0.07 for Model II. Thus the с indexes adjusted for this amount of 
overfitting were 0.61 - 0.03 = 0.58 and 0.67 - 0.07 = 0.60 for Models I and II, 
respectively (Table 4). 
The shrinkage estimate was 61% [(15.24 - 6) / 15.24] for Model I and 50% 
[(19.94 - 10) / 19.94] for Model II. When the shrinkage estimator was incorporated 
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into Model I (described in Table 6) and tested on the three populations, the с indexes 
remained the same as before shrinkage (Table 7). None of the women had a predicted 
probability of 0-5%. The proportion of women with a predicted probability of 0-10% 
who became pregnant was 9-15%. For Model II, the с indexes were 0.57, 0.56 and 
0.56 for Nijmegen 1995-1996, Eindhoven en Voorburg, respectively. The proportion of 
women with a predicted probability of 0-5% who became pregnant was between 8% 
and 25%, whereas in the women with a predicted probability of 0-10%, between 10% 
and 14% became pregnant. For the restricted Eindhoven population that excluded the 
women whose first IVF cycle had been cancelled because of too many follicles, the с 
index was 0.50. The proportion of women with a predicted probability of 0-10% who 
became pregnant was 10% after shrinkage of Model I; after shrinkage of Model II, 
these values were 0.65 and 3%, respectively (Table 7). Calibration with the prior 
overall probability did not consistently lead to a better fit of the models (see goodness-
of-fit statistic results in Tables 5 and 7). 
Discussion 
This study showed that the models developed on the basis of the data from Nijmegen 
1991-1994 did not show a good predictive performance in the three test populations. 
As expected, the overall discriminative performances of the models were the highest in 
the Nijmegen 1995-1996 population, but the predictions of a 0-5% or 0-10% 
probability of becoming pregnant were imprecise because of too small numbers of 
women with such a low predicted probability. There was one exception: when the 
women whose first IVF treatment had been cancelled because of too many follicles 
were excluded from the Eindhoven population, the prognostic model for ongoing 
pregnancy after the second treatment predicted well which patients had a low 
probability of achieving an ongoing pregnancy. In this population of 238 couples, a 
predicted probability of less than 10% occurred in those (i) without embryo transfer 
during the first IVF cycle, irrespective of the woman's age or indication for IVF 
(η = 64), or (ii) with embryo transfer and idiopathic infertility who were older than 30 
years at the first treatment (n = 12), or (iii) with embryo transfer and no idiopathic 
infertility who were older than 41 years at the first treatment (n = 2). In the Voorburg 
population, we did not succeed in finding a subsample in whom the predictive 
performance was good. Perhaps the predictive performance of the models at the other 
centres was hampered because of differences in the definitions of idiopathic infertility 
between the centres. In the case of idiopathic infertility, patients were offered IVF 
treatment after infertility duration of at least 3 years in Nijmegen and Eindhoven, 
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whereas in Voorburg it was only offered to patients after 4 years of infertility. 
Consensus in definitions and treatment protocols would facilitate the creation of 
externally valid prognostic models for ongoing pregnancy after IVF treatment. 
Moreover, it is possible that there are factors which were incorrectly not identified to 
be prognostic, because information was incomplete or absent. This might apply to, for 
instance, basal FSH level and infertility duration. 
For bootstrapping, variable selection was only based on the ρ value, whereas for 
the original model, the selection was based on both the ρ value and the change in с 
index. In comparison with the original models (Table 4), selection based on only the 
ρ value gave the same results for Model I, but for Model II, the woman's age was 
excluded, while the number of fertilized oocytes was included. The с index of the 
original model was slightly higher than that of the model developed for bootstrapping 
(0.67 and 0.66, respectively). The amount of variation explained by the original model 
was comparable [-21n(L,/L2) = 18.07 df = 3 ρ = 0.0004 and -21n(L,/L2) = 16.71 df = 3 
ρ = 0.0008, respectively]. Thus, because of the less restrictive selection criterion, the 
optimism calculated for both models might have been somewhat overestimated and 
thus the internal validity underestimated. Nevertheless, bootstrapping revealed that the 
models were overfitted and low с indexes were found for the original population after 
correction for the optimism. This means that the overall predictive performance of 
these models in the test populations would not be high. However, it does not preclude 
a reasonable discriminative performance at the lower probability range. 
In concordance with the results of bootstrapping, the shrinkage estimators for 
Model I and II were fairly high: 61% and 50%, respectively. Although the overall 
predictive performances (c indexes) in the test populations improved in some instances, 
the predictive values of the negative tests did not increase noticeably (Tables 5 and 7). 
The presumed benefit of calibration using the prior probability was doubtful, even 
in this ideal situation in which the exact 'prior' probability was known. This seems to 
indicate that there was no centre- or time-period-specific probability, but only 
differences in the overall probability because of another distribution of population 
characteristics. 
In conclusion, Model I designed to predict at the start of the first IVF treatment the 
probability of achieving an ongoing pregnancy during the first IVF treatment, showed 
no discriminative ability as the с indexes were fairly low, the number of couples with a 
predicted probability of 0-5% was negligible and the predictions of a probability of 
0-10% imprecise. Model II, designed to predict at the end of the first IVF treatment the 
probability of achieving an ongoing pregnancy during the second IVF treatment, only 
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could identify well women with a low probability of achieving an ongoing pregnancy 
in the Eindhoven population after excluding the women whose first IVF treatment had 
been cancelled because of too many follicles. Despite this finding, the external validity 
of the presented prognostic models can still be questioned. The experience gained in 
this search for prognostic models for IVF, emphasizes the need for caution when using 
such models without proper testing. The models presented here require further 
development and testing. In particular, additional testing of the discriminative 
performance of the models on future patients at the Nijmegen centre is warranted, 
because they have not yet been adequately evaluated as the number of patients was too 
small. Shrinkage might be of some use to correct for overfitting. The discriminative 
performance of a prognostic model should be evaluated by focusing on the predictive 
value of a test in the low range of probability (the negative test) rather than by 
parameters reflecting the overall discrimination, such as the с index. 
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3.4. The impact of the woman's age on the success of standard 
and donor in vitro fertilization 
A.M. Stolwijk, G.A. Zielhuis, M.V. Sauer, C.J.C.M. Hamilton, R.J. Paulson 
Objective: To study the effect of the age of the woman who provides the oocytes or who 
receives the embryos on results of in vitro fertilization-embryo transfer (IVF-ET). Design: 
Historical cohort study. Multivariate regression analysis was used to study the age effect 
continuously and after adjustment for confounding. Setting: Patients of the University of 
Southern California, Los Angeles, California. Patients: Couples who underwent standard 
(N = 277) or donor IVF-ET (N = 294) between January 1991 and July 1995. Interventions: 
One cycle of standard or donor IVF-ET. Main outcome measures: Successive IVF 
outcomes from number of oocytes to ongoing pregnancy and several measures of 
pregnancy loss. Results: The number of oocytes decreased with aging of the oocyte 
provider. More women who received oocytes from donors aged 20 to 23 years had at least 
one good embryo transferred than women who received oocytes from older donors. The 
age of the woman who received the embryos had no effect on IVF outcomes. In women 
older than 40 years who underwent standard IVF, the probability of pregnancy decreased. 
No such relationships were observed for donor IVF, but all the oocyte donors were 
younger. Conclusions: An age effect for ongoing pregnancy was only found in women 
older than 40 years who underwent standard IVF independent of the lower number of 
oocytes and suggests decreasing oocyte quality. 
Fertility and Sterility (in press) 
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Introduction 
Diminished fecundity with increasing woman's age is well-documented. An increase in 
anovulatory cycles has been found in women after age 40 years' and in perimenopausal 
women who experienced a sudden break in menstrual cyclicity after years of regular 
cycles.2 Pregnancy rates are known to decline with increasing woman's age after artificial 
insemination with donor semen,3"5 after standard in vitro fertilization-embryo transfer 
treatment6"10 and after standard IVF-ET using intracytoplasmatic sperm injection (ICSI)." 
Nevertheless it is still somewhat controversial whether the woman's age during IVF 
treatment has an effect on oocyte production, oocyte quality or uterine receptivity. 
Treatment with donor oocytes offers a means of studying these effects separately. Sauer 
et al,u Abdalla et al,u Navot et alu and Check et aP found an effect of the woman's age 
on the quality of the oocyte, but no or only a negligible effect on uterine receptivity. In 
more recent studies, Sauer and coworkers16'7 have confirmed that there is no aging effect 
of the uterus in women undergoing donor IVF. However, Levran et о/,18 Flamigni et α/,19 
Borini et al20 and Cano et al2ì found an age effect also on uterine receptivity. In the 
former three studies, the conclusion was based on decreased implantation or pregnancy 
rates in older recipients, whereas Cano etal2[ based their conclusion on increased abortion 
rates. 
Meldrum22 suggested that the differences in hormone replacement protocols may 
explain why several studies found an aging effect of the uterus while others did not. He 
observed that a dose of 100 mg progesterone (P) per day administered intramuscularly 
(IM) could fully replenish the uterine capacity. This effect was corroborated by Check et 
al,]5 who could not find an aging effect of the uterus when hormone supplementation was 
prolonged until the endometrium thickness was >10 mm. However, this factor cannot 
explain the aging effects of the uterus found by Flamigni et al,]9 Cano et al21 and Borini 
et al20 whose patients were all supplemented with high doses of P. Moreover, Meldrum22 
suggested that the low rate of spontaneous abortions observed in older women after donor 
IVF could be explained by the corrective effect of the hormone replacement. However, 
Cano et al2i employed high doses of Ρ and found an increased rate of spontaneous 
abortion in women of >40 years. 
Other explanations for the controversy in results between studies might be found in 
the characteristics of the population and the methods used for analysis. Most of the studies 
that used data from donor IVF' 2 ' 1 4 · ' 5 ' 7 ' 1 8 ' 2 0 " 2 2 only examined differences in IVF results 
between two age groups. Existing age effects might have been missed because the chosen 
cut-off point did not maximize the differences between the two age groups. Also the range 
in age might have been too small to detect an effect. Moreover, often no adjustment was 
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made for the confounding effects of factors such as type of infertility and man's age. 
In this study we addressed the question of whether there is an effect of the woman's 
age on IVF outcomes by using a data base containing a wide age range of women who 
provided oocytes and women who received the embryos. Multivariate regression analysis 
was used to fully account for the age of the oocyte providers and recipients and to fully 
account for any potential confounding effects. 
Materials and Methods 
To study the effect of the woman's age on IVF results, data were used from patients who 
underwent standard or donor IVF at the University of Southern California, Los Angeles, 
California, between January 1991 and July 1995. Before acceptance for donor IVF, the 
women were screened to ensure that they were in good health.23 A normal uterine cavity 
was documented in all patients by a normal hysterosalpingogram or prior hysteroscopy. 
Additionally, all recipients underwent a 'mock cycle' of steroid replacement with an 
endometrial biopsy, indicating appropriate histologic response to the regimen. The protocol 
for ovarian hyperstimulation in the oocyte donor women was the same as that in the 
women who underwent standard IVF. Most women received a long protocol of 
gonadotropin releasing hormone (GnRH) agonist, started at the midluteal phase of the 
previous cycle, and human menopausal gonadotropin. Hormone supplementation of the 
oocyte recipients consisted of oral oestradiol (E2), starting approximately 3 days before the 
donor's initiation of hMG treatment. Progesterone supplementation was started on the 
morning after human chorionic gonadotropin had been administered to the donor. On the 
first day of Ρ supplementation, the recipient received 50 mg of Ρ IM followed by 100 mg 
daily. Pregnancies were supported by E2 and 100 mg Ρ daily until 100 days after embryo 
transfer. The women who underwent standard IVF received 25 mg Ρ IM daily 
commencing on the day of embryo transfer and continuing until approximately 9 weeks 
of gestation. These protocols have been described more extensively by Paulson et al.24 
Only the data from IVF cycles utilizing controlled ovarian hyperstimulation were 
included. We excluded any cycles in which ICSI had been performed and all those in 
which there was no male partner. Data from women who underwent standard IVF were 
only used if follicle aspiration had been performed. To prevent bias because of repeated 
cycles after unsuccessful treatment, only the first IVF treatment cycle of each woman was 
analyzed. If donor IVF had been performed after standard IVF, only the donor IVF cycle 
was included in the analyses. Information on cryopreserved embryo transfer was 
disregarded. A total of 571 couples met the criteria for inclusion: 277 women underwent 
standard IVF and 294 donor IVF. All the oocytes retrieved after one controlled ovarian 
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hyperStimulation cycle in a donor woman were donated to only one recipient. Each donor 
woman could give more than one donation. None of the oocyte donors underwent IVF 
treatment themselves. Characteristics of the couples are given in Table 1; the age 
distribution is shown in Figure 1. 
Table 1. Characteristics of the couples who underwent standard IVF or donor IVF 
Characteristic 
Agepr„v,dcr (years) 
Age
rKlpimt (years) 
Man's age (years) 
Infertility factor woman: 
Tubal pathology 
Endometriosis 
Transitional menopause* 
Menopausef 
Genetic 
Chemotherapy 
NoneJ 
Male infertility factor 
Use of donor sperm 
Long GnRH-agonist ovarian 
stimulation protocol 
Range 
Median 
Mean 
(SD) 
Missing 
Range 
Median 
Mean 
(SD) 
Missing 
Range 
Median 
Mean 
(SD) 
Missing 
η ( % ) 
η ( % ) 
η ( % ) 
η ( % ) 
η ( % ) 
η ( % ) 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
Standard IVF 
(Ν = 277) 
24-45 
36 
35.4 (4.5) 
0 
24-45 
36 
35.4 (4.9) 
0 
23-66 
38 
37.5 (6.3) 
22 
126 (49.8) 
27 (10.7) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
0 (0.0) 
100 (39.5) 
24 
90 (34.2) 
14 
25 (9.1) 
2 
237 (89.4) 
12 
Donor IVF 
(Ν = 294) 
20-37 
30 
29.2 (4.0) 
34 
24-59 
43 
42.2 (6.2) 
0 
24-74 
42 
42.2 (7.9) 
20 
0 (0.0) 
0 (0.0) 
160(55.7) 
111 (38.7) 
9(3.1) 
7 (2.4) 
0 (0.0) 
7 
113(40.7) 
14 
33 (11.2) 
0 
271 (95.4) 
10 
* Including previous IVF failure and elevated basal FSH levels. 
t Including premature ovarian failure and castration. 
Î Including unexplained infertility (n = 46) and male factor infertility only (n = 49); (for 5 couples 
missing information on male factor). 
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Number of women 
D Donors 
• Standard IVF 
Recipienti 
30 35 40 45 
Age of the woman (years) 
SS 59 
Figure 1. Age distribution of the oocyte donors, oocyte recipients and women who underwent 
standard IVF 
The following outcomes were recorded from each aspiration cycle: number of oocytes 
retrieved, number of fertilized oocytes (counted 1 day after insemination), number of 
transferred embryos of good quality (at 48 hours after insemination: even blastomeres and 
<10% fragmentation if <6 blastomeres or<25% fragmentation if >6 blastomeres), positive 
pregnancy test result, clinical pregnancy (>1 gestational sac observed by ultrasound), and 
ongoing pregnancy (>12 weeks after embryo transfer). In addition, the occurrence of no 
implantation after embryo transfer, pregnancy loss (within 12 weeks after embryo transfer) 
after a positive pregnancy test result, and spontaneous abortion (within 12 weeks after 
embryo transfer) after a clinical pregnancy were studied in relation to the woman's age. 
The impact of age was studied in three phases. Phase I: the relationships with the age 
of the woman who provided the oocytes (agepr0Vlder) and the number of oocytes, fertilized 
oocytes and number of good quality embryos transferred were studied for standard and 
donor IVF separately. Phase II: the effect of the age of the woman who received the 
embryos (agerecipiem) on IVF outcomes after embryo transfer was studied. Owing to the fact 
that each woman who underwent standard IVF was both the oocyte provider and embryo 
receiver, it could not be determined whether a correlation between agen and 
implantation or pregnancy outcome was due to oocyte or uterus factors. Therefore, the 
associations between agerecipient and implantation and pregnancy outcome data were 
examined only in donor IVF. Phase III: if such an association with agerecipient exists, the 
relationships of agepr0Vldcr with treatment outcomes after embryo transfer can only be 
studied in women who undergo donor IVF. If there is no relationship with age, 
'recipient' it can 
be assumed that there is no aging effect of the uterus in standard IVF as well. In that case, 
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information from both standard and donor IVF can be used to investigate whether there 
remains an effect of the ageprovidcr on the outcomes of IVF after embryo transfer. 
Linear regression was used if the dependent variable had a continuous distribution, 
whereas logistic regression analysis was used if the dependent variable was dichotomous. 
Results of logistic regression analysis are presented in the form of odds ratios (OR) with 
95% confidence intervals (CI). To study whether the relationship between the IVF result 
and the woman's age showed a change in trend, categories were made for each 5 years 
of age if the number of couples in the age group was reasonably large. As a reference 
category, the age group with the largest number of couples was chosen. When a change 
in age trend was suspected on the basis of the regression coefficients of these categories, 
we performed several regression analysis to locate the best cut-off point, which allowed 
for a change in the continuous age effect. The best cut-off point was selected by choosing 
the model with the highest explained variation in IVF result by age as expressed by the 
F-tcst or the likelihood ratio test [-21n(L,/L2)J. 
An association between the woman's age and the outcome of IVF can be confounded 
by the effects of several factors. Confounding can be detected by observing a substantial 
change in the regression coefficients of the age variables after adjustment for confounding. 
To adjust for confounding, all the potential confounders were included into the linear or 
logistic regression model as dummy variables. For the number of oocytes retrieved, 
potential confounding factors were the type of hormonal ovulation stimulation (long 
protocol of GnRH-agonist versus others) and, only for standard IVF, type of infertility of 
the woman who provided the oocytes (tubal pathology, endometriosis or none). For the 
relationships with fertilized oocytes and the number of good quality embryos transferred, 
potential confounders included also a male infertility factor and the age of the male 
partner. For the other IVF results, additional potential confounders were the type of 
infertility of the embryo recipient (for standard IVF: tubal pathology, endometriosis or 
none; for donor IVF: transitional menopause, menopause, chemotherapy or genetic). For 
a description of the definitions of the types of infertility in women see Sauer etal.tb Male 
infertility factor was defined as abnormal semen analysis, vasectomy reversal, failed 
hamster test or prior failed fertilization. If donor sperm was used, a male infertility factor 
was considered to be absent. Dummy variables of 5-year groups were constructed for male 
age, which provided the possibility of including a dummy variable for male age if donor 
sperm was used. 
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Table 2. IVF outcomes of the couples who underwent standard IVF or donor IVF 
IVF outcome Standard 1VF 
(N = 277) 
Donor IVF 
(Ν = 294) 
No. of Oocytes 
/aspiration 
No. of Fertilized oocytes 
/aspiration 
No. of Transferred embryos 
/aspiration* 
No. of Good embryos transferred 
/aspiration* 
No. of Embryos implanted 
/aspiration* 
% Embryos implanted 
/embryo transfert 
>1 Good embryo transferred 
/aspiration* 
Positive pregnancy test result 
/aspiration* 
Clinical pregnancy 
/aspiration* 
Ongoing pregnancy 
/aspiration* 
No implantation 
/embryo transfert 
Pregnancy loss 
/positive pregnancy test result*. 
Spontaneous abortion 
/clinical pregnancy§ 
Range 
Median 
Mean (SD) 
Missing 
Range 
Median 
Mean (SD) 
Missing 
Range 
Median 
Mean (SD) 
Missing 
Range 
Median 
Mean (SD) 
Missing 
Range 
Median 
Mean (SD) 
Missing 
Range 
Median 
Mean (SD) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
η ( % ) 
Missing 
0-57 
12 
13.1 (8.2) 
0 
0-31 
5 
6.3 (4.9) 
0 
0-8 
5 
3.8(1.8) 
0 
0-5 
0 
0.6(1.0) 
0 
0-3 
0 
0.4 (0.8) 
14 
0-100 
0 
9.1 (18.2) 
14 
91 (33.2) 
0 
83 (30.9) 
5 
70 (26.0) 
5 
62 (23.0) 
5 
117(74.4) 
14 
21 (25.3) 
5 
8(11.4) 
5 
0-58 
15 
16.4 (7.8) 
0 
0-24 
7 
8.0 (4.8) 
0 
0-9 
5 
4.3(1.5) 
0 
0-5 
0 
0.5 (0.8) 
0 
0-5 
0 
0.6(1.0) 
5 
0-100 
0 
13.4(21.9) 
5 
90 (30.6) 
0 
109 (37.2) 
1 
102 (34.8) 
1 
81 (27.6) 
1 
175 (64.1) 
5 
28 (25.7) 
1 
21 (20.6) 
1 
* Excluding 3 women with all embryos frozen after standard IVF. 
t Excluding 25 and 16 women without embryo transfer, respectively, for standard and donor IVF. 
І Excluding 189 and 184 women without a positive pregnancy test result, respectively, for standard and donor 
IVF. 
§ Excluding 202 and 191 women without a clinical pregnancy, respectively, for standard and donor IVF. 
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Results 
The IVF results of the couples who underwent standard or donor IVF are shown in Table 
2. No oocytes were retrieved after follicle aspiration in one woman who underwent 
standard IVF and in one donor woman. No fertilization occurred in another 19 couples 
with standard IVF and in 13 couples with donor IVF. Additionally no embryos were 
transferred in another five women with standard IVF and two women with donor IVF. In 
three women with standard IVF, all the embryos were frozen. 
The results of the effects of agepr0Vldcr and agerecipient are shown in Tables 3 and 4A-C. 
As confounding was present in many instances, only the adjusted results are shown for the 
analyses with 5-year age groups. If a change in age effect by using a cut-off point 
explained the variation in IVF outcomes better than a continuous age effect (as presented 
in Tables 3 and 4A-C), the regression coefficients or odds ratios accompanying the lines 
before and after the cut-off point are presented in the text. They are not shown in Tables 
3 and 4A-C. To calculate percentages of women who had a specific IVF outcome, the 
most common distribution of confounders was assumed: tubal factor for standard IVF and 
transitional menopause for donor IVF, a long protocol of GnRH-agonist, no male 
infertility factor, no donor sperm and male age of 38 years for standard IVF and 42 years 
for donor IVF. 
Table 3. Regression coefficients (ß) of linear regression analysis for crude and adjusted associations* 
between the woman's age from whom the oocytes are retrieved (=agepro%lllcr) and to whom 
the embryos's are transferred (=agerecipiall) and 1VF outcomes for standard and donor IVF 
separately 
IVF 
outcome 
No of 
oocytes 
retrieved 
/aspiration 
No of 
oocytes 
fertilized 
/aspiration 
ß 
SE(0) 
η 
Ρ 
В 
SE(ß) 
η 
Ρ 
Α Standard IVF and age 
Crade 
-0 51 
0 И 
277 
0 0001 
-0 16 
0 07 
277 
0 01 
Adj 
-0 47 
0 11 
245 
0 0001 
-0 04 
0 08 
225 
0 64 
(N = 277)t 
In categories (years) 
Adjustedi§ 
24-29 
6 25 
174 
1 50 
1 17 
30-34 
0 79 
120 
245 
0 002 
-0 37 
0 78 
225 
0 27 
40-45 
-1 11 
1 45 
1 14 
0 97 
В Donor IVF and 
Crude 
-0 29 
0 12 
260 
001 
-0 14 
0 07 
260 
0 06 
Adj 
-0 24 
0 12 
253 
0 05 
-0 04 
0 08 
227 
061 
1 agepr0Vlde, (N - 260) 
In categories (years) 
Adjusted! | 
20-24 
2 16 
1 37 
1 40 
0 88 
25-29 
0 83 
1 14 
253 
0 38 
0 04 
0 74 
227 
0 07 
35-37 
-0 86 
2 00 
3 27 
1 47 
Variables adjusted for were, for 'number of oocytes retrieved' type of hormonal ovulation stimulation and, 
only for standard IVF, type of infertility of the woman who provided the oocytes, for 'fertilized oocytes' 
additionally male infertility factor and man's age 
For standard IVF ageprovlder = agereclplcnt 
Ρ values in this column refer to the variation in IVF result explained by age as expressed in the F-test, π 
refers to the sample size 
Reference category 35-39 years 
Reference category 30-34 years 
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Table 4A. Odds ratios (OR) and 95% confidence intervals (CI) for crude and adjusted 
associations* between the woman's age and IVF outcomes for standard IVF 
IVF outcome 
At least 1 good 
embryo transferred 
/aspirationt 
Positive pregnancy 
test result 
/aspirationt 
Clinical pregnancy 
/aspirationt 
Ongoing pregnancy 
/aspirationt 
No implantation 
/embryo transferí 
Pregnancy loss 
/positive pregnancy 
test§ 
Spontaneous abortion 
/clinical pregnancy || 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
Crude 
0.98 
0.93-1.04 
274 
0.54 
0.99 
0.93-1.05 
269 
0.63 
0.96 
0.91-1.03 
269 
0.25 
0.96 
0.90-1.02 
269 
0.18 
1.07 
1.00-1.14 
238 
0.06 
1.11 
0.97-1.27 
76 
0.12 
1.08 
0.88-1.32 
65 
0.47 
A. Standard IVF and age (N 
Adjusted 
1.06 
0.97-1.15 
222 
0.18 
0.97 
0.89-1.06 
217 
0.95 
0.88-1.04 
217 
0.29 
0.96 
0.87-1.05 
217 
0.32 
1.09 
1.00-1.20 
196 
0.06 
1.07 
0.89-1.28 
69 
0.46 
1.01 
0.78-1.30 
59 
0.97 
- 277Л 
In categories (years) 
Adjusted** t t 
24-29 
1.16 
0.40-3.38 
0.52 
0.14-1.90 
0.47 
0.12-1.87 
0.56 
0.13-2.30 
1.41 
0.33-6.04 
0.74 
0.05-10.17 
30-34 
0.82 
0.39-1.71 
222 
0.33 
1.55 
0.75-3.19 
217 
0.15 
1.49 
0.71-3.11 
217 
0.11 
1.70 
0.78-3.68 
217 
0.09 
0.47 
0.21-1.05 
196 
0.05 
0.70 
0.17-2.93 
69 
0.75 
0.48ÎÎ 
0.07-3.28 
59 
0.45 
40-45 
2.19 
0.82-5.86 
0.55 
0.19-1.60 
0.47 
0.15-1.44 
0.43 
0.13-1.42 
2.17 
0.68-6.96 
2.71 
0.31-23.79 
1 
** 
t t 
« 
Variables adjusted for were, for 'number of good quality embryos transferred': type of hormonal ovulation 
stimulation, male infertility factor, man's age, and, only for standard IVF, type of infertility of the woman 
who provided the oocytes, for the 'other IVF results': additionally type of infertility of the embryo recipient. 
Excluding 3 women with all embryos frozen. 
Excluding 25 women without embryo transfer. 
Excluding 189 women without a positive pregnancy test result. 
Excluding 202 women without a clinical pregnancy. 
For standard IVF agep„ïlJer = ageTO,pie„,. 
Ρ values in this column refer to the variation in 1VF result explained by age as expressed in the likelihood 
ratio test, η refers to the sample size. 
Reference category: 35-39 years (OR = 1). 
Age group 20-34 versus >35 years. 
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Table 4B. Odds ratios (OR) and 95% confidence intervals (CI) for crude and adjusted 
associations* between the woman's age from whom the oocytes are retrieved 
(= ageprovlder) and 1VF outcomes for donor IVF 
IVF outcome 
At least 1 good 
embryo transferred 
/aspiration 
Positive pregnancy 
test result 
/aspiration 
Clinical pregnancy 
/aspiration 
Ongoing pregnancy 
/aspiration 
No implantation 
/embryo transfert 
Pregnancy loss 
/positive pregnancy 
testj 
Spontaneous abortion 
/clinical pregnancy § 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
Crude 
0.95 
0.89-1.02 
260 
0.14 
0.99 
0.93-1.06 
260 
0.78 
0.99 
0.93-1.05 
260 
0.66 
1.00 
0.94-1.07 
260 
0.97 
1.00 
0.94-1.07 
244 
0.89 
0.97 
0.87-1.09 
86 
0.61 
0.96 
0.85-1.08 
83 
0.48 
В. Donor IVF and ageprovll 
Adjusted 
0.94 
0.87-1.01 
227 
0.08 
0.98 
0.91-1.05 
227 
0.50 
0.98 
0.91-1.06 
227 
0.63 
1.00 
0.92-1.08 
227 
0.95 
1.01 
0.94-1.09 
215 
0.73 
0.99 
0.87-1.13 
76 
0.92 
0.99 
0.86-1.14 
73 
0.88 
In 
20-24 
1.98 
0.91-4.31 
1.82 
0.83-3.99 
1.79 
0.81-3.96 
1.21 
0.51-2.89 
0.61 
0.27-1.35 
1.81 
0.47-7.03 
2.11 
0.50-8.83 
ia (N = 260) 
categories (years) 
Adjusted | | t 
25-29 
0.97 
0.48-1.94 
227 
0.31 
0.88 
0.45-1.73 
227 
0.27 
0.90 
0.45-1.79 
227 
0.22 
0.93 
0.44-1.96 
227 
0.65 
1.19 
0.59-2.42 
215 
0.29 
0.64 
0.15-2.75 
76 
0.64 
0.87 
0.19-3.90 
73 
0.68 
35-37 
1.37 
0.36-5.17 
1.90 
0.52-6.91 
2.49 
0.67-9.29 
2.21 
0.57-8.47 
0.46 
0.12-1.70 
1.47 
0.11-19.47 
1.88 
0.14-25.35 
* Variables adjusted for were, for 'number of good quality embryos transferred': type of hormonal ovulation 
stimulation, male infertility factor and man's age, and for the 'other IVF results': additionally type of 
infertility of the embryo recipient. 
t Excluding 16 women without embryo transfer. 
% Excluding 184 women without a positive pregnancy test result. 
§ Excluding 191 women without a clinical pregnancy. 
|| Ρ values in this column refer to the variation in IVF result explained by age as expressed in the likelihood 
ratio test, η refers to the sample size. 
К Reference category: 30-34 years (OR = 1). 
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Table 4C. Odds ; ratios ι 
associations* 
(OR) and 9 5 % confidence intervals 
between the woman's age to whom 
(= age
r e c i p i e n l) and IVF outcomes for donor IVF 
IVF outcome 
Positive pregnancy 
test result 
/aspiration 
Clinical pregnancy 
/aspiration 
Ongoing pregnancy 
/aspiration 
No implantation 
/embryo transfert 
Pregnancy loss 
/positive pregnancy 
testj 
Spontaneous abortion 
/clinical pregnancy§ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
OR 
95% CI 
η 
Ρ 
Crude 
1.01 
0.97-1.04 
293 
0.72 
1.02 
0.98-1.06 
293 
0.37 
1.01 
0.97-1.05 
293 
0.69 
0.98 
0.95-1.02 
273 
0.44 
1.00 
0.93-1.07 
96 
0.97 
1.02 
0.94-1.10 
92 
0.65 
; (CI) for crude and adjusted 
the embryos's are 
С Donor IVF and age
recipie„, (N = 
Adjusted 
1.01 
0.96-1.06 
252 
0.69 
1.01 
0.96-1.07 
252 
0.63 
1.00 
0.94-1.06 
252 
0.92 
0.99 
0.94-1.05 
236 
0.70 
1.03 
0.94-1.13 
85 
0.53 
1.05 
0.95-1.16 
81 
0.31 
24-34 
0.95 
0.29-3.10 
1.04 
0.31-3.47 
1.08 
0.29-4.03 
0.76 
0.20-2.91 
0.65 
0.06-6.52 
0.63 
0.05-8.35 
294) 
In categories (years) 
Adjusted | | t 
35-39 
0.59 
0.23-1.47 
252 
0.80 
0.59 
0.23-1.52 
252 
0.70 
0.63 
0.22-1.78 
252 
0.88 
1.41 
0.54-3.69 
236 
0.75 
0.87 
0.15-5.11 
85 
0.97 
0.81 
0.11-6.18 
81 
0.85 
45-49 
1.01 
0.48-2.13 
1.20 
0.56-2.56 
0.88 
0.38-2.00 
0.76 
0.35-1.65 
1.18 
0.31-4.51 
1.68 
0.42-6.75 
transferred 
50-59 
0.85 
0.31-2.30 
0.94 
0.34-2.59 
0.74 
0.24-2.21 
0.94 
0.33-2.65 
1.18 
0.19-7.45 
1.75 
0.25-12.25 
Variables adjusted for were, for 'number of good quality embryos transferred': type of hormonal ovulation 
stimulation, male infertility factor and man's age, and for the 'other IVF results': additionally type of 
infertility of the embryo recipient. 
Excluding 16 women without embryo transfer. 
Excluding 184 women without a positive pregnancy test result. 
Excluding 191 women without a clinical pregnancy. 
Ρ values in this column refer to the variation in IVF result explained by age as expressed in the likelihood 
ratio test, η refers to the sample size. 
Reference category: 40-44 years (OR = 1). 
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Figure 2. Number of oocytes per age of women who underwent standard IVF because of tubal 
pathology and who received a long GnRH-agonist ovulation stimulation protocol, and 
regression lines with and without cut-off point 
Phase I: Agepr0Vlder and IVF outcomes before embryo transfer 
Both in standard IVF and in donor IVF the number of oocytes decreased steadily with 
increasing age of the woman who provided the oocytes (Table 3, columns A and B). For 
standard IVF, this association was best described ( F 2 2 3 9 = 11.02, ρ = 0.0001) by a model 
that allowed for a rapid decrease before the age of 32 years [ß = -1.25, SE(ß) = 0.38], 
followed by a slower decrease thereafter [ß = -0.19, SE(ß) = 0.17]. In Figure 2 data are 
shown from the women who underwent standard IVF because of tubal pathology, who 
received a long GnRH-agonist ovarian stimulation protocol. Both the accompanying 
regression lines are presented in the Figure, one using no cut-off point, and the better-
fitting one which used a cut-off point at 32 years. For donor IVF, the number of oocytes 
donated by women aged 20 to 37 years decreased steadily by 0.24 oocyte per year. 
The number of fertilized oocytes seemed to be negatively related to the age of the 
woman who provided the oocytes. However, this association disappeared after adjustment 
for confounding (Table 3, columns A and B). 
In standard IVF, the transfer of at least one good quality embryo was not related to 
the age of the woman who provided the oocytes (Table 4A). In donor IVF a change in age 
effect best explained the variation in this IVF outcome [-21n(L,/L2) = 11.49, df = 2, ρ = 
0.003]. At least one good embryo was transferred in 78% and 52% of the women who 
received oocytes from donors of 21 and 22 years, respectively (OR = 0.32, 95% CI 0.15-
0.70). This occurred in only about 27% of those with agepr0Vldcr of 23 years and older (OR 
• 
i , ! 
Continuo!!! 
Cut-off: 32 year» 
! « · · 
• : : ι
 J
 « * | ι ί " " " " * · - - " 
• : « • « ι . 
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= 1.01, 95% CI 0.92-1.10). All the women who underwent standard IVF were older than 
23 years. 
Phase II: Age
recipie„r and IVF outcomes after embryo transfer 
Next, analyses were performed to study whether the age of the women who received the 
embryos from donor IVF was related to pregnancy outcome. No association was found 
between age
recipicnt and the probability of a positive pregnancy test result, clinical 
pregnancy, ongoing pregnancy, implantation, pregnancy loss and spontaneous abortion 
(Table 4C). 
Phase III: Ageprovider and IVF outcomes after embryo transfer 
As the aging effect of the recipient seemed to be negligible, the question remained as to 
whether the age of the oocyte provider affected these six pregnancy outcome parameters. 
On the basis of these data on donor IVF, it was assumed that there would be no effect of 
an aging uterus either in women who underwent standard IVF. This provided the 
opportunity to study the effect of ageprov]dcr using data from both standard and donor IVF. 
The results of the analyses on agcprovider are shown in Tables 4A-B. 
In standard and donor IVF, a positive pregnancy test result was not related to the age 
of the woman who provided the oocytes. After adjusting for confounding effects and after 
allowing for a change in trend, the probability of clinical pregnancy, as well as the 
probability of ongoing pregnancy after standard IVF only decreased steadily when the age 
of the oocyte provider exceeded 40 years. [For clinical pregnancy until age 40 years: OR 
= 1.01, 95% CI 0.92-1.12; after age 40 years: OR = 0.30, 95% CI 0.10-0.87; -21n(L,/L2) 
= 10.37, df = 2, ρ = 0.006] [For ongoing pregnancy until age 40 years: OR = 1.01, 95% 
CI 0.91-1.12; after age 40 years: OR = 0.32, 95% CI 0.11-0.91; -21n(L,/L2) = 9.00, df = 
2, ρ = 0.01]. The probabilities of clinical pregnancy and ongoing pregnancy were 25-29% 
and 20-23% between the ages of 24 to 40, respectively. These probabilities decreased 
rapidly after age 40 years to 11% and 9%, respectively, and were even lower at higher 
ages. In donor IVF the ageprovider did not affect the probability of achieving a clinical or an 
ongoing pregnancy, but the women who donated the oocytes were 37 years or younger. 
The probability of no implantation after embryo transfer in standard IVF increased 
with increasing woman's age (Table 4A). With higher age of the oocyte provider more 
often no implantation occurred. The variation in implantation was best explained by a 
logistic regression model that allowed for a change in trend after age 40 years [after 
adjustment for confounding effects: until age 40 years: OR = 1.03, 95% CI 0.93-1.14; 
after age 40 years: OR = 3.47, 95% CI 1.19-10.14; -21п(Ь,Л.2) = 12.32, df = 2, ρ = 
0.002]. This resulted in a probability of no implantation that increased slightly from 70% 
at age 24 years to 79% at age 40. This probability increased drastically after age 40 years 
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to 93% at age 41 and higher at older age. Analogues to the absence of an ageprovider effect 
on the probability of achieving a clinical or an ongoing pregnancy in donor IVF, no age 
effect was found on implantation in women who underwent donor IVF (Table 4B), 
because all the women who provided oocytes were younger than 40 years. 
In women who underwent standard or donor IVF, no ageprovider trend was apparent for 
the occurrence of pregnancy loss after a positive pregnancy test, or for the probability of 
spontaneous abortion after a clinical pregnancy (Tables 4A-B). 
Discussion 
Several studies have addressed the effect of woman's age on the success of IVF treatment 
with donated oocytes (e.g. Sauer et α/,12,16 Abdalla et α/,13 Flamigni et α/;19 Navot et α/;14 
Check et a/;15 Cano et α/;21 Borini et al.20) The results were contradictory. The influence 
of confounding factors, the use of arbitrary cut-off points, small numbers of women under 
study and a narrow age range might have caused the disagreement. Therefore we 
performed this study. We used an extended data base of the donor IVF cycles described 
by Sauer et α/1216 and Legro et al}1 In contrast with these previous reports and reports by 
others, we studied the age effect continuously, adjusted for confounding effects and used 
only the first IVF treatment cycle to prevent bias from repeated cycles after a failed 
treatment cycle. 
Although the data base used in this study contained a relatively large number of 
couples who underwent standard or donor IVF, the number might still be too small to 
demonstrate statistically significant age effects. Therefore, we did not interpret the p-values 
too rigidly and we attached more importance to the values and the directions of the 
regression coefficients. 
The importance of adjusting for confounding is illustrated by the results found for 
fertilized oocytes. The number of fertilized oocytes was related to the ageprovidcr only when 
no adjustment was made for the effects of the stimulation protocol, infertility factor of the 
women who underwent standard 1VF, type of IVF, male infertility factor and male age. 
Thus, the relationship between the number of fertilized oocytes and ageprov,der could be 
explained by the unequal distribution of the confounding factors over ageprüV¡dcr. Although 
we presume that we were able to adjust for confounding effects of the most important 
confounders, there might have been residual confounding. Examples of such factors might 
have been the number of ovaries and the basal follicle stimulating hormone (FSH) levels 
of the oocyte providers. Unfortunately, this information was not available. 
We categorized the women according to age only to see whether there was a change 
in age effect. Where appropriate, we used the age distribution on a continuous scale to 
Woman's age and IVF 155 
describe the age effect and allowed for a change in age effect by incorporating a cut-off 
point. Some changes in the age effect were found at a certain age in the women who 
underwent standard IVF. The number of oocytes retrieved declined rapidly by 1.25 oocyte 
per year between 24 and 32 years of age and by only 0.19 oocyte per year after the age 
of 32 years. In the women who underwent standard IVF, the probability of achieving a 
clinical or an ongoing pregnancy per aspiration decreased and the probability of no 
implantation after embryo transfer increased sharply after the age of 40 years. Although 
the model provided the best explanation for the variation in IVF results at the specific 
cut-off points, models that used cut-off points of one year higher or lower were also 
reasonably accurate. Therefore, these cut-off points should not be considered too strictly. 
The authors of a recent study on standard IVF reported that they could not demonstrate 
a change in age effect.25 However, as they included age only as a (log)linear variable in 
the model, it was not possible (by definition) to find a change in trend. In other studies, 
changes in the age effect were reported. A decline of about 12% per year in the 
probability of conception after treatment with artificial insemination with donor semen 
only occurred after the age of 31 years.5 This cannot be compared directly to our age 
effect results, because of the difference in treatment, especially the ovarian 
hyperstimulalion. For example, it is possible that controlled ovarian hyperstimulalion 
delays the appearance of this age effect. Two studies on standard IVF found a gradual 
decrease in positive pregnancy test results or ultrasound evidence of a gestational sac and 
live birth rates after the age of 34 years9 and a steeper decline in the pregnancy rate after 
the age of 37 than before the age of 37 years.7 
Although the age of the oocyte provider was negatively related to the number of 
oocytes retrieved, there was no effect on the occurrence of a positive pregnancy test. A 
decrease in the ultimate aim of IVF treatment, to achieve an ongoing pregnancy, only 
occurred after the oocyte provider had reached 40 years of age. This was also reflected 
by the lack of implantation after embryo transfer and no clinical pregnancy. These effects 
were only found in the women who underwent standard IVF, but not in donor IVF. This 
might be explained by the age distribution of the oocyte donors: they were all younger 
than 38 years. Such findings might indicate an aging affect of the oocytes, but we consider 
the possibility that the effects were due to a decrease in the number of oocytes with age, 
without any loss of oocyte quality in older women. To determine whether this hypothesis 
holds, we studied in couples without male infertility factor who underwent standard IVF, 
whether the occurrence of an ongoing pregnancy was still related to the ageprovlder after 
controlling for the number of oocytes retrieved in addition to adjusting for the 
confounding factors. There was still a decrease in the probability of achieving an ongoing 
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pregnancy after the age of 40 years [until age 40 years: OR = 1.02, 95% CI 0.90-1.15; 
after age 40 years: OR = 0.31, 95% CI 0.11-0.89; -21n(L,/L2) = 9.03, df = 2, ρ = 0.01]. 
Moreover, the amount of variation in the occurrence of an ongoing pregnancy that could 
be explained by agepr0Vld(.r was similar in the model which included the number of oocytes 
and in the model which excluded the number of oocytes in couples without a male 
infertility factor [-21n(L,/L2) = 8.85, df = 2, ρ = 0.01]. Thus, the effect of agepr0Vlder was 
not caused by the number of oocytes retrieved. 
A larger proportion of the women who received oocytes from donors aged 20-23 years 
had at least one good quality embryo transferred than those who received oocytes from 
older women. This age effect was not found in standard IVF and might be explained by 
the age distribution of the women who underwent standard IVF: all the women were 24 
years or older. This seems to indicate that the younger the oocyte donor, the more oocytes 
that will be retrieved and the higher the probability that at least one good quality embryo 
will be transferred. When we examined this in couples without a male infertility factor 
who underwent donor IVF, the observed relationship still remained after controlling for 
the number of oocytes [until age 23 years: OR = 0.28, 95% CI 0.11-0.68, after age 23 
years: OR = 1.01, 95% CI 0.90-1.13; -21n(L,/L2) = 12.78, df = 2, ρ = 0.002]. The quality 
of the oocytes from young oocyte donors seemed to be better than that from older donors. 
This study shows that there is no aging effect of the uterus, but that there is an aging 
effect of the oocyte in women of older than 40 years. 
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4. Discussion 
The studies described in this thesis were performed to gain greater insight into human 
fecundity under natural conditions and in the case of treatment with in vitro fertilization 
(IVF). Interest in this subject was nourished by the hypothesis that in situations of 
diminished fecundity, the probability of poor reproductive outcome is increased.' Various 
topics are presumed to cause variation in fecundity. In this thesis, the main focus is on the 
season of the year and the characteristics of patients undergoing IVF treatment, such as 
the woman's age and indications for treatment. 
In this chapter, studies on seasonality in fecundity are discussed to reach a conclusion 
about the actual effect of the season on fecundity. Subsequently, the consequences are 
considered for the studies on seasonality in poor reproductive outcome. Next, the influence 
of the woman's age on fecundity is evaluated under natural circumstances and during IVF 
treatment. Prognostic models are used to address the study on variation in fecundity during 
IVF treatment. The importance of prognostic models and their limits are discussed. 
Attention is paid to the quality of reproductive outcome after in vitro fertilization. The 
impact of this thesis on clinical management and further research is considered. 
Seasonality in fecundity and poor reproductive outcome 
Whether the season influences fecundity is addressed in this thesis by studying ovulation, 
the time to pregnancy and IVF outcomes. No seasonal pattern was found in ovulations in 
our study (Chapter 2.2). Two other studies observed seasonality in ovulations in women 
living under extreme situations of photoperiodicity2 or temperature.3 It might be concluded 
that the seasonal influence on a female's potential to conceive is negligible in countries 
such as the Netherlands with less extreme variation in the photoperiod and temperature. 
A bimodal seasonal pattern was found in the time to pregnancy in French-Canadian 
women living in the 17th and 18th centuries, indicating the most fecund periods during 
December-January and June-July. The difference in waiting time was small 
(Chapter 2.4.2). 
We also studied whether there were seasonal patterns in IVF results by using data from 
the University Hospital Nijmegen. Seasonality was apparent in consecutive IVF outcomes: 
in the number of oocytes retrieved; additionally, in the patients from whom at least one 
oocyte was retrieved seasonality was also apparent in the fertilization rate, embryo quality, 
pregnancy rate and birth rate. The best results were seen in November-February 
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(Chapter 2.3). Conceivably, the quality of the oocyte or sperm was better during this 
period. Another research group published their results at the same time on a study 
performed using data from couples in whom the male partner had sufficient sperm 
function. They found the least fertilization in IVF cycles during July-September and 
considered this to be a coincidence as it was strictly caused by a low fertilization rate in 
July, while no such pattern was reflected in other IVF outcomes.4 Another study found no 
seasonal variation in pregnancy rate after the transfer of cryopreserved embryos during an 
unstimulated cycle.5 In our prognostic models for predicting an ongoing pregnancy after 
IVF treatment, the season did not fulfil the criteria for inclusion into the models, i.e. a ρ 
value of <0.10 and a change in с index of >0.005 (Chapter 3.2). These three latter studies 
indicate that another reason for the seasonal pattern found in our former study 
(Chapter 2.3) is more likely, namely changes in IVF treatment protocol during the year. 
For developing the prognostic models, only the IVF treatments that had been carried out 
since March 1991 were analysed, because no major changes had been introduced in the 
treatment protocol from that time on. However, treatments before March 1991 were 
included in the study on seasonality in IVF outcome. 
Thus, from these studies on seasonality in fecundity it might be concluded that 
seasonal variation in human fecundity is negligible nowadays in countries such as the 
Netherlands with moderate photoperiodicity, moderate temperature changes and minor 
seasonal variation in energy intake and energy expenditure. The consequence of this 
conclusion for studies on seasonality in poor reproductive outcome is that if a seasonal 
pattern in poor reproductive outcome is found in countries similar to the Netherlands, it 
is unlikely to be the result of variation in fecundity. With this in mind, it is not surprising 
that a critical review of studies on seasonality in Down syndrome at birth showed very 
inconsistent patterns (Chapter 2.5). 
Influence of the woman's age on fecundity under natural circumstances and 
during IVF treatment 
Under natural circumstances, it is well-known that a female's fecundity decreases with 
increasing age. This phenomenon was also reflected in the time to pregnancy 
(Chapters 2.4.2 and 2.4.3). Moreover, fecundity was expected to be reduced during the 
first years after the menarche. Our large-scale study on seasonality in the interval between 
marriage and the first birth in French-Canadian women in the 17th and 18th centuries 
supported this hypothesis (Chapter 2.4.3). The studies on the time to pregnancy in 
Denmark (Chapter 2.4.2), however, did not confirm these findings, probably because the 
number of young women was too small. In the case of IVF, the aging effect on pregnancy 
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was the most obvious in women after the age of about 40 years who used their own 
oocytes. As the reduction in the pregnancy rate after IVF could not be explained by a 
lower number of oocytes retrieved after controlled hormonal ovulation induction, the age 
effect seemed to be due to a decrease in oocyte quality (Chapter 3.4). This result gives 
additional reason to reconsider the age criterion for IVF treatment, as cost-efficiency will 
decrease after the age of forty. Moreover, decreased quality of the oocyte in these women 
might affect the quality of the offspring. 
Variation in fecundity during IVF treatment 
IVF treatment is obviously meant to increase fecundity, but the probability of achieving 
a livebirth after IVF treatment varies greatly between patients. Prognostic models were 
used to determine which characteristics of patients and treatment modalities can predict 
fecundity during IVF treatment. Such prognostic studies are of great practical importance, 
because the outcome of an IVF treatment is uncertain and it makes high physical and 
psychological demands, involves high financial cost and can have serious side-effects. The 
results of prognostic studies can provide patients and physicians with information about 
the likelihood of pregnancy, which will facilitate decisions. Moreover, these models might 
help policy makers to specify the indications for IVF treatment. 
Before prognostic models can be implemented in clinical practice, their external 
validity must be demonstrated. The external validity of untested or only internally 
validated prognostic models must be seriously questioned (Chapter 3.2). In Chapter 3.2, 
a description is given of the development of prognostic models with data from the 
University Hospital Nijmegen and their application to data from the Camarina Hospital 
Eindhoven. The overall predictive performance of the models was low, except for a model 
that predicted ongoing pregnancy at the moment of embryo transfer. Although this model 
has no clinical value, it does provide clues about an explanation for the poor results of the 
other models: differences in treatment between the two centres might have decreased the 
predictive accuracy. This formed one of the topics addressed in a subsequent study 
(Chapter 3.3). In patients from Eindhoven who did not have the first IVF' treatment 
cancelled because of too many follicles, couples could be identified that had only a 0-10% 
probability of achieving an ongoing pregnancy in the second IVF treatment. A further test 
of the models with data from the Diaconessenhuis Voorburg showed poor discriminative 
performance. Thus the external validity of the models is still questionable. To test whether 
the models performed well at the clinic where they were developed, new data from the 
University Hospital Nijmegen were used. The results were inconclusive, because of the 
small number of women with a low predicted probability of achieving an ongoing 
162 Chapter 4 
pregnancy. Thus more data and further testing are required. 
Poor reproductive outcome after IVF treatment 
The hypothesis that IVF treatment increases the risk of poor reproductive outcome 
prompted several follow-up studies. Apart from an increased risk of poor reproductive 
outcome because of a high rate of multiple births, several of these studies reported that 
there was no increased risk of poor reproductive outcome after a standard 1VF procedure 
[e.g.68]. There are, however, reports on singleton births after IVF that gave reason for 
concern, because of a relatively high prevalence of preterm births9"15 and (very) low birth 
weight for gestational age.""141617 It remains to be seen whether these differences were still 
be present after adjusting for the presumably higher frequency of unfavourable 
characteristics of the women undergoing IVF.1217 One study reported increased perinatal 
mortality,9 but other large studies could not confirm this finding."14 Increased perinatal 
mortality rates were found in spina bifida and transposition of the great vessels,18 minor 
congenital malformations15 and major congenital malformations;19 but in large studies, no 
overall increased risk of minor or major congenital malformations was found.9"" Children 
with a very low birth weight, who are small-for-gestational age or are bom prematurely, 
are at increased risk for developmental problems.20'22 As these situations occur more 
frequently after IVF than after normal conceptions, a high prevalence of developmental 
problems can be expected in both singleton and multiple births after IVF. However, 
studies have shown that the mental and physical development of children bom after IVF 
were not delayed in comparison with normally-conceived children, when amongst others, 
birth weight, gestational age and multiple deliveries were taken into account;23 this 
remained valid regardless of birth weight and gestational age.24 Other authors showed that 
IVF children had even higher scores on developmental scales than the standards.25,26 The 
frequency of poor reproductive outcome after cryopreservation of the embryos was not 
increased in comparison with fresh embryo transfer.27 But again, there was a higher 
frequency of low birth weight and preterm births in these children compared to normally-
conceived children.28 The conclusion of Sutcliffc et al29 that the proportion of minor 
congenital malformations was similar in children bom after IVF with cryopreserved 
embryo transfer and in children conceived normally was unconvincing: minor congenital 
malformations occurred in 32.4% and 22.2% of the children, respectively (odds ratio = 
1.7, 95% confidence interval 0.8-3.5). The quality of the reproductive outcome after 
intracytoplasmatic sperm injection (ICSI) also seems to be similar to that after standard 
IVF.30 However, the potential genetic risk in men who are offered ICSI still forms a 
reason for concern and the treatment itself may carry further risks.3'"33 It is necessary to 
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implement this technique conservatively, perform genetic screening of male patients and 
to follow-up subsequent offspring to study whether developmental and physical problems 
exist. Problems are especially likely to arise when ICSI is used in combination with 
spermatozoa retrieved from the testicles (TESE) or epididymis (MESA), because increased 
genetic aberrations may occur in sperm as a consequence of a genetic cause of subfertility 
and because immature gametes may be retrieved in the case of TESE or postmature 
gametes in the case of MESA. 
Consequences for clinical management 
It is concluded that there is no or negligible seasonal variation in human fecundity 
nowadays in countries such as the Netherlands with moderate photoperiodicity and 
temperature changes and with minor seasonal variation in energy intake and energy 
expenditure. The season is no longer an important factor, if it ever was, for influencing 
human fecundity in countries such as these. 
Valid predictions for an ongoing pregnancy after IVF are not yet possible, although 
there may be a few exceptions. In general, IVF physicians should not use the models 
described in Chapter 3.2 and Chapter 3.3, or inadequately validated models from the 
literature. Until prognostic models have made reliable predictions in other populations, the 
risk that they will give false predictions is too large. 
Consequences for further research 
Nowadays, seasonal variation in human fecundity is absent or negligible in countries such 
as the Netherlands with only moderate photoperiodicity, temperature changes and seasonal 
variation in energy intake and energy expenditure. Therefore, seasonality in poor 
reproductive outcome, because of seasonality in fecundity, is not to be expected. Research 
into this topic should focus on populations living under more extreme conditions. Even 
if seasonality in fecundity does become apparent, it will not be possible to formulate a 
specific hypothesis about low- and high-risk months for poor reproductive outcome, 
because such a hypothesis would have to take into account the seasonal pattern in 
ovulation, in sperm characteristics, perhaps in fertilization and nidation, early pregnancy 
loss and spontaneous abortions. 
In the Introduction, other natural situations of subfecundity are mentioned: just after 
discontinuation of the use of oral contraceptives, after pregnancy, during and after 
lactation, with an endocrine disease, in the case of extreme under- or overweight and 
during weight changes. Whether these and other natural conditions of subfecundity cause 
poor reproductive outcome remains to be studied, but valid epidemiological studies 
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concerning these topics are very difficult to realize (Chapter 1). 
The development of valid prognostic models for IVF outcome is hampered by the lack 
of consensus in treatment and registration and by the small numbers of patients available 
for study. For instance, there are no uniform indications for IVF treatment and the 
controlled hormonal ovulation induction protocols differ between centres. The 
characteristics of the patients, the performed treatment techniques and the outcomes should 
be registered and entered into a computer prospectively to achieve a database of high 
quality. All IVF treatments, whether they resulted in oocyte aspiration or not, must be 
included. The reasons for the discontinuation of treatment should be registered as well, to 
enable the estimation of realistic cumulative pregnancy rates (Chapter 3.1). Compiling a 
data registry in retrospect by using information form the patients' charts is vulnerable to 
incompleteness and errors. Consensus meetings for IVF treatment and prospective data 
gathering on a national, or even on an international basis, are recommended. The 
availability of high quality databases will enable the further development of prognostic 
models to predict, for instance, the cumulative probability of achieving a livebirth after 
successive IVF cycles and the probability that IVF treatment will result in poor 
reproductive outcome. 
Former studies have indicated increased prevalences of poor reproductive outcome, 
such as small-for-gestational age and preterm birth, in children bom after IVF, which were 
only partly due to an increase in multiple pregnancies. Several follow-up studies showed 
no impaired mental or physical development in children bom after standard IVF. Further 
studies on developmental problems in children should focus on other IVF modalities, such 
as the transfer of cryopreserved embryos and fertilization using ICSI, especially in cases 
of severe male subfertility that require spermatozoa collection from the testicles or 
epididymis. Furthermore, it is highly recommended that each new procedure implemented 
as part of the IVF treatment should be tested before it is widely used on subfecund 
populations. Such tests should focus on both the efficiency of the treatment and the 
development of children bom after the infertility treatment. 
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Summary 
This thesis addresses human fecundity, the ability to conceive within one menstrual cycle 
when pregnancy is desired and no contraceptive methods are used. A combination of two 
approaches has been used, namely studying natural conditions and situations during 
infertility treatment. The core questions were: 1) Is there seasonal variation in human 
fecundity? and 2) Which combinations of factors have prognostic value regarding the 
results of treatment with in vitro fertilization (IVF)? Such knowledge might give directions 
to prevention programmes for subfertility and the allocation of infertility treatments. 
Seasonality in human fecundity was expected because there is seasonal variation in 
reproduction in most mammals and several studies on humans have indicated seasonal 
patterns in hormone levels associated with reproduction, ovulation, sperm characteristics, 
the probability of becoming pregnant, the time to pregnancy and births. These studies did 
not find a consistent seasonal pattern, however. There might be a trend towards higher 
fecundity in women during the 'light season', whereas the fertility of men seems to be 
increased during the 'dark season'. 
The first studies in this thesis concern methodological issues related to epidemiological 
studies on seasonality in reproductive outcome. One problem in comparing results of such 
studies is the variety in parameters used to describe this. Three frequently used parameters 
are the prevalence, the index and the ratio observed versus expected. The validity and 
precision of these three parameters are the same, only their levels of convenience differ. 
The statistical feasibility of the prevalence is the best, therefore this parameter has been 
used throughout the thesis (Chapter 2.1.1). The application of a regression analysis using 
a cosine function is described for testing seasonal patterns, which allows for adjustment 
of confounding effects (Chapter 2.1.2). Whether seasonality in pregnancy planning can 
confound a relation between a seasonally distributed exposure and poor reproductive 
outcome was studied by means of simulations. Under realistic circumstances this 
confounding was negligible (Chapter 2.1.3). 
Seasonality in ovulatory cycles was studied using data from 407 women with 
menstrual cycles that were shorter than 6 weeks who had visited the fertility clinic at the 
University Hospital Nijmegen for the first time in 1991 or 1992. To establish whether 
ovulation had occurred serial transvaginal ultrasound was performed and midluteal 
progesterone levels were measured during one menstrual cycle. No seasonal variation was 
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found. It is likely that changes in the photoperiod, environmental temperature and in 
seasonal energy intake and energy expenditure are too small in the Netherlands to cause 
any detectable seasonal variation in ovulation nowadays, as two other studies found a 
seasonal pattern in ovulation under more extreme circumstances (Chapter 2.2). 
Some seasonal variation was found in the results of the first IVF cycles of 1126 
couples treated at the University Hospital Nijmegen between 1987 and 1993. The best 
results were achieved when treatments were started in November-February (Chapter 2.3). 
However, when only the data were used from first IVF treatments between 1991 and 1994 
(N = 757) to develop prognostic models for ongoing pregnancy, the season did not show 
any predictive value (Chapter 3.2). This indicates that seasonal changes in treatment 
protocols may have occurred in the earlier years of IVF treatment at this hospital. 
To study seasonality in the time to pregnancy, data were used from three Danish 
studies in which pregnant women (N = 3,657) and textile workers or pharmacy assistants 
who had been pregnant (N = 1,053 and N = 734, respectively) were asked about the time 
it had taken for them to conceive. A higher probability of a prolonged time to pregnancy 
was found before conceptions in February-April and a lower probability before 
conceptions in August-October. However, this pattern might have been confounded by 
seasonality in pregnancy planning (Chapter 2.4.1). Therefore another study was performed 
using data from a population registry containing information about 18.970 French-
Canadian women who married for the first time in the 17th or 18th century. The time to 
pregnancy was approximated by the interval between marriage and the first birth minus 
38 weeks. This study showed a minor bimodal seasonal pattern in the time to pregnancy, 
with the most fecund periods during December-January and June-July. Moreover, it was 
illustrated that a large bias in seasonality in the time to pregnancy can occur if the season 
is defined by the month of conception and seasonal variation in pregnancy planning is 
apparent (Chapter 2.4.2). 
About 70% of all Down syndrome are caused by maternal nondisjunction during the 
first meiosis, which occurs in the last few days before ovulation. Seasonal influence of 
fecundity might have an influence on this stage of oocyte ripening, because of intervention 
with hormone production by the hypothalamus-pituitary-ovarian axis. No consistent 
seasonal pattern was found in a critical review of twenty studies on seasonality in the 
prevalence of Down syndrome at birth which were published during the period 1966-1995. 
It is unknown whether a seasonal pattern in Down syndrome at the moment of conception 
disappears because of pregnancy loss. This could not be studied with the data available 
(Chapter 2.5). 
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IVF treatment is meant to increase fecundity. The cumulative pregnancy rates that have 
been presented in the literature often give a too optimistic impression of the fecundability 
achieved after successive IVF cycles. This overestimation will occur if one assumes that 
the couples who stop treatment without having achieved a pregnancy have the same 
probability of becoming pregnant as those who continue. Λ common reason for 
discontinuation of IVF treatment is, however, poor results. Λ more realistic estimation of 
the cumulative pregnancy rate is recommended, which takes into account the reasons for 
stopping treatment. This was illustrated by using the data from 872 couples who were 
treated for the first time with IVF at the University Hospital Nijmegen between 1988 and 
1992. In this population, the estimated cumulative ongoing pregnancy rates after five 
initiated IVF cycles was 30% under the most conservative assumptions, 56% under the 
optimistic assumption which is often used in the literature and 34% when the reason for 
stopping treatment was taken into account (Chapter 3.1). 
Prognostic modelling was used to asses which combinations of patient characteristics 
indicate low or high fecundability during IVF treatment. Information for patients about 
their probability of success with IVF treatment can be improved using prognostic models 
and they can assist physicians when counselling a patient. Prognostic models to predict the 
probability of achieving an ongoing pregnancy at several stages during IVF treatment were 
developed using data from the University Hospital Nijmegen 1991-1994 (Ν = 757). The 
models were applied to data from the Catharina Hospital Eindhoven (N = 432). The only 
prognostic factors at the start of the first IVF treatment regarding the probability of 
achieving an ongoing pregnancy during the first IVF treatment were the age of the woman 
and prior gestations. Prognostic factors for predicting ongoing pregnancy during the 
second treatment were: the age of the woman, idiopathic infertility and embryo transfer 
during the first IVF treatment. These two models which made predictions at the start and 
at the end of the first 1VF cycle did not show any predictive value in the Eindhoven 
population. However, a model that made predictions at the time of embryo transfer 
performed fairly well. Although this model has no clinical meaning, it suggests that the 
poor predictive performance of the other two models may arise because of differences in 
the ovulation stimulation protocols and in the decisions for cancelling the treatment 
because of the risk of ovarian hyperstimulation (Chapter 3.2). In a subsequent study 
(Chapter 3.3), it was found that these models also made poor predictions of the probability 
of achieving an ongoing pregnancy in IVF patients at the University Hospital Nijmegen 
in 1995 and 1996 (N = 208) and at the Diaconessenhuis Voorburg (Ν = 1,424), even after 
calibration of the model by using a shrinkage estimator to adjust for overfitting of the 
models. However, for Nijmegen the testing was imprecise because of the small number 
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of patients with a low predicted probability. When the women in the Eindhoven population 
in whom the first IVF cycles were cancelled because of too many follicles were 
disregarded, it became possible to identify patients with a maximum probability of at the 
most 10% of achieving an ongoing pregnancy during the second IVF cycle. This applied 
to one third of the Eindhoven population. Thus as the prognostic models do not show good 
external validity, widespread use in clinical practice is not yet recommended, although 
there might be exceptions for specific situations. In addition, prognostic models from the 
literature that have been inadequately validated should not be used in clinical practice, as 
they will lead too often to false predictions. 
It has been known for a long time that the fecundity of women decreases with 
increasing age. Using data from couples who underwent standard IVF treatment (N = 277) 
or IVF treatment with donor oocytes (N = 294) at the University of Southern California, 
Los Angeles, the USA, such a decrease in fecundity was also noticed during IVF treatment 
when the woman's own oocytes were used, but this could be solved by using donor 
oocytes. An effect of aging of the uterus did not seem to occur. In women who used their 
own oocytes there was a steep decrease in the probability of achieving an ongoing 
pregnancy after the age of forty years. As this lower probability could not be explained 
by the lower number of oocytes retrieved from these women, it indicates decreasing 
oocyte quality in older women (Chapter 3.4). 
The following can be concluded from the studies described in this thesis. Seasonality in 
human fecundity was absent or negligible in countries such as the Netherlands with only 
moderate changes in the photoperiod, environmental temperature and seasonality in energy 
intake and energy expenditure. A seasonal pattern in poor reproductive outcome in such 
countries is unlikely to be the result of seasonality in fecundity, because of the negligible 
seasonal pattern in fecundity and the large proportion of conceptuses that are lost before 
a pregnancy is recognized. Human fecundity during IVF treatment is negatively associated 
with the woman's age. Moreover, it seems to be positively influenced by a prior gestation. 
If an IVF treatment has been performed without success, fecundity seems to be lower 
during the next treatment cycle in the case of idiopathic infertility in comparison with 
other indications for IVF treatment, and higher if prior embryo transfer has been 
performed. As the developed prognostic models which are described in this thesis did not 
always show good external validity, in general, they cannot yet be used for decision-
making. 
If further research into seasonality in fecundity is warranted, it should focus on 
populations who live under circumstances of extreme changes in the photoperiod or 
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temperature, or who show large seasonal variation in energy intake and energy 
expenditure. A theoretically-supported hypothesis on high-risk seasons is a prerequisite for 
studies on seasonality in poor reproductive outcome, because of seasonal variation in 
human fecundity. Consensus meetings concerning IVF treatment and prospective data 
collection on a national or even on an international basis are recommended. This will 
facilitate further research into, for instance, prognostic models for the cumulative 
probability of achieving a live birth after successive IVF treatments and models for 
predicting poor reproductive outcome. Moreover, several current IVF treatment modalities 
and future modalities should be evaluated and should focus not only on the effectiveness, 
but also on the effect on the development of subsequent offspring. 
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Samenvatting 
Het vermogen van een vrouw om zwanger te worden, de fecunditeit, wordt uitgedrukt 
als de kans op zwangerschap per menstruatiecyclus bij vrouwen met zwangerschaps-
wens. In dit proefschrift is onderzoek beschreven naar variatie in de fecunditeit onder 
natuurlijke omstandigheden en tijdens infertiliteitsbehandelingen. De kernvraagstellingen 
zijn: 1) Is er seizoenvariatie in de fecunditeit? en 2) Welke combinaties van factoren 
zijn voorspellend voor de resultaten van behandeling met in vitro fertilisatie (IVF)? 
Dergelijke kennis kan aanwijzingen geven voor preventieprogramma's ten aanzien van 
subfertiliteit en voor de toewijzing van infertiliteitsbehandelingen. 
De hypothese dat er sprake is van seizoenvariatie in de fecunditeit bij de vrouw kwam 
voort uit het gegeven dat de meeste zoogdieren seizoengebonden voortplanting 
vertonen. Ook is seizoenvariatie waargenomen in diverse studies naar reproduktie-
factoren bij de mens. Dit betreft bijvoorbeeld hormonen geproduceerd door de 
hypothalamus-hypofyse-ovarium as, ovulaties, spermakenmerken, zwangerschapskans, 
de wachttijd tot zwangerschap en de geboortefrequentie. Deze studies laten geen 
consistent patroon zien, zij het dat een zekere trend aanwezig lijkt te zijn naar een 
verhoogde fecunditeit van vrouwen gedurende het seizoen met lange dagen, terwijl de 
mannelijke vruchtbaarheid het beste lijkt te zijn gedurende het seizoen met korte dagen. 
De eerste studies in dit proefschrift betreffen methodologische kwesties bij epide-
miologische studies naar de voortplanting. Zo vormt de verscheidenheid in parameters 
een probleem bij het vergelijken van de resultaten van dergelijke studies. Drie veel-
gebruikte parameters zijn de prevalentie, de index en de ratio waargenomen versus 
verwacht. Aangetoond is dat de validiteit en de precisie van deze drie parameters 
hetzelfde zijn, maar dat het gebruikersgemak verschilt. In dit proefschrift is voor de 
prevalentie gekozen, omdat de statistische mogelijkheden van deze parameter de beste 
zijn (Hoofdstuk 2.1.1). Vervolgens is een toepassing van regressie-analyse gepresen-
teerd waarbij seizoenpatronen getoetst worden via een cosinusfunctie. Deze methode 
biedt de mogelijkheid voor verstorende factoren te corrigeren (Hoofdstuk 2.1.2). 
Tenslotte is via simulaties nagegaan of seizoenvariatie in zwangerschapsplanning een 
relatie tussen een seizoengebonden expositiefactor en ongunstige zwangerschaps-
uitkomsten kan verstoren. Het blijkt dat onder realistische omstandigheden een derge-
lijke invloed te verwaarlozen is (Hoofdstuk 2.1.3). 
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Seizoen variatie in ovulaties is bestudeerd met behulp van gegevens van 407 
vrouwen die in 1991-1992 voor het eerst naar de infertiliteitskliniek van het Acade-
misch Ziekenhuis Nijmegen kwamen. Alleen vrouwen met menstruatiecycli korter dan 
6 weken werden in dit onderzoek betrokken. Tijdens één cyclus werd nagegaan of er 
een ovulatie optrad door om de dag of dagelijks de follikelontwikkeling via trans-
vaginale echoscopie te volgen en het progesteronniveau halverwege de luteale fase te 
bepalen. Er bleek geen seizoenvariatie in ovulaties te bestaan. Mogelijk is de variatie in 
daglengte, omgevingstemperatuur en energie-inname en -verbruik gedurende het jaar in 
Nederland te klein om tegenwoordig tot waarneembare seizoenvariatie in ovulaties te 
leiden, aangezien in twee andere studies bij populaties die leefden onder meer extreme 
omstandigheden wel seizoenvariatie in ovulaties geconstateerd was (Hoofdstuk 2.2). 
Enige seizoenvariatie is gevonden in de resultaten van de eerste IVF-cycli van 1126 
paren die in de jaren 1987-1993 behandeld zijn in het Academisch Ziekenhuis 
Nijmegen. Het beste resultaat trad op als de behandeling startte in de periode 
november-februari (Hoofdstuk 2.3). Het seizoen bezat echter geen voorspellende waarde 
toen alleen de gegevens van de eerste IVF-cycli in de jaren 1991-1994 (N = 757) 
gebruikt werden voor het ontwikkelen van prognostische modellen voor doorgaande 
zwangerschap (Hoofdstuk 3.2). Dit lijkt te wijzen op seizoengebonden veranderingen in 
behandelingsprotocollen in de beginjaren van IVF-behandeling in dit ziekenhuis. 
Om seizoenvariatie in de wachttijd tot zwangerschap te bestuderen, is informatie 
van drie Deense studies gebruikt waarin zwangere vrouwen (N = 3.657) en werk-
neemsters in de textielindustrie en apothekersassistenten die zwanger waren geweest 
(respectievelijk N = 1.053 en N = 734) ondervraagd zijn over de wachttijd tot zwanger-
schap. Bij concepties in februari-april werd een hoge kans op een lange wachttijd 
waargenomen en bij concepties in augustus-oktober een lage kans. Dit patroon kan 
echter verstoord zijn geweest door seizoenvariatie in zwangerschapsplanning (Hoofdstuk 
2.4.1). Daarom is een vervolgstudie uitgevoerd waarbij gebruik gemaakt is van een 
bevolkingsregister met informatie over 18.970 Franscanadese vrouwen die voor de 
eerste keer trouwden in de 17e of 18e eeuw. Als benadering voor de wachttijd tot 
zwangerschap is het interval tussen het huwelijk en de eerste geboorte minus 38 weken 
gebruikt. Er was sprake van een klein bimodaal seizoenpatroon met de meest fecunde 
perioden in december-januari en juni-juli. In deze studie is tevens geïllustreerd dat sei-
zoenvariatie in de wachttijd tot zwangerschap sterk vertekend kan zijn als het seizoen 
gedefinieerd is aan de hand van de maand van conceptie terwijl er seizoenvariatie in 
zwangerschapsplanning is (Hoofdstuk 2.4.2). 
Tenslotte is via literatuuronderzoek gezocht naar seizoenvariatie in het optreden van 
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Down syndroom. Ongeveer 70% van alle gevallen van Down syndroom is veroorzaakt 
door een matemale nondisjunctie gedurende de eerste meiotische deling. Deze deling 
vindt plaats gedurende de laatste dagen voor ovulatie. Seizoeninvloed op de fecunditeit 
zou dit stadium van de eicelrijping kunnen beïnvloeden door interactie met de hormo-
nen die hierbij betrokken zijn. In een kritisch overzicht van twintig studies die 
gepubliceerd waren in de periode 1966-1995 werd geen consistent seizoengebonden 
patroon gevonden in de prevalentie van Down syndroom bij geboorte. Het is niet 
uitgesloten dat er wel een seizoenpatroon in Down syndroom op het moment van de 
bevruchting bestaat, maar verdwijnt door selectieve voortijdige vruchtdood. De 
beschikbare informatie was echter niet toereikend om dit te bestuderen (Hoofdstuk 2.5). 
IVF-behandeling is bedoeld om de fecunditeit te verhogen. De in de literatuur gepresen-
teerde cumulatieve zwangerschapskans na IVF geeft echter een te optimistisch beeld 
van de bereikte fecundabiliteit na opeenvolgende IVF-cycli. Men neemt namelijk aan 
dat vrouwen die na een IVF-behandeling gestopt zijn zonder dat zij zwanger zijn 
geworden, bij een volgende IVF-cyclus dezelfde kans op zwangerschap zouden hebben 
als vrouwen die doorgaan met IVF. Omdat een slecht resultaat juist een veel 
voorkomende reden is om te stoppen met IVF-behandeling is er sprake van 
overschatting van de zwangerschapskans. Een realistischere benadering is dan ook 
aanbevolen waarin rekening gehouden wordt met de reden om met de behandeling te 
stoppen. Dit is geïllustreerd aan de hand van gegevens van 872 paren die voor de eerste 
keer in 1988-1992 in het Academisch Ziekenhuis Nijmegen behandeld zijn met IVF. De 
geschatte kans op doorgaande zwangerschap na vijf gestarte IVF-cycli was in deze 
groep 30% gegeven de meest behoudende veronderstellingen, 56% onder de 
optimistische assumptie die in de literatuur vaak gebruikt wordt en 34% als er rekening 
gehouden werd met de reden om te stoppen (Hoofdstuk 3.1). 
Via prognostische modellen is nagegaan welke combinaties van patiëntkenmerken 
op een lage of hoge fecundabiliteit tijdens IVF-behandeling wijzen. Dergelijke modellen 
zouden gebruikt kunnen worden als hulpmiddel voor de gynaecoloog om patiënten te 
informeren over hun kans op succes met IVF-behandeling. Prognostische modellen voor 
de kans op doorgaande zwangerschap bij IVF-behandeling zijn ontwikkeld met behulp 
van gegevens van het Academisch Ziekenhuis Nijmegen uit 1991-1994 (N = 757). De 
modellen werden toegepast op data van het Camarina Ziekenhuis Eindhoven (N = 432). 
Bij aanvang van de IVF-behandeling bleken alleen de leeftijd van de vrouw en een 
voorgaande zwangerschap een voorspellende waarde te hebben voor doorgaande 
zwangerschap bij de eerste IVF-behandeling. Prognostische factoren voor de kans op 
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doorgaande zwangerschap bij de tweede IVF-behandeling waren: de leeftijd van de 
vrouw, onverklaarde infertiliteli en embryotcrugplaatsing tijdens de eerste IVF-cyclus. 
Deze twee modellen voor de situatie bij respectievelijk het begin en het einde van de 
eerste IVF-cyclus vertoonden geen voorspellend vermogen in de populatie van 
Eindhoven. Een ander model voorspelde op het moment van de embryoterugplaatsing 
wel tamelijk goed de kans op doorgaande zwangerschap. Ofschoon het laatste model 
niet van klinische betekenis is, geeft het aan dat een mogelijke verklaring van het 
slechte voorspellend vermogen van de andere twee modellen zou kunnen liggen in 
verschillen in ovulatie-stimulatie protocollen en in de besluitvorming rond het stoppen 
van een behandeling om ovarium-hyperstimulatie syndroom te vermijden (Hoofdstuk 
3.2). In een vervolgstudie (Hoofdstuk 3.3) is gevonden dat de twee modellen ook slecht 
voorspelden bij patiënten van het Academisch Ziekenhuis Nijmegen in 1995-1996 (N = 
208) en van het Diaconessenhuis Voorburg (N = 1.424). Zelfs na kalibratie van de 
modellen door middel van een "krimpfactor" om een te sterke weerspiegeling aan de 
onderliggende gegevens te corrigeren, bleef de voorspellende waarde van de modellen 
teleurstellend. De resultaten van het testen van de modellen in de Nijmeegse populatie 
waren echter onnauwkeurig vanwege te weinig patiënten met een lage voorspelde kans. 
Als vrouwen in de Eindhovense patiëntenpopulatie bij wie de eerste IVF-cyclus 
afgebroken was vanwege de aanwezigheid van teveel grote follikels werden uitgesloten, 
dan bleek het mogelijk om de groep patiënten te identificeren die slechts ten hoogste 
10% kans had op een doorgaande zwangerschap in de tweede IVF-cyclus. Het gaat hier 
om een derde van de patiëntenpopulatie. Dit is een mogelijke uitzondering op de 
algemene conclusie dat de prognostische modellen wegens gebrek aan externe validiteit 
nog niet in de klinische praktijk toegepast kunnen worden. Dat geldt niet alleen voor de 
in dit onderzoek ontwikkelde modellen, maar ook voor prognostische modellen die in 
de literatuur zijn gepresenteerd terwijl zij onvoldoende gevalideerd zijn. De kans op 
foute voorspellingen is doorgaans namelijk te groot. 
Dat de fecunditeit van vrouwen afneemt bij het ouder worden is al lange tijd 
bekend. In een studie met gegevens van paren die een standaard IVF-behandeling 
ondergingen (N = 277) of een IVF-behandeling kregen met donoreicellen (N = 294) bij 
de Universiteit van Zuid-Califomië in Los Angeles, Verenigde Staten, bleek een 
dergelijke afname ook waarneembaar te zijn bij IVF-behandeling met eigen eicellen, 
maar niet indien donoreicellen gebruikt werden. Veroudering van de baarmoeder lijkt 
dus niet van belang voor de afname van de fecunditeit. Een scherpe daling in de kans 
op doorgaande zwangerschap trad alleen op bij vrouwen die hun eigen eicellen 
gebruikten na de leeftijd van 40 jaar. Deze verminderde fecunditeit kon niet verklaard 
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worden door het kleinere aantal beschikbare eicellen en duidt op verminderde eicel-
kwaliteit bij deze oudere vrouwen (Hoofdstuk 3.4). 
Uit de studies die in dit proefschrift beschreven zijn, kunnen de volgende conclusies 
getrokken worden. Seizoenvariatie in fecunditeit bij de mens lijkt niet of nauwelijks te 
bestaan in landen met een matige jaarlijkse variatie in daglengte, omgevingstemperatuur 
en energie-inname en -verbruik zoals Nederland. Dat een seizoenpatroon in ongunstige 
zwangerschapsuitkomsten in dergelijke landen veroorzaakt wordt door seizoenvariatie in 
de fecunditeit is onwaarschijnlijk, gezien de verwaarloosbare seizoenvariatie in fecun-
diteit en het verlies van een groot deel van de concepties voordat een zwangerschap 
geconstateerd wordt. De fecunditeit gedurende IVF-behandeling is negatief geassocieerd 
met de leeftijd van de vrouw. Het lijkt positief te worden beïnvloed door voorgaande 
zwangerschappen. Zodra een IVF-behandeling is uitgevoerd, lijkt de fecunditeit 
verlaagd bij onverklaarde infertiliteit als reden voor IVF-behandeling en verhoogd als 
tenminste één embryo is teruggeplaatst in de eerste cyclus. Aangezien de ontwikkelde 
prognostische modellen niet altijd extern valide waren, kunnen zij over het algemeen 
nog niet gebruikt worden bij besluitvorming. 
Indien verder onderzoek naar seizoenvariatie in fecunditeit gewenst is, zou het 
gericht moeten zijn op populaties die leven onder extreme jaarlijkse variatie in dag-
lengte, omgevingstemperatuur, energie-inname en -verbruik. Voor de studie naar 
seizoenvariatie in slechte zwangerschapsuitkomsten als gevolg van seizoenvariatie in de 
fecunditeit van de mens is een hypothese noodzakelijk waarin theoretisch goed onder-
bouwd is in welke seizoenen een hoog risico verwacht wordt. Consensusbijeenkomsten 
ten aanzien van IVF-behandeling en prospectieve dataverzameling op nationale of zelfs 
internationale basis worden aanbevolen. Dit kan verder onderzoek vereenvoudigen naar 
bijvoorbeeld prognostische modellen voor de cumulatieve kans op een levendgeboren 
kind na opeenvolgende IVF-behandelingen en naar modellen om de kans op ongunstige 
zwangerschapsuitkomsten te voorspellen. Het is noodzakelijk dat bestaande en nog te 
ontwikkelen varianten van IVF-behandelingen geëvalueerd worden op zowel hun 
effectiviteit als op de ontwikkeling van de nakomelingen, teneinde rationele toepassing 
mogelijk te maken. 
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Stellingen 
behorende bij het proefschrift: 
Human fecundity under natural conditions and during in vitro fertilization 
I 
Indien er geen sprake is van seizoenvariatie in de menselijke vruchtbaarheid, is hiervan 
geen seizoenvariatie in aangeboren afwijkingen te verwachten. 
(dit proefschrift) 
II 
Als de externe validiteit van een prognostisch model niet aangetoond is, moet expliciet 
vermeld worden dat dit model niet voor praktische doeleinden bruikbaar is. 
(dit proefschrift) 
III 
Een overkoepelende maat alleen is onvoldoende om de bruikbaarheid van een 
prognostisch model te beoordelen. 
(dit proefschrift) 
IV 
Het prognostisch vermogen moet niet in sensitiviteit en specificiteit uitgedrukt worden, 
maar in de predictieve waarde van een positieve of negatieve test, aangezien het niet 
gaat om het herkennen van ziekte maar om het voorspellen wie ziek wordt. 
(dit proefschrift) 
V 
De cumulatieve zwangerschapskans na opeenvolgende IVF-behandelingen neigt men te 
overschatten. 
(dit proefschrift) 
VI 
Wie weet diep te zijn, streeft naar helderheid; wie voor de menigte diep wil schijnen, 
streeft naar duisterheid. 
(F Nietzsche, De Vrolijke Wetenschap Amsterdam De Arbeiderspers, 1994) 
VII 
Reverence for what somebody said is a stultifying quality. 
(W Somerset Maugham, Of Human Bondage London Penguin Books, 1992) 
VIII 
Wie gelooft, behoeft geen feiten. 
IX 
Zwangerschaps- en ouderschapsverlof werken bij tijdelijke arbeidscontracten niet 
emanciperend, maar discriminerend. 
X 
Seizoenen laten zien dat er meer is onder de zon. 
Nijmegen, 6 februari 1997 A.M. Stolwijk 


